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ABSTRACT
Innervation is an important regulator of neuromuscular development. At the
neuromuscular junction (NMJ), localized factors released from the motoneuron terminal
concentrate acetylcholine receptors (AChRs) in the postsynaptic membrane by inducing
the redistribution of existing AChRs to the synaptic site and by locally activating AChR
gene transcription in subsynaptic myofiber nuclei. At the same time, nerve-evoked
electrical activity represses AChR gene expression in nuclei throughout the myofiber. In
addition to AChRs, nearly two dozen other proteins accumulate in the postsynaptic
membrane of the vertebrate NMJ, including the 43 kDa protein (rapsyn). The 43 kDa
protein is a peripheral membrane protein expressed in a 1:1 stoichiometry with AChRs.
Results from 43 kDa protein-mutant mice and in QT6 cells in culture demonstrate that the
43 kDa protein plays a critical role in the accumulation of AChRs at the NMJ. The first
part of this thesis describes a primary muscle culture system I developed to identify
sequences within the 43 kDa protein that are required for its association with the plasma
membrane and with AChR clusters. I show that myristoylation is required for the 43 kDa
protein to associate with AChR clusters in primary myotubes. Moreover, the amino-
terminal half of the protein is insufficient to direct association of 43 kDa protein with
AChR clusters. Importantly, I also show that cell types differ in their ability to cluster 43
kDa protein at the cell surface; whereas cell surface clusters of 43 kDa protein form
readily in QT6 cells, such clusters form only occasionally in myoblasts and NIH3T3
fibroblasts. In addition to these studies, I also present strong evidence that dystrophin is a
component of the subsynaptic membrane in Torpedo electrocytes.
Electrical activity is required for the regulation and maintenance of adult muscle
physiology. To further understand the role of innervation in neuromuscular physiology
and gene expression, we used a subtractive-hybridization and cloning approach to
identify genes that are expressed differentially in innervated and denervated rat skeletal
muscle. Studies in the second part of this thesis describe the partial characterization of
three novel genes we identified using this technique: INN], DEN], and DEN2. We show
that INN] encodes three transcripts, all of which are differentially regulated by
innervation; expression of the major transcripts decreases following denervation, whereas
the expression of the two minor transcripts increases. These data suggest that alternative
splicing of INN] is differentially regulated by innervation. Antibodies against INN1 react
with a 22 kDa protein in skeletal muscle, and immunofluorescence studies indicate that
INN 1 may be a component of the sarcoplasmic reticulum. INN] is preferentially
expressed in brain, heart, and skeletal muscle, and these results suggest that INN1 may
have a role in the responsiveness of these tissues to electrical activity. Expression of the
other two genes, DEN] and DEN2, is up-regulated following denervation. DEN] encodes
a protein containing repeated motifs characteristic of muscle structural proteins such as
titin, whereas DEN2 encodes a protein with homology to aB-crystallin and a family of
small heat shock proteins. In addition, we found that expression of the acute myeloid
leukemia gene (AML1) increases dramatically following denervation. Since AML1 is a
transcription factor, it may play a role in regulating the expression of other muscle genes
following denervation.
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Chapter 1.
General Introduction
Introduction
Synapses are highly specialized structures designed for the transfer of signals from
neurons to their targets. During synaptic transmission, electrical potentials are converted
into chemical signals in the presynaptic nerve terminals and back to electrical potentials
in the postsynaptic cell. The ability of neurons to affect this conversion rapidly and
reproducibly is fundamental to the overall function of the nervous system. In addition,
certain aspects of learning and memory are thought to rely on modulation of synaptic
signaling, and such modulation is thought to occur through changes in synaptic
biochemistry. Accordingly, understanding how synapses are formed and are regulated
have become central themes in understanding how the nervous system works.
Much of what is currently known regarding synaptic structure and development has
come through the study of the vertebrate neuromuscular junction (NMJ), the site of
motoneuron-muscle contact. Although only one of cells at the NMJ is a neuron, the
NMJ's relatively large size, accessibility, and amenability to both in vivo and in vitro
manipulation have established it as a model system for understanding synaptogenesis in
the central nervous system (for reviews, see Bloch and Pumplin, 1988; Hall and Sanes,
1993).
Structure of the NMJ
Skeletal muscles are innervated by motoneurons whose cell bodies reside in the
spinal cord. Thus, motor axons must travel relatively long distances to reach their targets.
Upon reaching the muscle, the motor axon branches to innervate up to several hundred
individual muscle fibers. These axonal branches themselves branch upon reaching their
target muscle fibers, producing a fine spray of terminal branches. Unlike the rest of the
axon, the nerve terminals are not myelinated. Instead, each branch of the terminal is
capped by Schwann cell processes, leaving the apposed surfaces of the pre- and
postsynaptic membranes in close proximity.
Electron micrographs of the NMJ show that both the presynaptic nerve terminal and
postsynaptic muscle membrane are highly differentiated (Engel, 1986; Ogata, 1988).
Within the nerve terminals are found large numbers of 50 nm vesicles which contain the
neurotransmitter, acetylcholine (ACh). Many of these synaptic vesicles are clustered
adjacent to electron dense structures called active zones on the cytoplasmic side of the
presynaptic membrane. During synaptic transmission, synaptic vesicles fuse with the
presynaptic membrane at these active zones and release their complement of ACh into the
50 nm wide synaptic cleft which separates the pre- and postsynaptic membranes (Heuser
and Reese, 1981; Pecot-Dechavassin, 1982). Also found in nerve terminals are large,
dense-core vesicles that are thought to contain neuropeptides, including the calcitonin
gene-related peptide (CGRP) (Matteoli et al., 1988; 1990). Mitochondria are also very
abundant in nerve terminals, providing the energy required for neurotransmitter synthesis
and release and for vesicle membrane recycling.
Motoneuron terminals lie within shallow gutters on the surface of the muscle fiber.
Directly underneath the nerve terminals, the postsynapatic membrane is more deeply
folded, forming up to 1 gim deep invaginations into the myofiber. These junctional folds
are arranged such that the mouth of the folds are in precise register with the active zones
in presynaptic membrane. The crests of the junctional folds appear thickened, and these
thickened regions correspond to the location of acetylcholine receptors (AChRs) (Fertuck
and Salpeter, 1974; Daniels and Vogel, 1975; Matthews-Bellinger and Salpeter, 1978).
The density of myofiber nuclei is slightly higher under the synapse (Kelly and Zacks,
1969), and the Golgi apparatus surrounding synaptic nuclei are morphologically distinct
from those in nonsynaptic regions of the muscle fiber (Jasmin et al., 1989; 1995).
Moreover, synaptic nuclei are transcriptionally distinct from extrasynaptic nuclei, such
that in innervated muscle, synaptic nuclei selectively transcribe genes encoding synaptic
proteins (discussed below).
Lining the synaptic cleft and extending into the troughs between junctional folds is
the synaptic basal lamina. Although contiguous with the basal lamina which surrounds
the rest of the myofiber, the synaptic basal lamina is biochemically distinct from it.
Acetylcholinesterase (AChE), which hydrolyzes and inactivates ACh, is concentrated
within the synaptic basal lamina (McMahan et al., 1978), as are a3, a4, and a5 chains of
collagen IV (Sanes et al., 1990; Miner and Sanes, 1994), laminin P2 (s-laminin), a
synaptic form of the laminin p-chain which is thought to be important for nerve terminal
differentiation (Hunter et al., 1989; Noakes et al., 1995), and factors that regulate post-
synaptic development (discussed below).
Molecular components of the NMJ
Because the NMJ comprises only a small fraction (> 0.1%) of the muscle fiber,
neurobiologists have had to rely on indirect means to identify molecular components of
the NMJ. The most important source for the direct purification of synaptic molecules has
been the electric organ of Torpedo, a genus of marine ray. Derived from myotube
precursor cells, the electrocytes of the electric organ are innervated by cholinergic
neurons over a majority of their ventral surface; therefore, electromotor synapses
comprise a significantly large portion of electric tissue membranes, making the tissue a
rich source of synaptic molecules. For example, AChRs are -1000-fold more abundant
in the electric organ than in adult muscle. In addition to the electric organ, preparations
of synaptosomal membranes from the central nervous system have also permitted the
identification of synaptic proteins, particularly those associated with active zones in the
presynaptic nerve terminal. Finally, immunocytochemistry using antibodies raised
against proteins purified from other tissues has also contributed to our understanding of
the molecular components of the synapse.
At present, nearly four dozen different molecules have been identified which are
concentrated at the NMJ; nine concentrated in the presynaptic nerve terminal, eight in the
synaptic basal lamina, and roughly two dozen in the postsynaptic muscle fiber (see Hall
and Sanes, 1993 - Table 1). In the presynaptic nerve terminals, many components of
synaptic vesicles have now been identified, including synaptophysin and synapsin (Torri-
Tarelli et al., 1990), which may mediate synaptic vesicle transport to active zones via
interactions with cytoskeletal proteins (Stidhof and Jahn, 1991), and synaptotagmin
(Bixby and Reichardt, 1985), which is important for synaptic vesicle docking and fusion
with the presynaptic membrane (DeBello et al., 1993). Components of active zones have
also been identified, and these include voltage-gated calcium (Ca 2+) channels (Cohen et
al., 1991), syntaxin, a putative vesicle docking protein (Bennett et al., 1992), and a-
latrotoxin receptor/neurexin, which has also been implicated in synaptic vesicle
exocytosis (Valtorta et al., 1984; Ushkaryov et al., 1992). As the list of presynaptic
proteins grows, it has become increasingly clear that the mechanisms mediating synaptic
vesicle exocytosis are strikingly similar biochemically to those which mediate exocytosis
in other cell types (for reviews, see Pevsner and Scheller, 1994; Sollner and Rothman,
1994).
In muscle fibers, the postsynaptic membrane is biochemically different from
extrasynaptic regions of the sarcolemma. Further, the apical crests of the junctional folds
are biochemically distinct from the trough regions between the folds. For example,
AChRs are concentrated in the apical surfaces of the postjunctional folds, while voltage-
gated sodium channels are limited to the troughs (Flucher and Daniels, 1989). Several
cytoskeletal elements are also restricted to specific domains of the junctional folds. Both
a 43 kilodalton (kDa) protein (rapsyn) (Sealock et al., 1984), and utrophin (dystrophin-
related protein) (Bewick et al., 1992) are localized specifically with AChRs at the crests.
In contrast, ankyrin is concentrated in the trough membranes (Flucher and Daniels, 1989).
a7A and a7B integrins are also expressed specifically at the NMJ, but whether their
distributions are further restricted to either the tops or the bottoms of the folds remains
unknown (Martin et al., 1996). Other transmembrane proteins including N-CAM
(Covault and Sanes, 1986), 131 integrin (Bozyczko et al., 1989), components of the
dystrophin glycoprotein complex (DGC) (Ohlendieck et al., 1991; Peters et al. 1994), and
over a dozen cytoskeletal proteins, including vinculin and filamin (Bloch and Hall, 1983),
talin (Sealock et al., 1986), dystrophin (Sealock et al., 1991; Yeadon et al., 1991), and B-
spectrin (Bloch and Morrow, 1989) are also concentrated in, although not limited to, the
postsynaptic membrane.
AChRs
The AChR was the first ligand-gated ion channel to be purified, and remains the
most thoroughly understood neurotransmitter receptor both biochemically and
structurally. The AChR is a pentameric protein comprised of four distinct, yet
homologous subunits, a, P, 8, and y, which range in molecular mass from 40 to 65 kDa.
The five subunits of the pentamer form a central cation-conducting channel which opens
in response to ACh binding to the a-subunit (Weill et al., 1974; Karlin et al., 1983). The
stoichiometry of subunits within the AChR pentamer is a2 8P6y in both Torpedo
electrocytes and vertebrate fetal muscle (Raftery et al., 1980); however, at mature
vertebrate synapses, the y-subunit is replaced with a fifth subunit, e, resulting in channels
with greater conductances and shorter mean open times (Mishina et al., 1986; Gu and
Hall, 1988).
Oligonucleotides based on the protein sequences from purified AChR subunits were
used to isolate cDNAs encoding the a, P, 8, and y subunits from Torpedo (Noda et al.,
1983). Subsequently, mammalian homologs for each subunit, including the e subunit,
which is not expressed in Torpedo, were also cloned (Mishina et al., 1986; Takai et al.,
1985). To confirm that the cloned subunits could form a functional AChR channel,
synthetic RNAs transcribed in vitro from the cloned AChR subunit cDNAs were injected
into Xenopus oocytes to express the proteins. Electrophysiological measurements of the
expressed AChRs confirmed that four subunits were required for expression of functional
channels, and that substitution of E for y results in expression of channels with
characteristics of adult AChRs (Mishina et al., 1984; 1986). Comparisons between the
deduced protein sequences of the AChR subunits reveal a high degree of similarity
between them, which suggests that the genes encoding the AChR subunits evolved from a
single ancestral gene (Noda et al., 1983).
Interactions between AChRs and the subsynaptic cytoskeleton
AChRs are concentrated to a density of roughly 10,000/gm 2 at the apices of the
junctional folds, whereas in the troughs, the density of AChRs falls to >1,000/gm 2
(Fertuck and Salpeter, 1976; Salpeter and Harris, 1983). In extrasynaptic regions of the
innervated myofiber, there are fewer than 10 AChRs/igm 2 (Fertuck and Salpeter, 1976;
Salpeter et al., 1988). As mentioned above, many cytoskeletal elements are concentrated
at the postsynaptic membrane, and electron microscopic and deep-etch rotary shading
studies of the NMJ show that a meshwork of thin fibers directly underlies AChR domains
(Ellisman et al., 1976; Heuser and Salpeter, 1979; Hirokawa and Heuser, 1982). In
addition, alkaline treatment of AChR-enriched membranes, which removes membrane-
associated cytoskeletal elements (Neubig et al., 1979), increases the mobility of AChRs
within the plane of the membrane (Lo et al., 1980; Rousselet et al., 1982) and disrupts
AChR organization (Barrantes et al., 1980; Cartaud et al., 1981; Bloch and Froehner,
1987). Together, these observations suggest that AChRs are restricted to the postsynaptic
membrane, in part, by interactions with the underlying postsynaptic cytoskeleton.
A crucial link between the AChR and the subsynaptic cytoskeleton appears to be
the 43 kDa protein. Purified originally from AChR-enriched membranes of the
electrocyte, the 43 kDa protein is a peripheral membrane protein found on the
cytoplasmic face of the postsynaptic membrane (Sobel et al., 1977; Wennogle and
Changeux, 1980; St. John et al., 1982). Immunocytochemistry shows that the 43 kDa
protein precisely colocalizes with AChRs in both the electrocyte and the vertebrate NMJ,
and at AChR clusters on muscle cells in culture (Froehner et al., 1981; Sealock et al.,
1984; Burden, 1985; Flucher and Daniels, 1989). Moreover, the 43 kDa protein and
AChRs are present at approximately equimolar concentrations in the postsynaptic
membrane (Burden et al., 1983; LaRochelle and Froehner, 1986).
Direct biochemical evidence demonstrating interaction between the 43 kDa protein
and the AChR is lacking, but a number of studies suggest that such interactions occur.
First, 43 kDa protein is one of the proteins extracted from AChR-enriched membrane
domains by alkaline and LiS treatments which alter AChR mobility and organization
within the membrane (Neubig et al., 1979). Second, electron microscopy and X-ray
diffraction studies suggest that the 43 kDa protein lies in close proximity to the AChR
(Mitra et al., 1989). Third, studies have demonstrated that 43 kDa protein can be cross-
linked to the AChR p-subunit (Burden et al., 1983). Fourth, AChRs fail to concentrate at
the NMJs of 43 kDa protein-deficient mice, and muscle cell cultures derived from these
mutant mice also fail to cluster AChRs in response to the AChR clustering factor, agrin
(Gautam et al., 1995). Finally, co-expression of 43 kDa protein with AChRs in non-
muscle cells can promote AChR clustering (Froehner et al., 1990; Phillips et al., 1991;
Brennan et al., 1992). These studies showed that whereas AChRs are distributed
diffusely in the plasma membrane of cells transfected with AChR expression plasmids,
co-expression of 43 kDa protein and AChRs results in the clustering of both molecules in
the plasma membrane. Interestingly, when 43 kDa protein is expressed in the absence of
AChR in these non-muscle cells, it is clustered on the cell surface. Although these
experiments suggest that 43 kDa protein can self-organize, the 43 kDa protein may not be
sufficient to direct 43 kDa protein and AChR clustering. Myoblasts and myotubes in
culture express nearly equivalent levels of 43 kDa protein (Frail et al., 1989), but the 43
kDa protein clusters only in myotubes. Thus, clustering of the 43 kDa protein is
regulated during myogenesis. These results also raise the possibility that the mechanisms
responsible for 43 kDa protein/AChR clustering in muscle cells may differ from the
mechanisms mediating clustering of the transfected 43 kDa protein in the non-muscle
systems mentioned above. Understanding the relationship between 43 kDa protein
clustering mechanisms in muscle and non-muscle cells is important in order to interpret
results using non-muscle systems to dissect functional domains of the 43 kDa protein
important for AChR clustering. In Chapter 2 of this thesis, I describe a primary muscle
culture system which I developed in collaboration with Emma Dutton, a postdoctoral
fellow in the lab, which allowed us to begin to identify sequences in the 43 kDa protein
that are required for association of 43 kDa protein with the cell surface and with AChR
clusters in myotubes.
The spectrin-based cytoskeleton of the erythrocyte is often cited as a model for
understanding the skeleton of specialized cells. In the erythrocyte, spectrin tetramers and
short actin oligomers are linked in a lattice-like meshwork, and are tethered to an anion
transporter in the plasma membrane via ankyrin (Bennett, 1985). Such an actin/spectrin
cytoskeleton also underlies AChR domains in the postsynaptic membranes. Both P-
spectrin and non-filamentous actin are colocalized with AChRs in the postsynaptic
membrane and at substrate-attached AChR clusters in rat myotubes in culture (Hall et al.,
1981; Bloch, 1986; Bloch and Morrow, 1989), and quick-freeze, deep-etch, rotary-
shadowing electron microscopy of in vitro AChR clusters reveals a polygonal lattice on
the cytoplasmic surface of AChR membrane domains that is similar to that of the
erythrocyte submembrane skeleton (Pumplin, 1989). Further, when actin alone or actin
and p-spectrin together are selectively extracted from isolated, substrate-attached AChR
clusters, the organization of the AChR clusters is disrupted (Bloch, 1986; Bloch and
Morrow, 1989). These results suggest that actin and P-spectrin are necessary to maintain
the integrity of these in vitro AChR clusters.
In addition to actin and P-spectrin, dystrophin and the dystrophin-related protein,
utrophin, may have roles in organizing the postsynaptic membrane. Both dystrophin and
utrophin are large (-400 kDa), filamentous proteins. Both proteins have central rod-like
domains comprised of spectrin-like coiled-coil repeats (Koenig et al., 1988; Tinsley et al.,
1992) and amino-terminal actin-binding domains (Hemmings et al., 1992; Winder et al.,
1995). As described in Chapter 3 of this thesis, dystrophin is expressed in Torpedo
electrocytes, where it is localized to the postsynaptic membrane, and is concentrated at
vertebrate NMJs and at AChR clusters in rat myotubes in culture (see also Chang et al.,
1989; Jasmin et al., 1990; Sealock et al., 1991). Further, ultrastructural studies show that
dystrophin is incorporated into the spectrin-rich cytoskeleton underlying AChR clusters
in rat myotubes (Dmytrenko et al., 1993), and is also present in the postsynaptic
membranes of cortical neurons in the CNS (Lidov et al., 1990). Like, dystrophin,
utrophin is concentrated at the vertebrate NMJ and at AChR clusters in rat myotubes
(Ohlendieck et al., 1991; Phillips et al., 1993); however, whereas dystrophin is also
associated with the extrajunctional sarcolemma in adult muscle, utrophin is limited to the
NMJ. Moreover, high resolution light microscopy of rat NMJs suggests that utrophin is
colocalized with AChRs at the crests of the junctional folds, where as dystrophin is more
concentrated in the troughs (Sealock et al., 1991; Byers et al., 1991; Bewick et al, 1992).
These data suggest that utrophin has a specific role in organizing AChRs in the
postsynaptic membrane, while dystrophin may be important in organizing molecules,
such as sodium channels, in the troughs.
Dystrophin is attached to the sarcolemma via interactions between its carboxy-
terminal region and a group of membrane glycoproteins termed the dystrophin
glycoprotein complex (DGC) (Campbell and Kahl, 1989; Ervasti et al., 1990; Suzuki et
al., 1994). Like dystrophin, these proteins are concentrated at, but are not restricted to,
the NMJ (Ohlendieck et al., 1991; Bewick et al., 1992; Matsumura et al., 1992).
Utrophin has been shown to interact with a complex of sarcolemmal proteins identical to,
or at least antigenically similar to, components of the DGC (Matsumura et al., 1992), and
at least one dystrophin associated protein, p2-syntrophin, is selectively localized to the
postsynaptic membrane (Peters et al., 1994). Recently, a-dystroglycan, one of the
components of the dystrophin glycoprotein complex, has been shown to bind the
extracellular matrix molecules laminin and merosin (Ibraghimov-Beskrovnaya et al.,
1992; Ervasti and Campbell, 1993), as well as agrin, an extracellular matrix protein
which induces AChR clustering in myotubes in culture (see below) (Bowe et al., 1994;
Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al., 1994). In addition, a-
dystroglycan is also colocalized with 43 kDa protein in the cell membrane of transfected
quail fibroblasts when the two proteins are co-expressed (Apel et al., 1995). These
results suggest that dystrophin, utrophin, and the dystrophin glycoprotein complex are
important links connecting the extracellular matrix to the cytoskeleton, and may have
crucial regulatory roles in organizing the postsynaptic membrane.
Formation of the NM.T
The neuromuscular junction develops through multiple stages over a long period of
time. For example, in the developing rat, the period of neuromuscular synaptogenesis
lasts from approximately one week before birth (embryonic days 13-14) through the end
of the second postnatal week (Kelly and Zacks, 1976; Dennis et al., 1981). The steps in
NMJ formation are similar in mammals, chick, and frog, although each species displays
variations in the timing of the developmental events and the final structure of the
developing synapse.
Early nerve-muscle contact
Muscle differentiation occurs concomitantly with motoneuron outgrowth.
Motoneuron axons reach the differentiating mesenchymal tissues at roughly the same
time as myoblast precursors are fusing to from multinucleated myotubes (rat embryonic
day 13-14; chick embryonic stage 24). Although nerve and muscle membranes are in
close proximity at this stage, their apposed membranes remain unspecialized, and the
space between them lacks a defined basal lamina (Kelly and Zacks, 1976). Nevertheless,
these rudimentary synapses are functional, since miniature endplate potentials are
detected in the embryonic muscle at the earliest stages of nerve-muscle contact (Diamond
and Miledi, 1962; Kullberg et al., 1977; Dennis et al., 1981). Synaptic vesicles are
scattered in the nerve terminal, but, active zones are not distinguishable in the early
presynaptic membrane. Taken together, these observations suggest that quantal release of
ACh does not require fully differentiated active zones.
In the developing muscle, expression of AChRs begins at the onset of myotube
differentiation. Studies using radiolabelled a-bungarotoxin (a-BGT ), which binds tightly
to the AChR a-subunit, reveal that AChRs are distributed diffusely and uniformly over
the surface of the muscle fiber, reaching a density of 100-200/gm 2 (Bevan and
Steinbach, 1977). Beginning at embryonic day 15 (E 15) in the rat, clusters of AChRs
appear in the postsynaptic region (Bevan and Steinbach, 1977; Braithwaite and Harris,
1979), eventually coalescing into a more uniform 'plaque' (Steinbach, 1981; Slater,
1982a). Concomitant with the onset of AChR clustering, the amplitude of miniature
endplate potentials and the rate of rise of endplate potentials increase (Dennis et al., 1981;
Harris, 1981 b; Ziskind-Conhaim and Dennis, 1981). In addition, elements of the synaptic
basal lamina begin to accumulate at E15 (Chiu and Sanes, 1984), followed a day later by
the accumulation of AChE (Bennett and Pettigrew, 1974; Bevan and Steinbach, 1977;
Harris, 1981a; Chiu and Sanes, 1984).
Between E16 and birth, myofibers become innervated by multiple motoneurons at
the same synaptic site (Redfern, 1970; Bennett and Pettigrew, 1974; Brown et al., 1976).
The density of AChR in the postsynaptic membrane approaches that in the adult synaptic
membrane (-10,000/gm2) (Matthews-Bellinger and Salpeter, 1983), whereas the number
of AChRs in the extrasynaptic membrane declines to < 10/gm 2 (Bevan and Steinbach,
1977). Similarly, the level of AChE in the synaptic basal lamina increases, and its
distribution comes to approximate more closely the boundaries of the nerve terminal
(Harris, 198 1b; Steinbach, 1981). The decrease in extrajunctional AChR expression is
due primarily to the repression of AChR subunit gene transcription in extrasynaptic
nuclei, and is regulated by nerve-stimulated electrical activity (discussed below).
Postnatal synapse maturation
The final stages of NMJ maturation occur postnatally, concluding 2-3 weeks after
birth. Thereafter, the NMJ continues to enlarge in proportion to the overall growth of the
muscle fiber (Steinbach, 1981; Slater, 1982a; Matthews-Bellinger and Salpeter, 1983).
Beginning just prior to birth and continuing in the postnatal period, junctional AChRs
stabilize. In both embryonic and fetal rat muscle, the half-life of AChRs is -1 day
(Reiness and Weinberg, 1981), but beginning at E18, the half-life of junctional AChRs
increases to -10 days . In contrast, the half-life of extrajunctional AChRs remains
unchanged (Berg and Hall, 1975b; Steinbach et al., 1979; Reiness and Weinberg, 1981;
Steinbach, 1981). In chick muscle, a similar increase in the stability of junctional AChRs
occurs, but not until -3 weeks after hatching (Burden, 1977b). This change in the
stability of junctional AChRs is regulated by innervation-induced electrical activity, since
the half-life of junctional AChRs decreases following denervation or blockade of synaptic
transmission with tetrodotoxin (TTX) (Loring and Salpeter, 1980; Bevan and Steinbach,
1983; Fumagalli et al., 1990). Concurrent with the increase in their metabolic stability,
junctional AChR aggregates also become resistant to dissociation induced by denervation
(Slater, 1982b), low Ca2+, high KC1, or the AChR agonist, carbachol (Bloch and
Steinbach, 1981). Treatment of isolated muscle fibers with collagenase also disrupts
junctional AChR clusters and accelerates the turnover of the AChRs (Bloch et al., 1986).
Since the synaptic basal lamina increases in biochemical complexity during the postnatal
period (Chiu and Sanes, 1985), these data suggest that the resistance of synaptic AChRs
to dispersing treatments may be due to increased direct or indirect interactions with basal
lamina components.
The channel properties of the junctional AChRs also change during the perinatal
period, as junctional AChRs acquire a greater conductance and a shorter mean open time
(Sakmann and Brenner, 1978; Fischbach and Schuetze, 1980; Michler and Sakmann,
1980). As noted above, this change stems from the expression of the AChR e-subunit and
its substitution for the y-subunit in newly synthesized AChR pentamers (Mishina et al.,
1986; Schuetze and Role, 1987; Gu and Hall, 1988). The initial induction of adult (e-
type) AChRs is nerve-dependent, and requires both electrical activity- and motoneuron-
derived factors (Brenner and Sakmann, 1983; Brenner et al., 1987; Martinou and Merlie,
1991). Once established, however, the continued AChR E-subunit expression becomes
both activity- and nerve-independent (Brenner et al., 1990; Martinou and Merlie, 1991),
and signaling molecules associated with the synaptic basal lamina are sufficient to
stimulate AChR e-subunit mRNA in synaptic nuclei (see below).
Junctional folds begin differentiating after the first postnatal week, and the AChR
aggregates become restricted to the crests of these folds (Matthews-Bellinger and
Salpeter, 1983). At the same time, the number of synaptic inputs each muscle fiber
receives is reduced until each muscle fiber is innervated by only a single motoneuron
(Redfern, 1970; Brown et al., 1976; Slater, 1982a). This reduction in the number of
innervating motoneurons is called synapse elimination.
Synapse elimination
Synapse elimination at the NMJ is thought to result from competition between the
innervating motoneurons (for review, see Coleman and Lichtman, 1993), but the
biochemical nature of this competition remains unclear. Evidence suggests that muscle
activity influences some aspects of this competition. In both developing chick and rat
muscle, blocking synaptic transmission using pharmacological agents such as curare,
botulinum toxin, TTX, or a-BGT prevents synapse elimination (Srihari and Vrbova,
1978; Thompson et al., 1979; Brown et al., 1981; Duxson, 1982; Ding et al., 1983). In
contrast, direct electrical stimulation of postnatal rat muscle accelerates the rate at which
polyneuronal innervation is lost (O'Brien et al., 1978).
Direct observations of developing NMJs undergoing synapse elimination in vivo
also support the idea that the postsynaptic muscle plays an active role in synaptic
competition (Balice-Gordon and Lichtman, 1993). In this study, the developing
presynaptic nerve terminals and the postsynaptic AChRs were visualized with the
mitochondrial dye 4-Di-2-ASP and rhodamine-conjugated a-bungarotoxin, respectively.
Observations of the same NMJ made over several days showed that in synapses destined
for elimination, AChRs are lost from the postsynaptic membrane prior to obvious
changes in the overlying nerve terminal. A similar early loss of AChRs beneath nerve
terminals is also seen during synapse elimination in denervated/reinnervated adult
muscle, a process which mimics synapse elimination during development (Rich and
Lichtman, 1989). These data suggest that changes in the postsynaptic membrane may
trigger the removal of the overlying nerve terminals; these data do not preclude the
possibility, however, that presynaptic changes occur prior to the loss of postsynaptic
AChR.
One attractive model to explain the role of muscle activity in synaptic competition
is a Hebbian mechanism in which synchronous depolarization of the nerve terminal and
the muscle stabilizes, whereas asynchronous depolarization of the two destabilizes their
synaptic connection. Evidence in support of such a model has come from in vitro studies
using Xenopus myocytes and spinal neurons in coculture (Lo and Poo, 1991; Dan and
Poo, 1992). In these experiments, synaptic potentials in myocytes were measured after
stimulating each of two innervating neurons. One neuron was then given a tetanic
stimulus, and the synaptic potentials elicited by each neuron were re-measured. These
experiments showed that tetanic stimulus of the one neuron induces a rapid and
prolonged suppression of the synaptic response generated by the unstimulated neuron.
Further, asynchronous stimulation of the two neurons results in the repression of one or
both of their synaptic responses, whereas synchronously applied tetanic stimuli to both
neurons produces little effect. In singly innervated myocytes, repeated application of
ACh to the synaptic site in the absence of nerve stimulation or asynchronously with
stimulation also results in synaptic suppression, whereas synchronous application of ACh
with stimulation does not. Thus, muscle stimulation is sufficient to produce synaptic
suppression in the absence of a competing neuron. Quantal analysis indicates that the
synaptic suppression induced in all of these experiments results from a reduction in the
amount of ACh released by the stimulated nerve, rather than changes in the
responsiveness of the myocyte. Interestingly, preloading the myocyte with BAPTA,
which buffers changes in cytosolic Ca 2+, prevents the synaptic suppression seen in these
studies. These data argue that synaptic repression is mediated by a short-lived retrograde
signal released by muscle in response to increases in intracellular Ca2+ which follow
AChR activation.
One candidate retrograde signaling molecule is nitric oxide (NO). NO is a free
radical implicated in several forms of synaptic plasticity in the CNS (for review, see
Schuman and Madison, 1994), and recent studies have shown that NO donors can
suppress evoked synaptic currents in Xenopus nerve and myocyte cocultures (Wang et al.,
1995). Further, synaptic suppression induced by asynchronous pre- and postsynaptic
depolarization is prevented by bathing the cultures in the NO-binding protein
hemoglobin, or in inhibitors of NO synthase. These studies suggest that NO released
from the postsynaptic muscle following nerve-evoked depolarization may induce the
suppression of competing synaptic inputs. Interestingly, an isoform of NO synthase is
expressed in fast skeletal muscle (Kobzik et al., 1994) and associates with the
sarcolemma via interactions with al-syntrophin, a component of the DGC (Brenman et
al., 1996). Moreover, immunofluorescence studies using antibodies raised against NO
synthase show that NO synthase, like dystrophin, is enriched at, although is not restricted
to, the NMJ (Brenman et al., 1996). Thus, NO synthase is placed appropriately for NO to
act as a retrograde signal in modulating NMJ development. The relationship between
synaptic suppression and synaptic competition, however, is unclear. Since the effects of
synaptic suppression on the morphological characteristics of the individual synapses were
not examined in the in vitro synaptic suppression experiments described above, it is not
known whether the induced suppression ultimately leads to synapse elimination.
Trophic factors have also been proposed as retrograde mediators of synaptic
competition. In this scenario, trophic factors released from the stimulated muscle
stabilize the stimulating nerve terminal by promoting its survival. Indeed, one recent
study demonstrated that exogenous application of ciliary neurotrophic factor (CNTF) or
basic fibroblast growth factor (bFGF) near developing neuromuscular synapses extends
the period of polyneuronal innervation in rats (English and Schwartz, 1995). Although
mice which lack a functional CNTF gene appear normal with respect to the number and
morphology of motoneurons during the period of synapse elimination (Masu et al., 1993),
studies of individual synapses were not reported. Thus, it remains unknown whether
either of these trophic factors have any role in synapse elimination in vivo .
Multiple mechanisms regulate AChR clustering at the NMJ
The appearance of AChR clusters in the postsynaptic muscle is one of first
morphological changes to occur during NMJ differentiation. As described above, the
concentration of AChRs beneath the nerve terminal reaches a density of -10,000/gm 2 in
adult muscle. In contrast, the density of AChRs in the extrasynaptic sarcolemma is
<10/gm2. How AChR clusters are formed and how their density is maintained in the
postsynaptic membrane has been the subject of intensive investigation, and it is now clear
that at least three independent mechanisms are involved (for review, see Jennings and
Burden, 1993; Hall and Sanes, 1993). First, pre-existing AChRs in the muscle membrane
are redistributed to the postsynaptic membrane following contact with the motoneuron.
This process is thought to be mediated by agrin, a component of the synaptic basal
lamina. Second, AChR gene transcription is induced in subsynaptic nuclei by a signal
released from the motoneuron. Finally, nerve-evoked electrical activity in the muscle
represses AChR expression in extrasynaptic nuclei. Each of these mechanisms is
described in greater detail below.
Agrin-mediated AChR clustering
Some of the earliest insights into the regulation of AChR clustering in muscle were
gained from studies of nerve and muscle cocultures in vitro. These studies took
advantage of the fact that AChR clusters form in myotubes cultured in the absence of
neurons (Fischbach and Cohen, 1973; Anderson et al., 1977) and showed that rather than
innervating sites of pre-existing AChR clusters, motoneurons induce the formation of
new AChR aggregates at the site of contact (Frank and Fischbach, 1979; Anderson and
Cohen, 1977). Further, prelabelling of AChRs prior to nerve contact revealed that the
new receptor clusters form, in part, from a redistribution of pre-existing AChRs on the
muscle surface (Anderson and Cohen, 1977; Ziskind-Conhaim et al., 1984). These
studies suggest that the motoneuron releases a localized factor that induces the
redistribution of pre-existing AChRs to the synaptic site.
Studies in regenerating frog muscle suggested that such a clustering factor is
deposited in the synaptic basal lamina (Burden et al., 1979; McMahan and Slater, 1984).
In these studies, muscles were damaged and allowed to regenerate in the absence of the
nerve. When muscle fibers degenerate, their cellular contents are engulfed and removed
by macrophages, but the basal lamina surrounding each muscle fiber remains intact.
Myoblast-like satellite cells which lie alongside the muscle fibers proliferate and
subsequently differentiate to regenerate a new myofiber within the former fiber's basal
lamina sheath. These studies showed that AChRs in the regenerated muscle reappear at
former synaptic sites even in the absence of the nerve, and this suggests that an AChR
clustering factor is locally deposited in the synaptic basal lamina.
The search for an AChR aggregating activity in synaptic basal lamina led to the
purification of agrin from the electric organ of Torpedo (Godfrey et al., 1984; Nitkin et
al., 1987). Agrin fits many of the requirements demanded of the AChR aggregating
factor active at developing NMJs. First, soluble agrin induces the aggregation of AChRs
in myotubes in culture by a post-translational mechanism without increasing receptor
number. Moreover, when applied locally, agrin induces the clustering of AChRs at the
site of application (Campanelli et al., 1991). Second, agrin immunoreactivity is
concentrated in the synaptic basal lamina of adult muscle (Reist et al., 1987). Third,
agrin proteins are expressed in motoneurons, and are transported anterogradely down
motor axons (Magill-Solc and McMahan, 1988; 1990). These results suggest strongly
that agrin mediates AChR clustering at developing NMJs in vivo. Surprisingly, agrin is
expressed by several other tissues, including skeletal muscle (Godfrey et al., 1988;
Godfrey, 1991; Rupp et al., 1991). Moreover, in chick, agrin immunoreactivity
associates with AChR clusters in aneural myotubes in vivo (Fallon and Gelfman, 1989),
and muscle-derived agrin is found at both nerve-induced and Torpedo agrin-induced
AChR clusters in vitro (Leith et al., 1992; Lieth and Fallon, 1993). These results raised
questions about the specificity of agrin in clustering AChRs at the NMJ during
development. Experiments in chimeric nerve-muscle cocultures, however, demonstrated
that the muscle form of agrin does not participate in nerve-induced AChR clustering
(Reist et al., 1992). Chick agrin-specific antibodies effectively block AChR clustering in
chick nerve/rat muscle cocultures; however, these same antibodies fail to prevent AChR
clustering when rat nerve and chick muscle are cocultured. These results demonstrate
that the neural form of agrin has the primary role in stimulating AChR clustering.
Agrin has been cloned from several species including Torpedo, rat, chick, and
mouse (Rupp et al., 1991, 1992; Tsim et al., 1992), and the deduced protein sequences
have multiple domains with similarity to those from several classes of proteins. The
amino-terminal half of the protein is comprised of nine domains with homology to
protease inhibitors, plus a domain homologous to the laminin domain III located between
the eighth and nine protease inhibitor domains. The carboxy-terminal half of agrin
contains three regions with similarity to laminin G domains interspersed between four
epidermal growth factor (EGF)-like repeats commonly found in signaling molecules.
The protease inhibitor and laminin III domains of the amino-terminal half of agrin are not
required for AChR clustering, since truncated proteins containing only the carboxy-
terminal half of the protein are as effective as full-length agrin at clustering AChRs (Tsim
et al., 1992; Ferns et al., 1993; Hoch et al, 1994; Gesemann et al., 1995). Specific
functions for the protease inhibitor and laminin III domains in agrin have not been
assigned, but it is worth noting that C-terminal fragments of agrin which lack these
domains are more soluble than the full-length protein (Ferns et al., 1993). Thus, it seems
likely that one or more of these amino-terminal domains may mediate agrin attachment to
the extracellular matrix or to the presynaptic nerve terminal.
Multiple isoforms of agrin are generated by alternative splicing at three distinct
sites, denoted x, y, and z, in the carboxy-terminal portion of the molecule (Rupp et al,
1991; Ruegg et al., 1992; Ferns et al., 1992). Whereas splicing at the y-site (4 a.a insert)
has only a modest affect on the biological activity of agrin, splicing at the z-site has a
profound affect (Ruegg et al., 1992; Tsim et al., 1992; Ferns et al., 1992, 1993). One or
both of two separate exons, encoding 8 and 11 a.a. respectively, may be included at the z-
site, giving inserts of 8, 11 and 19 a.a. Agrin isoforms containing either the 8 a.a. or the
11 a.a. exon can cluster AChRs in myotubes, but those containing the 8 a.a. exon (8 or 19
a.a.) are the most active, having -1000-fold greater activity than agrin which contains
neither insert (Ferns et al., 1993). Differences in the activity of agrin isoforms, however,
vary depending upon the conditions of the assay. For example, primary rat or mouse
C2C12 myotubes respond to all rat agrin isoforms, whereas chick myotubes only respond
to those containing the 8 or 11 a.a. exons at the z-site (Ferns et al., 1992, 1993). In these
assays, the agrin is presented to the myotubes on the surface of agrin expressing COS
cells. In contrast, when soluble chick agrin is used in similar assays, differences between
chick and C2C12 myotubes are not observed; neither respond to agrin which lacks z-site
inserts (Gesemann et al., 1995). These data suggests that the manner in which the lower
activity agrin isoforms are presented to the myotubes can affect their activity. The most
active agrin isoform, that which contains the 4 a.a. y-site insert and the 19 a.a z-site
insert, is only expressed in neural tissue (Ruegg et al., 1992; Hoch et al., 1993). In
skeletal muscle cells, only isoforms lacking inserts at the z-site are expressed. Although
the experiments with interspecies nerve and muscle cocultures suggest that muscle agrin
is neither required nor sufficient to initiate AChR clustering in vitro, the ability of these
isoforms to cluster AChRs in rat and C2C12 cells in the cell-attached agrin assay
suggests that they may function during synaptogenesis in vivo.
The biochemical mechanisms responsible for agrin-induced AChR clustering
remain largely uncharacterized; however, several studies indicate a role for
phosphorylation. For example, activation of protein kinase C with phorbol esters inhibits
agrin-induced AChR aggregation in chick myotubes (Wallace, 1988). Chick myotubes
transformed by infection with Rous sarcoma virus also fail to cluster AChRs either
spontaneously or in response to electric organ extracts, and these affects are dependent on
activation of the src tyrosine kinase (Anthony et al., 1984). These transformed myotubes
were subsequently shown to lack expression of tropomyosin 2, a cytoskeletal component
which is enriched at the NMJ, and microinjection of monoclonal antibodies against this
protein also inhibits the formation of AChR clusters (Anthony et al., 1988; Marazzi et al.,
1989). These data suggest a link between tyrosine phosphorylation, cytoskeletal proteins
and AChR clustering. Other evidence suggests that phosphorylation of the AChRs
themselves may be required. In both chick and C2 myotubes, agrin treatment results in
rapid tyrosine phosphorylation of the AChR p-subunit, and this increase in P-subunit
phosphorylation precedes agrin-induced AChR clustering (Wallace et al., 1991; Ferns et
al., 1996). Moreover, both herbimycin and staurosporine, two inhibitors of tyrosine
kinases, effectively block both agrin-induced tyrosine phosphorylation of the p-subunit
and agrin-induced AChR clustering (Wallace, 1994; Ferns et al., 1996). Since
herbimycin and staurosporine undoubtedly inhibit the phosphorylation of numerous
substrates, these studies do not address directly the role of AChR p-subunit
phosphorylation in receptor clustering. Further, phosphorylation of the AChR P-subunit
is not required for AChR clustering induced by co-expression of AChRs with the 43 kDa
protein in COS cells (Yu and Hall, 1994). Thus, the role of AChR phosphorylation in
AChR clustering remains unclear.
Proteoglycans have also been implicated in agrin-induced AChR clustering.
Heparin and heparan sulfate inhibit both nerve- and agrin-induced AChR clustering in
myotubes in culture (Hirano and Kidokoro, 1989; Wallace, 1990; Saito et al., 1993).
Further, genetic variants of C2 muscle cells which are deficient in proteoglycan synthesis
are significantly less responsive to exogenous agrin (Ferns et al., 1992, 1993). Treatment
of myotubes with p-N-acetylhexosaminidase, which removes N-acetylgalactosaminyl
(GalNAc)-terminated saccharides from proteins, or incubation with GalNAc-conjugated
bovine serum albumin (BSA) also inhibits clustering, suggesting that agrin-induced
AChR clustering involves a GalNAc-dependent step (Martin and Sanes, 1995).
Interestingly, heparan sulfate proteoglycans (HeSPs) also aggregate in response to
agrin (Wallace, 1989), even when aggregation of AChRs is blocked with treatment of
anti-AChR antibodies (Nitkin and Rothschild, 1990). Unlike agrin-induced AChR
clustering, agrin-induced HeSP clustering requires ongoing protein synthesis, and does
not occur through a redistribution of existing HeSPs (Wallace, 1989). These data suggest
that agrin may direct the clustering of synaptic molecules via multiple mechanisms;
however, agrin-induced HeSP clustering may also occur as a consequence of agrin-
induced redistribution of pre-existing HeSP binding proteins in a manner analogous to
agrin-induced redistribution of AChRs.
Recent efforts to identify the agrin receptor have suggested a role for a-
dystroglycan, a component of the dystrophin glycoprotein complex which links
dystrophin and utrophin to the sarcolemma. a-dystroglycan binds agrin with high affinity
and is the principal agrin binding protein in both muscle and electrocyte membranes
(Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al., 1994).
Moreover, a-dystroglycan is colocalized with AChRs at agrin-induced AChR clusters,
and, like agrin-induced clustering activity, agrin binding to a-dystroglycan is Ca 2+-
dependent, and can be inhibited by heparin (Wallace, 1988, 1990; Campanelli et al.,
1994; Gee et al., 1994). Despite these results, studies suggest that a-dystroglycan is not a
functional agrin receptor. First, attempts to use an anti-a-dystroglycan monoclonal
antibody, IIH6, to inhibit agrin-induced AChR clustering have produced conflicting
results; in one study, IIH6 completely blocked agrin-induced AChR clustering in C2
myotubes in a concentration-dependent manner (Gee et al., 1994), whereas in other
studies, IIH6 had little or no effect on agrin-induced AChR clusters (Campanelli et al.,
1994; Sugiyama et al., 1994). Second, treatment with p-N-acetylhexosaminidase does not
alter the eletrophoretic mobility of a-dystroglycan, nor do GalNAc-specific lectins bind
a-dystroglycan (Martin and Sanes, 1995). In addition, a carboxy-terminal agrin fragment
which retains some AChR clustering activity fails to bind a-dystroglycan in vitro , and
pretreatment of muscle cells with inactive agrin (0y, O0), which binds a-dystroglycan with
high affinity, does not prevent AChR clustering induced by active agrin (4 y, 8z)
(Gesemann et al., 1996). Finally, estimates of the concentration of agrin necessary for
half-maximal binding are over 100-fold greater than that necessary for half-maximal
clustering activity (Nitkin et al., 1987; Nastuk et al., 1991; Ma et al., 1993), and this
result suggests that agrin-induced clustering is amplified by downstream events. Since
neither a-dystroglycan nor other characterized proteins of the dystrophin glycoprotein
complex possess kinase domains common to receptors for signaling molecules, it is
unclear how agrin binding to a-dystroglycan would lead to amplification of the agrin
signal. Thus, it appears that agrin binding to a-dystroglycan is not sufficient to initiate
AChR clustering; however, a-dystroglycan may enhance agrin-induced AChR clustering
by providing additional agrin binding sites to increase the local concentration of agrin
molecules at the postsynaptic membrane.
Recent evidence suggests that MuSK, a muscle-specific kinase, is involved in agrin
signaling. MuSK is a transmembrane receptor tyrosine kinase with similarity to the trk
family of receptors. It is expressed very early during embryonic myogenesis, and in adult
rat muscle, MuSK becomes precisely colocalized with AChRs at the NMJ (Valenzuela et
al., 1995). MuSK homologues are also expressed in both Torpedo electric organ and
skeletal muscle (Jennings et al., 1993), and in muscle, MuSK expression is dramatically
induced throughout the myofiber following denervation (Valenzuela et al., 1995). A
critical role for MuSK in NMJ formation was revealed by the generation of MuSK-
deficient mice (DeChiara et al., 1996). These mice are generally immobile, fail to breathe
at birth, and subsequently die. An examination of the muscles from these MuSK-
deficient mice revealed a complete absence of NMJs. Indeed, no evidence of any
postsynaptic differentiation (e.g. AChR clusters, AChE deposits) could be found in these
muscles, and these data suggest that MuSK expression is essential for NMJ
differentiation in vivo. A similar, although slightly less severe phenotype is also seen in
mice which lack agrin (Gautam et al., 1996), and this suggests that MuSK is a component
of the agrin signaling pathway. Consistent with this idea, primary myotubes prepared
form MuSK-deficient muscle fail to cluster AChRs in response to agrin (Glass et al.,
1996). Further, studies in myotubes in culture show that MuSK is specifically and
rapidly tyrosine phosphorylated in response to active, but not inactive (no z-site
insertions) forms of agrin (Glass et al., 1996). On the other hand, agrin binding to the
extracellular domain of MuSK has not been detected, suggesting that MuSK does not
directly interact with agrin. Thus, MuSK may be part of a multi-component agrin
receptor analogous to receptors for bFGF (Yayon et al., 1991; Rapraeger et al., 1991),
CNTF (Davis et al., 1993; Stahl and Yancopoulos, 1993), and glial-cell-line-derived
neurotrophic factor (GDNF) (Jing et al., 1996; Treanor et al., 1996); in all three of these
examples, binding of ligand to non-kinase components of the receptor complex is
required for signal transduction. Consistent with this idea, binding of a soluble form of
the MuSK extracellular domain to the surface of myotubes occurs only if agrin is
included in the medium (Glass et al., 1996), suggesting that MuSK interacts with a
component on the myotube surface in the presence of agrin. Interestingly, agrin-
dependent MuSK binding in this assay only occurs on myotubes. Moreover, studies in
which mouse C2C12 myoblasts were transfected with a chicken MuSK expression
construct showed that agrin-induced phosphorylation of the chicken MuSK occurs only
following myotube differentiation (Glass et al., 1996). Thus, the factors required for
agrin-dependent MuSK binding and agrin-induced MuSK phosphorylation are regulated
during myogenesis. The identity of such myotube-specific MuSK activation factors
remains unknown, but a-dystroglycan is an unlikely candidate since it is expressed in
both myoblasts and myotubes.
Two other tyrosine kinases, fyn andfyk have been shown to coimmunoprecipitate
with AChRs in preparations of Torpedo electric organ membranes (Swope and Huganir,
1993). While neither protein has been implicated directly in AChR clustering or NMJ
formation, it is tempting to speculate that one of these molecules may mediate AChR
phosphorylation in response to agrin.
Local AChR synthesis and synapse-specific transcription
AChRs at mature NMJs are not stable. Throughout the life of the animal, junctional
AChRs continue to turnover, yet their density at the NMJ remains high (Berg and Hall,
1975b; Chang and Huang, 1975; Salpeter and Harris, 1983). These observations suggest
that local synthesis of AChRs in the synaptic region may contribute to the maintenance of
high AChR density at the NMJ. Indeed, both direct measurement of AChR RNA levels
from synapse-enriched and synapse-poor regions of muscle and in situ hybridization
studies show that the mRNAs encoding the AChR a, P, 8, and E subunits are more
abundant in synaptic than in extrasynaptic regions of the muscle fiber (Merlie and Sanes,
1985; Fontaine et al., 1988; Fontaine and Changeux, 1989; Goldman and Staple, 1989;
Brenner et al., 1990). Several mechanisms could account for this synaptic accumulation
of AChR mRNA. For example, AChR genes could be selectively transcribed in synaptic
nuclei. Alternatively, AChR genes could be transcribed in all myofiber nuclei, and the
mRNA subsequently transported to, or selectively stabilized in the synaptic region. To
distinguish between these alternatives, transgenic mice have been generated in which
regulatory regions of either the AChR 8 or e subunit genes control the expression of
reporter genes (Sanes et al., 1991; Simon et al., 1992). In both studies, the products of
the reporter genes accumulated near synaptic nuclei, whereas reporter gene products were
widely distributed when regulatory regions from other muscle specific genes (e.g. muscle
creatine kinase (MCK)) were used to direct their expression. These studies demonstrate
that selective transcription of AChR subunit genes in synaptic nuclei is responsible, at
least in part, for the accumulation of AChR mRNA at synaptic sites.
Like AChR clustering, stimulation of synaptic transcription depends on one or more
signals deposited in the synaptic basal lamina. This conclusion is the result of several
studies on the expression of either endogenous AChR or AChR promoter-controlled
reporter genes in muscles allowed to regenerated in the absence of innervation (Goldman
et al., 1991; Jo and Burden, 1992; Brenner et al., 1992). In each study, AChR mRNA or
reporter gene products reappeared in regions underneath former synaptic sites. Since in
the latter two of these studies Schwann cells and perisynaptic fibroblast-like cells were
destroyed in addition to the muscle, only signals associated with the synaptic basal
lamina could account for the induction of synaptic transcription.
Although it is associated with the synaptic basal lamina, agrin probably does not
mediate synapse-specific transcription, since treatment of myotubes in culture with crude
agrin preparations does not alter AChR metabolism (Godfrey et al., 1984), nor does agrin
induce expression of an AChR e reporter gene in muscle cultures from transgenic mice
(Chu et al., 1995). On the other hand, the absence of agrin-induced AChR transcription
seen in these assays may reflect the inability of soluble agrin to stimulate AChR
expression. Unfortunately, the ability of substrate- or cell-attached agrin to stimulate
AChR expression has not been reported.
Several molecules which do increase AChR synthesis have been identified in neural
tissues. These include ascorbic acid (Knaack et al., 1986; Horovitz et al., 1989),
acetylcholine receptor-inducing activity (ARIA) (Usdin and Fischbach, 1986), CGRP
(New and Mudge, 1986; Fontaine et al., 1986), and sciatin/transferrin (Markelonis et al.,
1982; Oh and Markelonis, 1982). Of these, CGRP and ARIA have received the most
attention.
CGRP is a small neuropeptide expressed throughout the nervous system and in
several peripheral tissues. CGRP is synthesized in motoneurons, is stored in dense-core
vesicles in the nerve terminal, and is released following stimulation (Matteoli et al., 1988,
1990; Uchida et al., 1990). Incubation of chick primary myotubes in culture with CGRP
results in increases in both AChR mRNA (3-fold) and protein levels (1.5-fold) (New and
Mudge, 1986; Fontaine et al., 1986), however, CGRP treatment has no effect on AChR
subunit mRNA levels in primary mouse myotube cultures (Martinou et al., 1991).
ARIA is a 42 kDa protein initially purified from chick brain extracts which also
stimulates AChR synthesis in chick myotube cultures (Usdin and Fischbach, 1986).
Subsequent cloning of ARIA cDNAs (Falls et al., 1993) revealed that ARIA is one of a
family of ligands which includes Neu differentiation factor (Peles et al., 1992; Wen et al.,
1992), glial growth factor (Marchionni et al., 1993) and heregulin (Holmes et al., 1992,
for review, see Peles and Yarden, 1993). Since all of these ligands are derived from
alternatively spliced transcripts of a single gene, the name neuregulin (NRG) has been
adopted to describe both the gene and its products.
Neuregulins are the most promising candidates for a motoneuron-derived inducer of
AChR expression. Although both CGRP and neuregulin induce AChR a-subunit
synthesis in chick aneural myotubes, neuregulin induces a more robust response (10-fold
vs. 3-fold for CGRP) (Harris et al., 1988), and unlike CGRP, neuregulin also induces
expression of AChR subunit genes in mouse muscle cell cultures (Martinou et al., 1991;
Chu et al., 1995; Jo et al., 1995). The AChR E-subunit exhibits the most dramatic
response to ARIA, increasing 7- to 10-fold following treatment (Martinou et al., 1991;
Chu et al., 1995). As stated above, expression of the E-subunit is induced significantly by
motoneuron innervation during perinatal development (Martinou and Merlie, 1991), and
unlike the AChR a-, f-, y-, and 8-subunits, which are expressed throughout the myofiber
both prior to innervation and following denervation, the e-subunit is expressed
exclusively in the synaptic region (Brenner et al., 1990; Kues et al., 1995). Thus,
induction of AChR e-subunit expression is one of the properties expected of the
motoneuron-derived signal which mediates synapse-specific gene expression. Consistent
with the idea that neuregulin is this signaling molecule, neuregulin immunoreactivity is
detected at synapses (Jo et al., 1995; Sandrock et al., 1995). Importantly, neuregulin
immunoreactivity remains associated with the synaptic basal lamina following nerve and
muscle degeneration (Jo et al., 1995). Moreover, RNAs encoding the erbB tyrosine
kinases, the putative receptors for neuregulins, are expressed in skeletal muscle cells, and
antibodies specific for erbB2, erbB3, or erbB4 all label the postsynaptic membrane (Jo et
al., 1995; Moscoso et al., 1995; Zhu et al., 1995). Together, these data strongly suggest
that neuregulin is a signal which mediates synapse-specific gene expression in skeletal
muscle in vivo.
Electrical activity-dependent regulation of gene transcription
While expression of synaptic AChRs continues following innervation, expression
of extrasynaptic AChRs falls dramatically (Diamond and Miledi, 1962; Bevan and
Steinbach, 1977). This developmental decline in extrasynaptic AChR density can be
prevented by pharmacological blockade of synaptic transmission in vivo (Burden, 1977a;
Braithwaite and Harris; 1979; Harris, 1981b). In addition, extrasynaptic AChRs reappear
following either denervation or pharmacological paralysis of adult skeletal muscle
(Axelsson and Thesleff, 1959; Hartzell and Fambrough, 1972; Berg and Hall, 1975a), and
direct electrical stimulation of denervated muscle reduces AChR levels back to those
observed in innervated muscle (Lomo and Rosenthal, 1972; Lomo and Westgaard, 1975).
These data suggest that nerve-evoked electrical activity is primarily responsible for the
regulation of extrasynaptic AChR density. Further, since the increase in extrasynaptic
AChRs following denervation results from the synthesis of new AChRs rather than the
redistribution of junctional AChRs (Brockes and Hall, 1975; Linden and Fambrough,
1979), these data suggest that electrical activity actively represses AChR biosynthesis.
The mechanism of electrical activity-dependent repression of extrasynaptic
AChRs is transcriptional. AChR a-, 13-, y- and 8-subunit mRNA levels increase following
denervation (Merlie et al., 1984; Goldman et al., 1988; Evans et al., 1987), and nuclear
run on assays demonstrate that these elevated levels of AChR mRNAs are due, at least in
part, to increased rates of transcription (Tsay and Schmidt, 1989). In addition, AChR
subunit promoters confer electrical activity responsiveness to reporter genes in both
transgenic mice (Merlie and Kornhauser, 1989; Merlie et al., 1994; Simon et al., 1992)
and in transfected cells in culture (Chahine et al., 1992; Dutton et al., 1993). Studies
using these AChR promoter/reporter gene fusions, have begun to identify the electrical
activity-responsive regulatory sequences within the AChR promoters. For example,
sequences within the 181 bp 5' flanking DNA of the mouse AChR 8-subunit gene are
sufficient to confer electrical activity dependent regulation on a human growth hormone
reporter gene both in transfected cells in culture (Dutton et al., 1993) and in skeletal
muscle of transgenic mice (Tang et al., 1994). This latter study also showed that
mutation of an E-box, a binding site for myogenic basic helix-loop-helix (bHLH)
proteins, near the transcriptional start site effectively eliminates the increase in reporter
gene transcription in response to denervation. Similar results have also been reported for
a mutation in an E-box in the chick AChR al-subunit promoter (Bessereau et al., 1994).
These data suggest that E-box binding proteins may mediate electrical activity-dependent
gene regulation. Consistent with this idea, members of the MyoD family of
transcriptional activators, a family of E-box binding proteins that are involved in the
induction of many muscle-specific genes during myogenesis, are regulated by electrical
activity in parallel with AChR expression (Duclert et al., 1991; Eftimie et al., 1991;
Witzemann and Sakmann, 1991; Neville et al., 1992; Weis, 1994). E-boxes alone,
however, are not sufficient to confer electrical activity-dependent responsiveness, since
other muscle specific genes which contain E-boxes in their promoter regions, such as
MCK, are not regulated by electrical activity (Merlie and Kornhauser, 1989; Asher et al.,
1992; Dutton et al., 1993). One explanation for the failure of E-box containing genes
such as MCK to respond electrical activity may be the presence of other, dominant
promoter elements which render these genes insensitive to electrical activity-induce
changes in bHLH protein activity. Alternatively, additional transcriptional regulators
acting via as yet uncharacterized electrical activity-responsive promoter sequences may
be required, in conjunction with E-boxes, to regulate electrical activity-responsive gene
expression.
In an effort to identify potential transcriptional regulators of electrical activity-
dependent gene expression, as well as genes which may mediate other physiological
responses of muscle to innervation, Xuejun Zhu, a graduate student in the lab, developed
a PCR-based subtractive-hybridization and cloning technique to identify mRNAs that are
differentially-expressed in innervated and denervated rat skeletal muscle. Using this
technique, Xuejun and I identified three novel genes whose expression is differentially
regulated in innervated and denervated muscle. Two of these genes, DEN] and DEN2 are
up-regulated following denervation. The third gene, INN], is expressed at roughly equal
levels in innervated and denervated muscle; alternative splicing of the INN] transcripts,
however, is altered following denervation such that the levels of two transcripts increase
while the level of a third decreases. The initial characterization of these three genes is
described in Chapter 4 of this thesis. Additionally, our screen revealed that the rat
homolog of the acute myeloid leukemia 1 (AML1) gene is significantly induced in
denervated muscle. Since AML1 encodes a potential transcription factor, we also
investigated more thoroughly its expression in skeletal muscle. These results are reported
in Chapter 5, and they suggest that AML1 may act as a regulator of electrical activity-
dependent gene expression in muscle.
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Chapter 2.
Membrane Targeting of the 43 kDa Protein (Rapsyn) in Muscle
and Non-muscle Cells
SUMMARY
The 43 kDa protein is a peripheral membrane protein that is expressed in skeletal
muscle, where it is associated with acetylcholine receptors (AChRs) in the postsynaptic
membrane. It has been suggested that the 43 kDa protein may be involved in clustering
AChRs in the postsynaptic membrane and in crosslinking AChRs with the underlying
cytoskeleton. We developed a primary muscle culture system to identify sequences in the
43 kDa protein that are required for its association with the cell surface and with AChR
clusters in myotubes. A plasmid directing expression of the mouse 43 kDa protein, tagged
with an epitope from influenza hemagglutinin (HA), was transfected into myoblasts, and
the distribution of the HA-tagged 43 kDa (43 kDa-HA) protein was analyzed in both
myoblasts and myotubes. We show here that the 43kDa-HA protein is targeted to the
myotube cell surface and is associated with AChR clusters. In addition we show that both
wild-type 43 kDa protein and 43 kDa-HA protein form clusters in the quail fibroblast-like
QT6 cell line. In contrast, 43kDa-HA protein expressed in myoblasts and NIH3T3
fibroblasts is clustered only rarely on the cell surface and is usually found intracellularly.
These results indicate that the 43 kDa protein is targeted efficiently to the cell surface in
myotubes and QT6 cells, but not in myoblasts or fibroblasts.
We studied the distribution of mutant 43kDa-HA proteins in primary myotubes.
We found that mutant 43kDa-HA proteins containing only amino-terminal portions of the
43 kDa protein form clusters in the periphery of the myotube, some possibly on the
myotube surface, but these clusters are not associated with AChR clusters. Mutation of an
amino-terminal myristoylation addition site blocks association of the 43 kDa protein with
AChR clusters and causes the 43 kDa protein to accumulate in nuclei.
Our results demonstrate that cell types differ in their ability to direct the 43 kDa
protein to the cell surface, and that N-terminal myristoylation of the 43 kDa protein is
required, but is not sufficient, for cell surface targeting and association with AChR clusters
in myotubes.
INTRODUCTION
Accumulation of AChRs in the postsynaptic membrane is an early and essential
event in neuromuscular synapse formation. The mechanisms that regulate postsynaptic
differentiation have been studied extensively in cell culture, and evidence suggests a role
for both extracellular matrix and cytoskeletal proteins in AChR clustering (for reviews see
Phillips and Merlie, 1992; Froehner, 1993; Hall and Sanes, 1993; Jennings and Burden,
1993). In studies designed to analyze the mechanism of AChR clustering, considerable
attention has been given to an intracellular, peripheral membrane protein, the 43 kDa
protein (rapsyn). The 43 kDa protein is expressed in 1:1 stoichiometry with AChRs
(Burden et al., 1983; LaRochelle and Froehner, 1987), and is codistributed precisely with
AChRs at synaptic sites in both Torpedo electric organ and skeletal muscle (Froehner et al.,
1981; Sealock et al., 1984; Burden, 1985). The 43 kDa protein becomes concentrated at
synapses early during synapse formation (Burden, 1985; Noakes et al., 1993), and it is
clustered together with AChRs in muscle cells grown in cell culture in the absence of
innervation (Burden, 1985; Peng and Froehner, 1985; Bloch and Froehner, 1987; Daniels,
1990).
Direct biochemical evidence demonstrating interaction between the 43 kDa protein
and AChRs is lacking; however, numerous studies suggest that 43 kDa protein/AChR
interactions play an important role in the formation and/or maintenance of AChR clusters.
Electron microscopy and X-ray diffraction studies suggest that the 43 kDa protein and
AChRs lie in close proximity (Mitra et al., 1989), and cross-linking studies have shown
that the 43 kDa protein is closely associated with the AChR P3 subunit (Burden et al.,
1983). In addition, treatments which remove the 43 kDa protein and other peripheral
membrane proteins from preparations of AChR-enriched membranes disrupt the
organization of AChRs (Barrantes et al., 1980; Cartaud et al., 1981; Bloch and Froehner,
1987) and increase the rotational and lateral mobility of AChRs within the membrane (Lo et
al., 1982; Rousselet et al., 1982). More recently, studies have shown that 43 kDa protein-
mutant mice fail to cluster AChRs at their NMJs, and muscle cell cultures derived from
these mutant mice fail to cluster AChRs in response to the nerve-derived AChR clustering
factor, agrin (Gautam et al., 1995). These results show that the 43 kDa protein is required
for normal synaptogenesis and AChR clustering in vertebrate skeletal muscle.
Efforts to reconstitute the AChR clustering pathway in non-muscle cells show that
43 kDa protein can promote AChR clustering. Expression of AChRs in Xenopus oocytes
(Froehner et al., 1990), quail QT6 cells (Phillips et al., 1991) and COS cells (Brennan et
al., 1992) leads to AChRs that are distributed diffusely on the cell surface; however, co-
expression of AChRs and the 43 kDa protein leads to co-clustering of AChRs and the 43
kDa protein (Froehner et al., 1990; Phillips et al., 1990; Phillips et al., 1991; Brennan, et
al., 1992). Importantly, even in the absence of AChR expression, the 43 kDa protein is
clustered in these cells (Froehner et al., 1990; Phillips et al., 1990). These results suggest
that the 43 kDa protein can self-organize, and that AChR clusters induced by coexpression
of 43 kDa protein form via association with the 43 kDa protein. More recently, similar
studies have suggested that 43 kDa protein may have a broader role in NMJ development
than merely organizing AChR domains. These studies showed that in addition to clustering
AChRs, 43 kDa protein also induces clustering of a-dystroglycan (Apel et al., 1995) and
MuSK, an agrin and laminin binding protein (Gillespie et al., 1996), when these proteins
are coexpressed with 43 kDa protein in QT6 cells. Moreover, clustering of MuSK by 43
kDa protein activates the MuSK kinase domain, and co-clustering of 43 kDa protein,
MuSK, and AChRs induces the tyrosine phosphorylation of the AChR P-subunit (Gillespie
et al., 1996), the same AChR subunit that is phosphorylated during agrin-induced AChR
clustering in myotubes (Wallace, 1991; Ferns et al., 1996). These results suggest that the
43 kDa protein may cluster other subsynaptic proteins at the NMJ and may play a role in
the MuSK signalling pathway.
Myoblasts and myotubes express similar levels of the 43 kDa protein (Frail et al.,
1989); the 43 kDa protein, however, is clustered only in myotubes. These results indicate
that expression of the 43 kDa protein is not sufficient for clustering in myoblasts and
suggest that clustering of the 43 kDa protein is regulated during myogenesis. Moreover,
these results also raise the possibility that the mechanisms that direct clustering of the 43
kDa protein in muscle cells may differ from the mechanisms that mediate clustering of the
transfected 43 kDa protein in QT6 cells, COS cells and Xenopus oocytes. In order to study
the mechanisms that regulate clustering of the 43 kDa protein during myogenesis Emma
Dutton, a post-doctoral fellow in the lab, and I transfected mammalian myoblasts and
fibroblasts with expression vectors encoding the 43 kDa protein tagged with an epitope
from influenza hemagglutinin (HA) and determined the distribution of the transfected
protein in myoblasts, fibroblasts and myotubes. In this chapter, we demonstrate that
clusters of the transfected 43 kDa protein are found frequently on the cell surface of
myotubes but not on the cell surface of the other cell types. These results indicate that the
cellular distribution of the endogenous and transfected 43 kDa proteins are regulated
similarly during myogenesis.
The primary sequences of 43 kDa protein from Torpedo electric organ (Carr et al.,
1987; Frail et al., 1987), mouse (Frail et al., 1988) and Xenopus skeletal muscle (Baldwin
et al., 1988) share 70-80% amino acid identity throughout their length, and possess several
conserved regions which may be important for AChR clustering (Froehner, 1991). These
include a highly conserved myristoylation addition site at the amino-terminus, a sequence
of four leucine heptad repeats characteristic of leucine-zipper containing proteins, and a
cysteine-rich sequence near the carboxy-terminus which has homology to the regulatory
region of protein kinase C and which may fold into a zinc-finger-like structure. The
carboxy-terminus also contains potential sites for phosphorylation by cAMP-dependent
protein kinase or protein kinase C (PKC). In order to identify which domains in the 43
kDa protein are necessary for targeting the protein to the cell surface of myotubes and for
mediating the association of the 43 kDa protein with endogenous AChR clusters, we
transfected myoblasts with expression plasmids encoding mutant 43 kDa proteins and
analyzed the distribution of the expressed 43 kDa proteins in differentiated myotubes. Our
results show that N-terminal myristoylation is required for targeting the 43 kDa protein to
the myotube surface. We also show that sequences within the amino-terminal 227 amino
acids of the 43 kDa protein are not sufficient for mediating the association of the protein
with AChR clusters in myotubes, and that phosphorylation of serine residues near the
carboxy-terminus of 43 kDa protein is not required for association of the protein with
AChR clusters in the myotube membrane.
MATERIALS AND METHODS
Plasmid construction
A 1.5 kb cDNA encoding the full-length murine 43 kDa protein (Frail et al., 1988)
was digested with BglI or NcoI to create deletion constructs encoding the N-terminal 113
or 227 amino acids of the 43 kDa protein, respectively. Oligonucleotides with appropriate
overhanging ends were used to introduce the influenza hemagglutinin (HA) epitope
YPYDVPDYA (Wilson et al., 1984) at the C-terminus of the truncated 43 kDa proteins.
An aspartic acid was included in the C-terminus of the epitope tag since charged amino
acids at the C-terminus have been shown to stabilize recombinant protein in prokaryotes
(Parsell et al., 1990). In the HA-tagged, wild-type 43 kDa (43kDa-HA) protein construct,
the wild-type stop codon was removed and a unique BamHI site was introduced by PCR to
permit introduction of the HA tag; this modification resulted in the addition of two amino
acids, glycine and serine, between the normal 43 kDa protein C-terminus and the HA tag.
The 5'-flanking sequence upstream of the initiator methionine was removed by PCR.
Amino acid substitutions in the 43 kDa protein were introduced by site-directed
mutagenesis (Taylor et al., 1985). All 43 kDa-HA constructs were subcloned into the pJ4
expression vector (Morgenstern and Land, 1990) and sequenced to confirm the intended
mutations. Wild-type and mutant constructs are shown in schematic form in Figure 2.1.
Tissue culture, transfection and microscopy
Primary rat myoblast and myotube cultures were prepared essentially as described
(Dutton and Olek, 1990). QT6 quail fibroblasts (American Type Culture Collection, CRL-
1708), NIH3T3 fibroblasts and C2C12 myoblasts were cultured as described previously
(Moscovici et al., 1977; Simon and Burden, 1993). Cells were plated in 35 mm tissue
culture dishes, transiently transfected using calcium phosphate precipitation (Maniatis et
al., 1982) at approximately 50% confluence and glycerol shocked 6-24 hours later. One to
two days following transfection, the cultures were rinsed with Dulbecco's phosphate
buffered saline (DPBS) and fixed with 2% paraformaldehyde in DPBS. After rinsing with
DPBS, the cells were permeablized with 0.1% Triton X-100 (in DPBS) for 7 minutes,
rinsed once with 0.1 M glycine, and incubated with 10% bovine serum albumin or 10%
normal goat serum (in DPBS) for 30 minutes. The expressed 43 kDa-HA protein was
detected using a monoclonal antibody (12CA5; Kolodziej and Young, 1991) against the
HA tag and a fluorescein-conjugated secondary antibody. For some experiments, untagged
43 kDa protein was detected using a polyclonal rabbit antiserum against a glutathione-S-
transferase/mouse 43 kDa fusion protein (Dyer and Burden, unpublished results), followed
by a fluorescein-conjugated secondary antibody. Expression of the 43 kDa-HA protein
was analyzed in myotubes that had differentiated from transfected myoblasts. In these
experiments, the AChRs were labeled with tetramethylrhodamine-a-bungarotoxin (TMR-a-
BGT) (50 nM) prior to fixation as described previously (Dutton and Olek, 1990). Cells
were viewed with a Zeiss microscope equipped with filters selective for either rhodamine or
fluorescein. Dorsal and ventral (substrate attached) surfaces of myotubes were
distinguished by focusing through the myofiber (Olek et al., 1983; Bursztajn et al., 1984;
Wallace, 1988; Dutton and Olek, 1990).
RESULTS
To determine whether the HA epitope tag interferes with targeting of 43 kDa protein
to the cell surface, we transiently transfected quail QT6 fibroblasts and analyzed the
distribution of wild-type and epitope-tagged (43 kDa-HA) proteins by
immunofluorescence. The full-length, wild-type 43 kDa protein is targeted to the cell
surface and forms clusters in QT6 cells (Phillips et al., 1991), and we found that the
distribution of the wild-type and 43 kDa-HA protein was similar in QT6 cells (Fig. 2.2A,
B). Cell surface clusters of the 43 kDa protein are detected in approximately 70% of cells
expressing the transfected wild-type or the 43 kDa-HA protein. Smaller aggregates of the
43 kDa protein are observed in approximately 90% (wild-type) and 80% (epitope-tagged)
of transiently expressing cells (Fig. 2.2B). It is our impression that most of these
aggregates are cytoplasmic. Diffuse staining is also detected occasionally throughout the
cytoplasm (21% and 11% in wild-type 43 kDa and 43 kDa-HA expressing cells,
respectively) and within the nucleus (54% and 82%, respectively) (Fig. 2.2A, B). Since
both wild-type and 43kDa-HA protein have similar patterns of expression, we conclude
that the HA epitope tag does not interfere with normal protein folding or cellular localization
of the 43 kDa protein.
43 kDa protein is targeted to the cell surface and is colocalized with AChR clusters in
primary rat myotubes
The 43 kDa protein is colocalized with AChRs in AChR-rich membrane domains in
Xenopus myocytes (Peng and Froehner, 1985) and rat primary myotubes (Bloch and
Froehner, 1987) grown in cell culture. To determine whether the 43 kDa-HA protein is
targeted to the cell surface and is associated with endogenous AChR clusters in primary rat
myotubes, we transfected primary rat myoblasts with the 43 kDa-HA expression plasmid,
allowed the myoblasts to fuse to form myotubes, and examined the distribution of the HA-
tagged protein. Our results show that the 43 kDa protein is colocalized with endogenous
AChR clusters on the ventral (substrate attached) surface of the myotube (Fig. 2.3A, B).
In addition, the 43 kDa protein is associated with small (1-10 jim) AChR clusters on the
dorsal surface of myotubes (Fig. 2.3C, D). Because AChR clusters usually are not found
on the dorsal surface of primary rat myotubes (Olek et al., 1983; Dutton and Olek, 1990),
our results raise the possiblity that the transfected 43 kDa protein induces the formation of
AChR clusters on the dorsal surface. Although it has been reported that overexpression of
43 kDa protein in stably transfected myotubes can disrupt AChR clustering (Yoshihara and
Hall, 1993), AChR clusters on the ventral surface appear similar in both transfected and
untransfected myotubes. This probably reflects lower levels of 43 kDa protein expression
in transiently transfected than in stably transfected myotubes.
43 kDa protein forms cell surface clusters in QT6 cells, but not in primary rat myoblasts or
fibroblasts, C2 myoblasts or NIH3T3 fibroblasts
In contrast to the cell surface clustering of 43 kDa protein observed in myotubes,
the 43 kDa protein in mononucleated cells is usually found in small (1-5 jim) cytoplasmic
aggregates which are concentrated in the perinuclear region of transfected cells (Fig. 2.2C,
4A). Surface clusters of the 43 kDa protein are found in only a minority (6%) of the cells
that expressed the transfected protein. The distribution of the 43 kDa-HA protein in
primary rat myoblasts and fibroblasts is clearly different from that observed in QT6 cells,
where a majority (70%) of the transfected cells have surface clusters of the 43 kDa protein
(Fig. 2.2). To determine whether the absence of surface clusters of the 43 kDa protein in
myoblasts and fibroblasts was unique to primary cells, we transfected C2C12 myoblasts
and NIH3T3 fibroblasts. We found that the distribution of the 43 kDa protein in these cell
lines is similar to that observed in primary rat myoblasts and fibroblasts. Thus, cell surface
clusters of 43 kDa protein are detected readily in QT6 cells and primary myotubes, but not
in primary rat myoblasts and fibroblasts, C2 myoblasts or 3T3 fibroblasts. These results
indicate that the 43 kDa protein does not cluster efficiently at the surface in all cell types.
Targeting of mutant 43 kDa-HA proteins in myotubes
Recently, studies in QT6 cells (Phillips et al., 1991) and Xenopus oocytes
(Scotland et al., 1993) using co-expression of mutant 43 kDa protein and AChR have
identified regions of the 43 kDa protein which are necessary for clustering of the 43 kDa
protein on the cell surface and for mediating 43 kDa protein interactions with AChR. These
regions include an amino-terminal myristoylation consensus sequence, which is required
for targeting the 43 kDa protein to the cell surface of QT6 cells (Phillips et al., 1991), and a
zinc-finger motif (a.a. 363-403) which has a role in determining the size of 43 kDa protein
clusters in Xenopus oocytes, but is not required for association of the protein with AChR
(Scotland et al., 1993). These studies also showed that a leucine zipper domain (a.a. 82-
110) is not required for clustering of the 43 kDa protein in QT6 cells (Phillips et al., 1991),
and that a putative serine phosphorylation site (Ser 406) (Carr et al., 1987; Froehner, 1991)
is not required for either clustering the 43 kDa protein at the cell surface or for association
with AChRs in Xenopus oocytes (Scotland et al., 1993). Our results with the wild-type 43
kDa protein raise the possibility that the mechanisms used to cluster the 43 kDa protein in
these non-muscle cells might differ from those in myotubes. Therefore, we determined
whether the domains that are necessary for targeting the 43 kDa protein to the cell surface
of non-muscle cells are also necessary for targeting the 43 kDa protein to the cell surface of
myotubes.
To determine whether myristoylation is required for targeting the 43 kDa protein to
the plasma membrane in myotubes, we mutated the myristoylation addition site (Gly2 to
Glu2 substitution) and studied expression of the mutant protein in both primary rat
myoblasts and myotubes. The mutated 43 kDa protein is not found associated with surface
AChR clusters in myotubes; rather, most staining is confined to the nucleus (Fig. 2.4). In
myoblasts also the mutated protein is detected primarily in the nucleus. Diffuse
cytoplasmic staining also is detected in some cells (42%). Similar results have been
reported for the distribution of a myristoylation site mutant in QT6 cells (Phillips et al.,
1991). These results indicate that myristoylation is important for targeting 43 kDa protein
to the cell surface in both QT6 cells and myotubes.
Deletion mutants were constructed which expressed either the amino-terminal 113
or 227 amino acids of the 43 kDa protein. These mutants, which lack both the zinc finger
domain and the putative phosphorylation site, were transfected into primary rat myoblasts,
and the distribution of the mutant proteins in myotubes was determined by
immunofluorescence. When expressed in QT6 cells or myoblasts, the mutant 43 kDa
proteins forms small aggregates (1-5 gm) distributed throughout the cell (Fig. 2.5A, B).
In myotubes, the mutant 43 kDa proteins forms clusters (1-10 gm) in the periphery of the
myotube, but these clusters are not colocalized with AChR clusters (Fig. 2.5C, D). Due to
the abundance and small size of the clusters, however, we can not determine conclusively
how many, if any, of these clusters are associated with the cell surface, but the distribution
of these truncated 43 kDa protein clusters is clearly different from the distribution of wild-
type 43 kDa protein in transfected myotubes (compare Fig. 2.3 with 2.5C, D) These
results suggest that the amino-terminal portion of the 43 kDa protein is not sufficient to
direct the association of the 43 kDa protein with AChR clusters in muscle.
The 43 kDa protein from Torpedo electric organ contains phosphoserine, and
peptide mapping indicates that the phosphorylated serine(s) are contained in a single tryptic
peptide (Hill et al., 1991). Ser406 is within consensus sequences for phosphorylation by
either cAMP-dependent protein kinase or protein kinase C. In order to determine whether
Ser406 has a role in targeting the 43 kDa protein to the cell surface and to AChR clusters in
myotubes, we mutated Ser406 to Ala406, and expressed the mutated protein in rat primary
myoblasts and myotubes. The distribution of the mutant 43 kDa protein in myotubes is
similar to that observed for the wild-type 43 kDa protein. Since amino acid 405 is also
serine, we were concerned that Ser405 might be phosphorylated in the Ala406 mutant
construct. The distribution of 43 kDa protein with an Ala405/Ala406 double mutation,
however, is similar to that observed for the wild-type protein in myotubes (Fig. 2.6).
These results demonstrate that phosphorylation of Ser406 and Ser405 is not required for
targeting the 43 kDa protein to the cell surface or for interaction of the 43 kDa protein with
AChR clusters in myotubes. Although 43 kDa protein clusters are detected more frequently
in C2 myoblasts expressing the 43 kDa protein containing a Ser to Ala mutation at Ser405
and/or Ser406 (14% of cells expressing Ala405/Ala406, 6% of cells expressing Ala405 and
8% of cells expressing Ala406) than in myoblasts expressing the wild-type (2% of
expressing cells), these results suggest that phosphorylation of 43 kDa protein at Ser406
cannot account alone for the absence of 43 kDa protein clusters at the cell surface of
myoblasts.
DISCUSSION
We show here that cell types differ in their ability to cluster the 43 kDa protein at the
cell surface. While cell surface clusters of the 43 kDa protein are found frequently in
transiently transfected QT6 cells and rat primary myotubes, such clusters are found rarely at
the surface of transfected C2 myoblasts, primary myoblasts and fibroblasts and 3T3
fibroblasts. Our results do not support results reported by Phillips and colleagues in C2
myoblasts (Phillips et al., 1993). In C2 myoblasts transfected with expression vectors
encoding AChR subunits and 43 kDa protein, they reported that 91% of cells expressing
both AChR and 43 kDa protein displayed surface domains in which both proteins were
colocalized. In contrast, in our experiments, surface domains of 43 kDa-HA protein were
observed in only -2% of transfected C2 myoblasts expressing 43 kDa-HA protein.
Moreover, we observed few surface clusters of 43 kDa-HA protein in transfected rat
primary myoblasts and fibroblasts and in NIH3T3 fibroblasts, although these frequencies
were not rigorously quantitated. Perhaps the coexpression of AChRs with 43 kDa protein
in transfected C2 myoblasts might stabilize 43 kDa protein clusters in the membrane and
prevent their aggregation in an intracellular compartment. Unfortunately, Phillips et al. do
not report the localization of 43 kDa protein in C2 myoblasts transfected with 43 kDa
protein expression vector alone.
Previous studies have demonstrated that the 43 kDa protein can cluster in the
plasma membrane of QT6 cells (Phillips et al., 1991), COS cells (Brennan et al., 1992)
and Xenopus oocytes (Froehner et al., 1990; Scotland et al., 1993). Moreover, the 43 kDa
protein can cause clustering of AChRs in these cells. We show here that 43 kDa-HA
protein is colocalized with AChR clusters on the ventral (substrate attached) surface of
transiently transfected myotubes. Because the 43 kDa protein is associated with small
AChR clusters on the dorsal surface of transfected myotubes, where AChR clusters rarely
are found (Dutton and Olek, 1990; Olek et al., 1983), we favor that the 43 kDa protein can
induce the formation of AChR clusters in myotubes.
The primary sequence of the 43 kDa protein contains several conserved structural
features, including sites for N-terminal myristoylation and serine phosphorylation, a zinc
finger domain, and a leucine zipper motif (see Froehner, 1991). Using heterologous cell
culture systems, others have begun to define regions of the 43 kDa protein that are
necessary to promote membrane targeting and AChR clustering (Phillips et al., 1991;
Scotland et al., 1993). Their results demonstrate that N-terminal myristoylation is required
for targeting of the 43 kDa protein to the plasma membrane (Phillips et al., 1991), and that
mutation of the zinc finger region did not prevent association of the recombinant 43 kDa
protein with AChRs, but did reduce the size of 43 kDa protein induced clusters in Xenopus
oocytes (Scotland et al., 1993), indicating a role for the zinc finger domain in 43 kDa
protein clustering. Neither deletion of the leucine zipper (Phillips et al., 1991) nor mutation
of the potential phosphorylation site (Scotland et al., 1993) prevented clustering of the 43
kDa protein in the plasma membrane, but deletion of the leucine zipper did reduce the
ability of the 43 kDa protein to associate with AChRs. Since it is possible that the
mechanisms which regulate 43 kDa protein clustering and 43 kDa protein/AChR
association in these heterologous cell systems may differ from those in muscle, we have
studied the localization of HA-tagged mutated 43 kDa protein directly in muscle cells in
culture. Similar to those reported by others using heterologous cell systems, our results
show that N-terminal myristoylation is required to target 43 kDa protein to the cell
membrane in myotubes and that mutation of the potential serine phosphorylation site did
not prevent association of the recombinant 43 kDa protein with endogenous AChR clusters.
Previously, Phillips et al. demonstrated that 43 kDa protein containing only the N-terminal
254 amino acids was not targeted to the membrane and was not able to associate with
AChRs in QT6 cells (Phillips et al., 1991). Consistent with these results, we found that
HA-tagged recombinant 43 kDa protein containing only the N-terminal 113 or 227 amino
acids failed to cluster in the membrane of QT6 cells, and did not associate with endogenous
AChR clusters in myotubes. In summary, our results are consistent with those reported in
heterologous cell culture systems, and suggest that mechanisms regulating 43 kDa protein
induced AChR clustering in these systems reflect those in myotubes.
The endogenous 43 kDa protein is expressed at similar levels in myoblasts and
myotubes but is only clustered in myotubes (Frail et al., 1989). The mechanisms that
regulate clustering of the 43 kDa protein during muscle differentiation are not known. It is
possible that negative factors, which are present in myoblasts but not in myotubes, prevent
the 43 kDa protein from clustering in myoblasts. Alternatively, it is possible that positive
factors in myotubes are required for clustering the 43 kDa protein. Because the 43 kDa
protein can cluster in QT6 cells, these cells, like myotubes, would appear to either lack
negative factors or contain positive factors for clustering the 43 kDa protein. Interestingly,
expression of 43 kDa protein alone in QT6 cells induces the tyrosine phosphorylation of a
large number of proteins (Gillespie et al., 1996), and this suggests that endogenously
expressed molecules in the transfected QT6 cells interact with the 43 kDa protein and may
be important for its clustering in these cells. Clusters of 43 kDa and AChRs fail to form
spontaneously in a C2 muscle cell variant that is defective in glycosaminoglycan synthesis
(Gordon et al., 1993). Moreover, these cells are also less responsive to agrin (Ferns et al.,
1992,1993), and these studies suggest a role for glycosaminoglycans in AChR clustering.
In addition, utrophin is present at the earliest stages of AChR clustering at the developing
NMJ and at AChR-rich domains in C2 myotubes (Phillips et al., 1993), and more recently,
43 kDa protein was found to induce clustering of a-dystroglycan (Apel et al., 1995).
These studies suggest that utrophin and the dystrophin glycoprotein complex (DGC) may
be important for the formation of 43 kDa protein/AChR clusters and that 43 kDa protein
may link AChRs to the cytoskeleton via interactions with the DGC. At the present time, it
is not known whether glycosaminoglycans play a role in 43 kDa protein/AChR clustering
in QT6 cells, nor whether utrophin and members of the DGC are expressed in QT6 cells.
Similarly, differences in glycosaminoglycan synthesis and differences in the expression of
many of the DGC components in myoblasts and myotubes have not been thoroughly
investigated. The differential expression of any of these molecules in myotubes and QT6
cells but not in myoblasts and 3T3 fibroblasts would be consistent with the idea that they
act as positive factors which support clustering of the 43 kDa protein.
Since QT6 cell are derived from a tumor that was chemically induced by
intramuscular injection (Moscovici et al., 1977), it is possible that QT6 cells are derived
from mononucleated satellite cells which are present in adult muscle. In support of this
idea, subclones of QT6 cells have been isolated which can fuse to form myotube-like
syncitia and which express several muscle specific proteins (Antin and Ordahl, 1991).
Moreover, these QT6-derived cells also express low levels of the AChR a-subunit and
agrin when grown in low-serum containing medium (J. Fallon, personal communication).
A myogenic origin for QT6 cells might account for their ability to cluster the 43 kDa protein
with an efficiency comparable to that of myotubes.
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Figure 2.1. Summary of 43 kDa-HA fusion proteins. Schematic
representations of the wild-type 43 kDa protein and HA-tagged wild type and mutant 43
kDa proteins are shown. The amino terminus of each protein is on the left. The positions
of the N-myristoylation addition site (Gly 2) and the potential phosphorylation site (Ser406)
are indicated by arrows. The HA epitope tag is represented by a solid black box. Gray-
shaded and hatched boxes indicate the locations of the leucine zipper (L-zip) and zinc finger
(Zn) domains, respectively. Solid vertical bars indicate the positions of amino acid point
mutations. Amino acids (parentheses) and point mutations contained within the mutant 43
kDa-HA fusion proteins (boxes) are given.
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Figure 2.2. Wild-type and 43 kDa-HA protein clusters on the cell surface
of transiently transfected QT6 cells but not in myoblasts. Transiently
transfected QT6 cells (A,B) and C2 myoblasts (C) expressing the 43 kDa protein (A) or
HA-epitope tagged 43 kDa protein (B,C) were fixed, permeablized and stained either with
affinity purified rabbit anti-43 kDa protein antibodies (A) or the 12CA5 anti-HA
monoclonal antibody (B,C) followed by appropriate FITC-conjugated secondary
antibodies. In QT6 cells, immunoreactivity is frequently detected on the edge of cells
transfected with either 43 kDa protein or 43 kDa-HA protein (arrowheads in A and B). We
interpret such staining on the edge of cells as evidence for cell surface 43 kDa protein
clusters. Smaller aggregates are present in most stained cells (arrows in B) and in some
transfected cells which lack staining at the cell surface (not shown). Nuclei in most
transfected cells also stain weakly. (Compare nucleus of transfected cell in A with nuclei of
surrounding untransfected cells (n)). In myoblasts, aggregates of the 43 kDa-HA protein
are concentrated in the perinuclear region of transfected cells. (see also Fig 2.4A).
Aggregates of the 43 kDa-HA protein are seen rarely at the cell surface (see text).
Calibration bar (A, B; C)= 10 gim.
I
Figure 2.3. 43 kDa-HA protein is localized to AChR clusters in transiently
transfected rat myotubes.
Transiently transfected primary rat myoblasts expressing 43 kDa-HA protein were allowed
to differentiate into myotubes. Prior to fixation, dishes were incubated with TMR-a-BGT
to label AChRs. Cells were fixed and stained with anti-HA monoclonal antibody (12CA5)
as described (Materials and Methods). 43 kDa-HA protein (A) is coincident with AChR
clusters (B) on the ventral (substrate attached) surface of the myotubes. Coincident
aggregates of 43 kDa-HA protein (C) and AChR (D) also are found on the dorsal surface of
the myotube. The appearance of AChR clusters (e.g. number and size) is similar in both
transfected and non-transfected myotubes. Diffuse immunoreactivity is occasionally
detected in the nucleus of transfected myotubes (out of focus in C). Calibration bar = 10
gm.

Figure 2.4. Mutation of the myristoylation addition site prevents targeting
of 43 kDa protein to the cell surface.
Transiently transfected C2 myoblasts (A, B) and rat primary myotubes (C, D) expressing
either 43 kDa-HA protein (A, C) or 43 kDa-HA protein containing a mutated myristoylation
site (Gly2 to Glu2) (B,D) were stained for HA immunoreactivity as described (Materials
and Methods). In both C2 myoblasts (B) and myotubes (D) the mutant 43 kDa protein is
detected primarily in the nucleus. The intensity of the nuclear immunoreactivity in both
myoblasts (B) and myotubes (D) expressing this mutant 43 kDa protein appears brighter
than in myoblasts (A) and myotubes (C) expressing wild type 43 kDa-HA protein. AChR
clusters are detected readily in myotubes expressing the mutant 43 kDa protein (not
shown), indicating that the mutant 43 kDa protein is not acting as a dominant-negative
suppressor of AChR clustering in these myotubes. Calibration bar = 10 gim.
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Figure 2.5. C-terminal truncation of the 43 kDa protein promotes
intracellular aggregation of 43 kDa protein and prevents association of 43
kDa protein with AChR clusters in myotubes.
Truncated, 43 kDa-HA proteins containing either the amino-terminal 113 or 227 amino
acids were transiently expressed in QT6 cells, C2 myoblasts and primary rat myoblasts;
the latter were allowed to differentiate into myotubes. Myotubes were treated with TMR-a-
BGT just prior to fixation to label AChRs. Cells were fixed, permeablized and stained for
HA as described (Materials and Methods). The HA-tagged 227 amino acid 43 kDa proteins
is found in small aggregates (0.5 -1 gm) throughout the cytoplasm of both transfected QT6
cells (A) and C2 myoblasts (B). Similar results are observed in transfected cells expressing
the mutant 113 amino acid 43 kDa protein (not shown). The 113 amino acid (C) and 227
amino acid (not shown) 43 kDa-HA protein also aggregate in transfected rat primary
myotubes, but these aggregates are not associated with AChR clusters (D; C and D at same
plane of focus). Although aggregates of these mutant 43 kDa proteins seems distributed
throughout the cytoplasm of transfected cells, we cannot exclude the possiblity that some of
these aggregates are associated with the cell surface. Calibration bar (A, B; C, D)= 10 lm.
Ih
Figure 2.6. Mutation of a potential phosphorylation site does not prevent
the 43 kDa protein from associating with AChR clusters in rat primary
myotubes.
Transiently transfected rat primary myotubes expressing 43 kDa-HA proteins containing a
double mutation (Ser405, Ser406 to Ala405, Ala406) were allowed to differentiate and were
stained for HA as described (Materials and Methods). Surface AChR clusters were labeled
with TMR-a-BGT prior to fixation as described (Materials and Methods). Mutant 43 kDa
protein (A) associates with AChR clusters (B) at the surface of transfected myotubes,
suggesting that mutation of this potential phosphorylation site does not affect the ability of
the mutant 43 kDa protein to associate with AChR clusters at the cell surface. Arrows are
included for reference points. Calibration bar = 10 pm.

Chapter 3.
Dystrophin is a Component of the Subsynaptic Membrane
The work described in this chapter has been published in:
Yeadon, J. E., Lin, H., Dyer, S. M., and Burden S. J. (1991). Dystrophin is a component
of the subsynaptic membrane. J. Cell Biol. 115, 1069-1076.
Ravin, A. J., Dyer, S. M., Yeadon, J. E., and Burden, S. J. (1991). Multiple dystrophin
isoforms are associated with the postsynaptic membrane of Torpedo electric organ. J.
Physiol. Paris, 85, 131-133.
SUMMARY
A subsynaptic protein of Mr -300 kDa is a major component of Torpedo electric
organ postsynaptic membranes and copurifies with the AChR and the 43 kDa subsynaptic
protein. Monoclonal antibodies against this protein react with neuromuscular synapses in
higher vertebrates, but not at synapses in dystrophic muscle. The Torpedo 300 kDa protein
comigrates in SDS-PAGE with murine dystrophin and reacts with antibodies against
murine dystrophin. The sequence of a partial cDNA isolated by screening an expression
library with monoclonal antibodies against the Torpedo 300 kDa protein shows striking
homology to mammalian dystrophin, and in particular to the b isoform. A partial cDNA
encoding the a isoform of Torpedo dystrophin has also been isolated. These results
indicate that dystrophin is a component of the postsynaptic membrane in Torpedo electric
organ and at neuromuscular synapses and raise the possibility that loss of dystrophin from
synapses in dystrophic muscle may have consequences that contribute to muscular
dystrophy.
INTRODUCTION
Mutations in the gene encoding dystrophin can result in X-linked myopathies termed
Duchenne or Becker muscular dystrophy (Hoffman and Kunkel, 1989). Duchenne
muscular dystrophy (DMD), the most severe of these myopathies, is characterized by
progressive and severe muscle wasting resulting in death of the patient usually before the
age of twenty. Becker muscular dystrophy (BMD) is much less common than DMD (1 in
30,000 vs. 1 in 3500 boys), and BMD patients exhibit a less severe phenotype and have a
much longer survival rate. In DMD, mutations of the dystrophin gene usually result in the
complete absence of dystrophin protein, whereas in BMD, mutations are often in frame
deletions which result in either mildly altered forms of dystrophin, lower levels of the
protein or both (Monaco et al., 1988; Koenig et al., 1989).
Dystrophin is a 427 kDa cytoskeletal protein composed of four distinct domains
(Koenig et al., 1988; Koenig and Kunkel, 1990). The amino terminal domain of
dystrophin bears similarity to the actin-binding domain of a-actinin, and, when expressed
in bacteria, can bind f-actin in vitro (Hemmings et al., 1992; Way et al., 1992). The large,
central domain of the molecule is comprised of twenty-four a-helical coiled-coil, spectrin-
like repeats and four putative 'hinge' domains which give the protein an extended, yet
flexible, rod-like structure. Rotary-shadowed electronmicroscopic images of purified
dystrophin confirm a 100 nm rod-like shape, and also suggest that dystrophin monomers
combine to form staggered tetramers which can in turn form end-to-end oligomers (Pons et
al., 1990; Sato et al., 1992). Downstream of the central rod domain is cysteine-rich
domain, resembling the amino-terminal domain of a-actinin, followed by a leucine-rich,
globular carboxy-terminal domain . These later domains are vital for the normal function of
dystrophin since mutations within the cysteine-rich domain and the first half of the
carboxy-terminal domain often result in severe DMD phenotypes (Koenig et al, 1989;
Roberts et al., 1992).
Expression of full-length dystrophin is restricted to muscle and nervous tissue
(Chamberlain et al., 1988; Hoffman et al., 1988; Nudel et al., 1988). The brain and
muscle isoforms of dystrophin are regulated by separate promoters which produce
transcripts which differ only in the first exon of their transcribed mRNAs (Nudel et al.,
1989; Feener et al., 1989). A third promoter encoding a unique first exon has also been
identified which regulates dystrophin expression in cerebellar Purkinje neurons (Gorecki et
al., 1992). In addition, three smaller dystrophin-derived transcripts, expressed from two
different promoters, have been isolated which encode only the 3' end of the DMD locus
(for reviews, see Ahn and Kunkel, 1993; Tinsley et al., 1993). Alternative splicing of
dystrophin transcripts produces multiple dystrophin isoforms which differ in their carboxy-
terminal domains (Feener et al., 1989). Although functional differences between these
isoforms have not been established, tissue and developmental-stage specific splicing
patterns suggest that such differences may exist (Bies et al., 1992).
In skeletal muscle, dystrophin is found at the intracellular surface of the sarcolemma
(Watkins et al., 1988; Zubrzycka-Gaarn et al., 1988; Bonilla et al., 1988; Sugita et al.,
1988). Dystrophin constitutes roughly 5% of cytoskeletal proteins associated with the
sarcolemma (Ohlendieck and Campbell, 1991a), and is therefore a major constituent of the
subsarcolemmal cytoskeleton. Dystrophin associates with the sarcolemma via interactions
with an oligomeric complex of proteins termed the dystrophin glycoprotein complex (DGC)
(Campbell and Kahl, 1989; Ervasti et al., 1990; Yoshida and Ozawa, 1990). The DGC is
comprised of at least six distinct proteins (for review, see Tinsley et al., 1993), which
include the transmembrane proteins p-dystroglycan (Ibraghimov-Beskrovnaya et al.,
1992), a- (adhalin) (Roberds et al.., 1993), p- (Btinnemann et al., 1995; Lim et al., 1995),
and y-sarcoglycan (Noguchi et al., 1995), the extracellular protein a-dystroglycan
(Ibraghimov-Beskrovnaya et al., 1992), and members of the syntrophin family of
cytoplasmic proteins (Adams et al., 1993). Recently, fusion proteins containing both the
cysteine-rich and first half of the carboxy-terminal domains of dystrophin have been shown
to bind to P-dystroglycan in vitro (Suzuki et al., 1992, 1994). Similar studies have also
revealed binding sites for both al and pl3-syntrophin in the distal half of the carboxy-
terminal domain of dystrophin (Ahn and Kunkel, 1995; Suzuki et al., 1994, 1995). Thus,
interaction between carboxy-terminal domains of dystrophin and the DGC appear to
mediate the linkage of dystrophin to the sarcolemma. Since a-dystroglycan can interact
extracellularly with laminins (Ibraghimov-Beskrovnaya et al., 1992; Ervasti and Campbell,
1993), dystrophin and the DGC may be important linkages connecting the sarcoplasmic
cytoskeleton with the extracellular basal lamina.
It is not clear how loss of dystrophin results in myopathies. Increased Ca 2+ leak
channel activity (Fong et al., 1990) and Ca2+ influx (Turner et al., 1991) have been
reported in dystrophic muscle. These changes in internal Ca2+ concentration correlate with
changes in Ca2+-sensitive protease activity (Spenser and Tidball, 1992) and increased
protein degradation and turnover (Turner et al., 1988; MacLennan and Edwards, 1990),
and suggest a causal relationship between dystrophin deficiency-induced changes in Ca2+
regulation and muscle necrosis. The changes in Ca2+ metabolism in dystrophic muscle
may reflect a direct role for dystrophin in Ca2+ regulation across the sarcolemma.
Alternatively, these changes may be important secondary consequences of dystrophin
deficiency-induced changes in the integrity of the sarcolemma. Consistent with this idea,
immunohistochemical analysis shows that the levels of all DGC proteins are drastically
reduced in muscle from DMD patients and dystrophin-deficient mdx mice (Ervasti et al.,
1990; Ohlendieck and Campbell, 1991b; Ohlendieck et al., 1993). These data suggest that
dystrophin may organize and/or stabilize the DGC. Since muscle fibers from mdx mice are
more susceptible to contraction-induced rupture than are muscle fibers from normal mouse
muscle (Petrof et al., 1993), loss of dystrophin and/or disruption of the dystrophin/DGC
linkage may affect the overall stability of the sarcolemma, making the muscle more
vulnerable to damage during repeated cycles of muscular contraction. Recent studies have
demonstrated that certain severe childhood autosomal-recessive muscular dystrophies, a
class of myopathies clinically similar to DMD or severe BMD, results from defects in the
genes encoding any one of the sarcoglycans (Roberds et al., 1994; Ljunggren et al., 1995;
B6nnemann et al., 1995; Lim et al., 1995; Noguchi et al., 1995). In addition, a form of
congenital muscular dystrophy (CMD) in humans, as well as the CMD-like dystrophia
muscularis myopathy in mouse, have been linked recently to deficiencies in the gene
encoding the laminin a2-chain (merosin M-chain) (Sunada et al., 1994; Xu et al., 1994;
Helbling-Leclerc et al., 1995). These data highlight the importance of the
dystrophin/DGC/extracellular matrix linkage in normal muscle physiology, and suggest that
abnormalities in the expression of any one its components may result in muscular
dystrophy.
In addition to its association with the sarcolemma, dystrophin immunoreactivity is
also concentrated at neuromuscular synapses (Chang et al., 1989; Jasmin et al., 1990;
Fardeau et al., 1990). Because antibodies against dystrophin can cross-react with other
proteins that contain homologous domains (Hoffman et al., 1989a, b), however, it was
difficult to ascertain whether the cross-reacting molecule at the synapse was dystrophin
rather than another molecule which shares epitopes with dystrophin. Indeed, one study
showed that dystrophin-like immunoreactivity persists at synaptic sites in dystrophic
muscle (Fardeau et al., 1990), and subsequent studies revealed that utrophin, a protein
closely related to dystrophin, is specifically expressed with AChRs and 43 kDa protein at
the NMJ (Nguyen thi Man et al., 1991; Ohlendieck et al., 1991), specifically at the crests
of postjunctional folds (Bewick et al., 1992). Therefore, it remained unresolved whether
dystrophin itself was present at neuromuscular synapses. In this chapter, I provide strong
evidence that dystrophin is present at synaptic sites. The work presented here was done in
collaboration with Helen Lin and Amy Ravin, two UROP students in the Burden lab.
We showed previously that a peripheral membrane protein of Mr -300 kDa copurifies
with postsynaptic membranes isolated from Torpedo electric organ and appears
concentrated at neuromuscular synapses (Burden et al., 1983; Woodruff et al., 1987). We
have now isolated a cDNA by screening an expression library with monoclonal antibodies
against the Torpedo 300 kDa protein, and show that the amino acid sequence encoded by
this partial cDNA is homologous to dystrophin. The cDNA encodes a protein with repeat
units that have 50-70% amino acid sequence identity with the repeat units in human
dystrophin and a carboxy-terminal region with 90% homology to the dystrophin b isoform.
A second partial cDNA has also been isolated which is homologous to the a isoform of
dystrophin. Moreover, antibodies against murine dystrophin react with a Torpedo 300 kDa
protein, which comigrates with murine dystrophin in SDS-PAGE, and monoclonal
antibodies against the Torpedo 300 kDa protein react with neuromuscular synapses in
normal, but not dystrophic, mouse muscle. These results provide strong evidence that
dystrophin is present at neuromuscular synapses and raise the possibility that the absence
of dystrophin from synapses in dystrophic muscle may perturb the structure and/or
function of the synapse and contribute to muscular dystrophy.
MATERIALS AND METHODS
Isolation ofAChR-rich membranes and Western blotting
AChR-rich and AChR-poor membranes were isolated from Torpedo electric organ as
described previously (Burden et al., 1983). The Mr of 300 kDa protein was determined in
6% polyacrylamide SDS gels with human erythrocyte spectrin and rabbit macrophage actin-
binding protein as molecular weight standards (Woodruff et al., 1987). Peripheral proteins
from AChR-rich membranes were fractionated by two-dimensional gels as described
previously (Burden, 1985). Western blots were probed with monoclonal antibody (mAb)
hybridoma supernatant, affinity-purified antibodies against a trpE+60 kDa mouse
dystrophin fusion protein (encoding the first four repeats in murine dystrophin, Hoffman et
al., 1987) diluted 1/2000, and affinity-purified antibodies against a trpE fusion protein
containing the carboxy-terminal region of human dystrophin (antibody 11, Koenig and
Kunkel, 1990) diluted 1/500, followed by alkaline phosphatase-coupled secondary
antibodies.
Immunohistochemistry
Staining of unfixed frozen sections from Torpedo electric organ was performed as
described previously (Woodruff et al., 1987). Affinity-purified antibodies against a
trpE+60 kDa murine dystrophin fusion protein dystrophin (Hoffman et al., 1987) were
used at 1/2000, and hybridoma supernatant containing mAb 602 was used undiluted.
Frozen sections (8 um) from unfixed intercostal muscles were stained with biotinylated
mAb 601 (identical results were obtained with a different mAb against the Torpedo 300
kDa protein, mAb 607) or with antibodies against the trpE+60 kDa dystrophin fusion
protein (Hoffman et al., 1987) diluted 1/2000 for 1 hour at room temperature. Following
incubation with either fluorescein-labeled avidin or fluorescein-labeled goat-anti-sheep IgG
and TMR-BGT, sections were visualized with optics selective for either rhodamine or
fluorescein (Woodruff et al., 1987).
Rat myotubes were fixed (1% paraformaldehyde in PBS) for 15 minutes, washed (in
PBS), permeabilized with 0.1% NP-40 (in PBS), incubated with hybridoma supernatant
containing mAb 601 (2 hours at room temperature) and subsequently with fluorescein-
labeled goat-anti-mouse IgG and TMR-BGT. AChR clusters in the murine C2 muscle cell
line are labeled with mAb 601 as well (J. A. Theriot and S. J. Burden, unpublished
results).
Molecular biological methods.
300,000 recombinant phage from a Xgtl 1 Torpedo electric organ cDNA library
(Baldwin et al., 1988b) were screened with four different mAbs (601, 602, 603, 604) that
react exclusively with the Torpedo electric organ 300 kDa protein (Woodruff et al., 1987).
One positive phage (Tordys 1) was detected with mAb 602, and was found to contain a 4.1
kb cDNA insert. Our other monoclonal antibodies against the Torpedo 300 kDa protein do
not react with the fusion protein, and these antibodies presumably react with regions of the
Torpedo 300 kDa protein that are not encoded by the partial cDNA. Affinity purified
antibodies against the carboxy-terminal region of human dystrophin (antibody 10, Koenig
and Kunkel, 1990) also react with the fusion protein and with the Torpedo 300 kDa protein
(data not presented). cDNA from the purified phage was mapped with restriction
endonucleases and sequenced (Sanger et al., 1977; Baldwin et al., 1988a). The cDNA
clone encodes an additional -1.5 kb beyond the termination codon and ends with a 44 bp
poly A tract, which presumably represents the 3' end of the mRNA. The deduced amino
acid sequences of Torpedo 300 kDa protein and human dystrophin were aligned (Wilbur
and Lipmann, 1983).
An additional seven cDNAs were isolated by screening 80,000 recombinant phage
with an 915 bp probe derived from the 4.1 kb cDNA (nt 22 - 937 in Fig. 3.7; hybridization
in 5X SSC, 50 0 C, washed in 0.2X SSC, 56 OC) (Ravin et al., 1991). Thus, the relative
abundance of cDNAs in this library encoding dystrophin (0.9/10,000), 43 kDa protein
(4.5/10,000) (Baldwin et al., 1988b) and AChR alpha subunit (11/10,000) (Baldwin et al.,
1988a) is similar to the relative abundance of the corresponding proteins (1:10:20; Burden
et al., 1983).
32P-labeled, random-primed probe derived from the 4.1 kb cDNA encoding the
Torpedo 300 kDa protein was hybridized to a Northern blot of total RNA (-27 jgg) isolated
from Torpedo electric organ. The blot was hybridized overnight (in 5X SSPE) at 55 0 C
and washed (in 0.2X SSC, 0.1% SDS) at 570C (Baldwin et al., 1988a). An RNA ladder
of 9.5, 7.5, 4.4, 2.4, 1.4, 0.2 kb was used to estimate the size of the Torpedo transcript.
RESULTS
The Torpedo 300 kDa protein and dystrophin share epitopes.
Antibodies against the first four repeats in murine dystrophin react with a protein
concentrated in AChR-rich membranes isolated from Torpedo electric organ (Fig 3.1A).
The cross-reacting protein comigrates in SDS-PAGE with the 300 kDa subsynaptic protein
that we identified previously as a component of the postsynaptic membrane in Torpedo
electric organ and in skeletal myofibers (Fig. 3.1A) (Burden et al., 1983; Woodruff et al.,
1987).
Because several proteins could comigrate at 300 kDa, proteins from AChR-rich
membranes were resolved further by isoelectric focusing, and blots from two dimensional
gels were probed either with antibodies against human dystrophin or with a monoclonal
antibody (mAb) against the Torpedo 300 kDa protein. Figure 3.1B shows that the different
antibodies react with the same protein, since the 300 kDa protein, as well as the same set of
proteolytic fragments, are labeled with both antibodies. Thus, antibodies against
dystrophin react with the 300 kDa protein which we identified previously. Further, all of
our mAbs against the 300 kDa protein (Woodruff et al., 1987), and antibodies against
murine dystrophin (Hoffman et al., 1987), react in situ with the postsynaptic membrane of
the electrocyte (Fig. 3.1C; see also Chang et al., 1989).
mAbs against the Torpedo 300 kDa protein react with synaptic sites in normal, but not
dystrophic, muscle.
Among the mAbs that we produced against the Torpedo 300 kDa protein, mAb 601
cross-reacts with neuromuscular synapses in both amphibian and mammalian muscle
(Woodruff et al., 1987). We used mAb 601 to determine whether the molecule recognized
by this antibody is absent from synaptic sites in dystrophic (mdx) mouse muscle (Bullfield
et al., 1984). Figure 3.2 demonstrates that mAb 601 reacts with synaptic sites in normal,
but not in dystrophic, mouse muscle. Similarly, antibodies against murine dystrophin react
with synaptic sites in normal (Fig. 3.2; see also Chang et al., 1989), but not dystrophic,
muscle (Fig. 3.2). Extrasynaptic staining is also detectable with both antibodies in normal,
but not dystrophic, mouse muscle (Fig. 3.2). Thus, a protein in normal mouse muscle that
reacts with mAb 601 is absent from dystrophic muscle.
Utrophin (dystrophin-related protein, DRP) is the product of an autosomal gene, and
has striking homology to the product of the X-linked dystrophin gene (Love et al., 1989;
Tinsley et al., 1992). Since utrophin is retained in muscle from mdx mice (Khurana et al.,
1990; Ohlendieck et al., 1991), however, neither mAb 601 nor the antibodies against
murine dystrophin used in this study react with utrophin.
Clusters of AChRs occur at synaptic sites in innervated skeletal muscle and can also
form in the absence of innervation in cultured embryonic myotubes (Vogel et al., 1972;
Fischbach and Cohen, 1973). We examined whether the molecule recognized by mAb 601
is concentrated at AChR clusters in myotube cultures as well as at synaptic sites. Figure
3.3 demonstrates that mAb 601 staining is present throughout the myotube, but is
concentrated at AChR clusters. Moreover, there is an intricate arrangement of AChRs
within a cluster, and a similar, although not identical arrangement is seen with mAb 601
(see also Sealock et al., 1991). Since mAb 601 reactivity is concentrated at AChR clusters
in non-innervated embryonic myotubes and at synapses in newborn rats (data not
presented), the association of the 300 kDa subsynaptic protein with the postsynaptic
membrane is likely to be an early event during synaptogenesis. Further, since folding of
the plasma membrane at AChR clusters in cultured myotubes is rare (Vogel and Daniels,
1976), the accumulation of the 300 kDa protein at these sites cannot be attributed entirely to
an increase in membrane folding.
Dystrophin and the Torpedo 300 kDa protein
In our previous studies we used SDS-PAGE to estimate a Mr of 300 kDa for the
Torpedo electric organ subsynaptic protein (Woodruff et al., 1987). The molecular mass
of human dystrophin, calculated from the amino sequence deduced from cDNA, is 427 kDa
(Koenig et al., 1988). Figure 3.4 demonstrates that the Torpedo electric organ 300 kDa
protein and murine dystrophin comigrate in SDS-PAGE, since antibodies against murine
dystrophin react with a protein of identical size in Torpedo AChR-rich membranes and in
normal but not mdx mouse muscle.
The central domain of dystrophin is composed of 24 repeats (Koenig and Kunkel,
1990) which have structural similarity to repeats in spectrin and a-actinin (Davison and
Critchley, 1988; Hammond, 1987; Koenig et al., 1988). Each repeat is thought to be
organized into three alpha helices which form coiled-coil interactions, and this common
structural feature can be detected with antibodies raised against dystrophin, which can
cross-react with a-actinin (Hoffman et al., 1989). Antibodies against a-actinin (Bloch and
Hall, 1983) and P-spectrin (Bloch and Morrow, 1989), as well as antibodies against
dystrophin (Fig. 3.2; see also Chang et al., 1989), react with synaptic sites in skeletal
muscle; however, identification of the molecule(s) recognized by these antibodies is
complicated by the possibility of cross-reactivity due to the conserved structural feature
described above.
Although the lack of reactivity of mAb 601 in dystrophic muscle strongly suggests
that the antibody recognizes dystrophin, it remains possible, however, that the mAb cross-
reacts with another molecule whose loss is an indirect consequence of the absence of
dystrophin. Indeed, it is clear that other proteins, in addition to dystrophin, are absent
from skeletal muscle in the mdx mouse (Ervasti et al., 1990; Ohlendieck and Campbell,
1991b) and in individuals with Duchenne muscular dystrophy (Ohlendieck et al., 1993).
Thus, we sought to isolate cDNAs encoding the 300 kDa subsynaptic protein to more
firmly establish its relationship to dystrophin.
The sequence of a Torpedo electric organ cDNA is homologous to dystrophin.
We used mAbs against the Torpedo 300 kDa subsynaptic protein to screen an
expression library from Torpedo electric organ, and isolated a cDNA (Tordys ) which
encodes a protein that reacts with one of these mAbs (602). Since the isolated cDNA is 4.1
kb and hybridizes to RNA which is -14 kb in length (Fig. 3.5), the sequence encoded by
the Tordys 1 cDNA is incomplete. Sequencing of the protein-coding portion of the Tordys 1
cDNA revealed that the amino acid sequence deduced from this Torpedo cDNA is strikingly
homologous to human dystrophin (Fig. 3.6 and Fig. 3.7).
The amino acid sequence deduced from the 5' end of the cDNA has 59% and 72%
homology, respectively, with the 23rd and 24th repeat in human dystrophin (Koenig and
Kunkel, 1990; Davison and Critchley, 1988). This same repeat region has more limited
sequence homology with spectrins (-20%), a-actinin (28%) and myosins (-20%).
Moreover, alignment of the sequences encoded by the Tordys 1 cDNA and dystrophin
requires no gaps, whereas alignment of either the Tordys 1 cDNA or dystrophin with
spectrin requires two single amino acid gaps within each repeat (Koenig and Kunkel, 1990;
Davison and Critchley, 1988).
Additional sequence from this region of the Torpedo 300 kDa protein was obtained
by rescreening our Torpedo cDNA library with a 915 bp fragment from the 5' end of the
Tordys cDNA. One cDNA (Tordys2) isolated from this screen begins -2.15 kb further 5'
to the Tordys 1 cDNA, and has good homology with mammalian dystrophin in the region
encoding the 1 8th through 2 0 th repeats (Fig. 3.6 and Fig. 3.8). The remainder of this
cDNA, except for the very 3' end, has not been sequenced (see Fig. 3.6). The homology
between the 18 th repeat in human dystrophin and the sequence encoded by the Tordys2
cDNA is 53%, and gapping is not required. The homology between the 19th repeat in
human dystrophin and the sequence encoded by the Tordys2 cDNA is 48%, however this
alignment requires two gaps. One gap occurs near the beginning of the 19 th repeat where
mammalian dystrophin has seven amino acids that are not encoded by the Tordys2 cDNA
(Fig. 3.8B). Interestingly, these very same seven amino acids are also absent from the
same region of chicken dystrophin (Lemaire et al., 1988). A second gap of two amino acid
has also been introduced at the end of the 19 th repeat unit, and extends an additional four
amino acids into the 3rd hinge region which precedes the 20 th repeat unit. This 3rd hinge
region encoded by the Tordys2 cDNA is 51% similar to the corresponding region of human
dystrophin. Together these results show that the region of sequence homology between the
300 kDa protein encoded by the Tordys and Tordys2 cDNAs and human dystrophin
includes a region of dystrophin that is thought to be fundamental for establishing its tertiary
structure (Koenig and Kunkel, 1990; Davison and Critchley, 1988).
Since the dystrophin sequence which follows the repeat units is unrelated to spectrin
and vertebrate a-actinin, comparison within this region is a more stringent criterion for
establishing structural similarity to dystrophin (Koenig et al., 1988; Feener et al., 1989).
Figures 3.6 and 3.7 show that there is 97% homology between the fourth hinge region of
dystrophin and the proline-rich sequence following the predicted 24th repeat encoded by the
Tordys 1 cDNA. This degree of conservation suggests that the fourth hinge region of
dystrophin has a critical functional role, and that this domain has an importance in addition
to disruption of the alpha helical organization. Moreover, beyond the hinge region of
dystrophin is a cysteine-rich region followed by the carboxy-terminal domain. Both of
these regions are highly conserved in the Torpedo cDNA (91% and 89% identity,
respectively). Thus, the sequence encoded by the cDNA is highly homologous to
dystrophin, and is only distantly related to spectrin, a-actinin and myosin.
Since utrophin is strikingly homologous to dystrophin (the carboxy-terminal region
of utrophin has 80% amino acid sequence identity with the dystrophin a isoform) (Love et
al., 1989; Tinsley et al., 1992), it seemed possible that the protein encoded by the Torpedo
cDNAs could be the homolog of this autosomal gene, rather than of dystrophin. However,
alignment of the sequence encoded by the Tordys 1 cDNA with the protein product of
utrophin reveals 73% identity in the cysteine-rich and carboxy-terminal domains and
requires several gaps, whereas alignment with dystrophin shows 88% identity and requires
no gaps. Moreover, antibodies against mammalian dystrophin (antibody 11, Koenig and
Kunkel, 1990) react with the Torpedo 300 kDa protein, but not with mammalian utrophin
(Hoffman et al., 1989). Thus, we think it likely that the protein encoded by the Torpedo
cDNAs is Torpedo dystrophin.
Multiple dystrophin transcripts, which are generated by alternative splicing, yield
several isoforms (Feener et al., 1989). The b isoform of dystrophin lacks 13 amino acids
present in the carboxy-terminal region of the a isoform, and is generated by splicing and
removal of 39 nucleotides (Feener et al., 1989). The Tordys 1 Torpedo dystrophin cDNA
corresponds to the b isoform, and this alignment supports further the conclusion that the
protein encoded by the Torpedo cDNA is dystrophin. Further, a second cDNA isolated
during our rescreening of the electric organ cDNA library encodes an additional 13 amino
acids and corresponds to the a isoform (Tordys 3) (Figure 3.9). Thus, both the a and b
isoforms of dystrophin are present in Torpedo electric organ. Moreover, since all of our
monoclonal antibodies against the Torpedo 300 kDa protein react with the synaptic but not
the nonsynaptic membrane of the electrocyte, the a and b isoforms coexist on the
postsynaptic membrane.
DISCUSSION
This study demonstrates that a protein in Torpedo electric organ is highly
homologous to mammalian dystrophin. The extent of sequence homology with mammalian
dystrophin, and the conservation of at least one alternatively spliced exon, indicates that
this Torpedo protein is Torpedo dystrophin rather than a dystrophin-related protein.
Consistent with this interpretation, antibodies against murine dystrophin, which do not
cross-react with murine utrophin, react with the same 300 kDa electric organ protein that
copurifies with the AChR-rich postsynaptic membranes, and a mAb (601) directed against
the electric organ 300 kDa subsynaptic protein reacts with synaptic and nonsynaptic
membranes in normal, but not dystrophic, mouse muscle.
We think it is likely that the protein encoded by the three Tordys cDNAs, which we
designate Torpedo dystrophin, is the 300 kDa subsynaptic protein that we identified
previously on the basis of co-purification with AChR-rich postsynaptic membranes from
Torpedo electric organ. First, the cDNA encodes a protein that reacts with a mAb (602)
directed against the electric organ 300 kDa subsynaptic protein. Second, affinity purified
antibodies against the carboxy-terminal region of human dystrophin (antibody 10, Koenig
and Kunkel, 1990) also react with a P-gal fusion protein containing the protein encoded by
the Tordys 1 cDNA and with the Torpedo 300 kDa protein (data not presented). These
results support the conclusion that the 300 kDa subsynaptic protein which copurifies with
electric organ postsynaptic membranes is Torpedo dystrophin.
Furthermore, we have rescreened our electric organ cDNA library at moderate
stringency with a probe derived from the 4.1 kb Tordys 1 cDNA and isolated seven
additional cDNAs that encode Torpedo dystrophin. Thus, the abundance of dystrophin
cDNAs in the electric organ library is similar to the abundance of 300 kDa protein in the
electric organ (see Methods). Since no cDNAs encoding a dystrophin-like protein were
isolated during our library screens, dystrophin-related sequences are likely to be present at
much lower abundance than dystrophin, if at all, in the electric organ.
Studies have demonstrated that antibodies against dystrophin cross-react with a
Torpedo electric organ protein of -400 kDa that is enriched at the postsynaptic membrane
(Chang et al., 1989; Jasmin et al., 1990). Moreover, the former study showed that
antibodies against murine dystrophin cross-react with a protein at neuromuscular synapses
in normal rat muscle, and that antibodies against the Torpedo 400 kDa protein react with
non-synaptic membrane in normal, but not dystrophic, human muscle (Chang et al., 1989).
Because antibodies against dystrophin can cross-react with other proteins that contain
homologous domains, as described above, and because these studies did not determine
whether antibody staining was absent from synaptic sites in dystrophic muscle, it is
difficult to ascertain whether the cross-reacting molecule at the synapse is dystrophin,
rather than another molecule which shares epitopes with dystrophin. Indeed additional
studies demonstrated that some antibodies against dystrophin do react with synaptic sites in
dystrophic muscle, and these authors suggest that a dystrophin-related protein is present at
synaptic sites in normal muscle and persists in dystrophic muscle (Fardeau et al., 1990;
Pons et al., 1991). The residual anti-dystrophin immunoreactivity seen in these studies is
likely due to the cross-reactivity of these antibodies with utrophin, since subsequent studies
showed that utrophin is specifically concentrated in the postsynaptic membrane of the NMJ
(Nguyen thi Man et al., 1991; Ohlendieck et al., 1991; Bewick et al., 1992). Our study
demonstrates that there is extensive homology between the amino acid sequences for
mammalian dystrophin and the Torpedo 300 kDa subsynaptic protein, and that antibodies
against the Torpedo subsynaptic protein react with synaptic sites in normal but not
dystrophic muscle. Thus, we conclude that dystrophin itself is present in the electric organ
and at synaptic sites in skeletal muscle.
Consistent with the observations of others, our data suggests that in skeletal muscle
dystrophin is found in the both synaptic and nonsynaptic myofiber membrane, but is more
concentrated at synaptic sites (Chang et al., 1989; Fardeau et al., 1990). Unfortunately,
we can not determine from these data to what extent the increase in membrane surface area
at the synaptic site, due to the postsynaptic folds, contributes to the higher dystrophin
concentration observed by conventional immunofluorescence microscopy.
Immunoelectronmicroscopy of the mouse NMJ using gold-labeled antibodies against
dystrophin also suggests that dystrophin is slightly more abundant in the postsynaptic
membrane than in the remainder of the sarcolemma (Byers et al., 1991); however, these
results have yet to be confirmed by careful quantitative analysis.
The presence of dystrophin in the electrocyte, a cell which is specialized for synaptic
transmission and does not contract, suggests that dystrophin can have a role other than
stabilizing the plasma membrane from structural distortion during contraction. Further, the
location of dystrophin exclusively at the postsynaptic membrane of the electrocyte suggests
that dystrophin's function in this cell is associated with synaptic structure and/or function.
This idea is further strengthened by studies showing that dystrophin immunoreactivity is
concentrated at postsynaptic membrane specializations in cortical neurons of the central
nervous system (Lidov et al., 1990; Kim et al., 1992). Since AChRs are concentrated at
synaptic sites in dystrophic muscle (Fig. 3.2), it seems clear that dystrophin is not required
for the formation of AChR clusters. Indeed, dystrophin also appears to be absent from
many AChR-rich domains at AChR clusters in cultured myotubes (Sealock et al., 1991; see
also Fig. 3.4). Both high resolution fluorescence microscopy (Sealock et al., 1991) and
immunoelectronmicroscopy studies (Byers et al., 1991) suggest that dystrophin is more
specifically associated with the troughs of the junctional folds, and is only infrequently
seen at the crests. These results suggest a role for dystrophin in organizing the structure of
the postsynaptic membrane, and in particular the postjunctional folds. Consistent with this
idea, electron microscopic studies of dystrophic muscle have illustrated simplification of the
synapse, notably a reduction in the number of postjunctional folds (Jerusalem et al., 1974;
Torres and Duchen, 1987; Nagel et al., 1990). However, these changes may reflect
properties of degenerating or regenerating muscle and may only be an indirect consequence
of loss of dystrophin.
Recent studies suggest that utrophin, in contrast to dystrophin, associates specifically
with AChR domains at the crests of the postjunctional folds (Bewick et al., 1992), and
utrophin immunoreactivity is also coincident at AChR clusters in developing muscle and at
AChR clusters in cultured muscle cells (Phillips et al., 1993). These studies suggest that
utrophin may be involved in clustering AChRs and/or organizing AChR-rich domains in
the postsynaptic membrane, and that its function at the postsynaptic membrane is different
from that of dystrophin. Alternatively, dystrophin and utrophin may be functionally
identical. Consistent with this idea, high resolution immunofluorescence microscopy of the
electric organ reveals dystrophin immunoreactivity throughout the postsynaptic membrane
of the electric organ, including AChR-rich domains (Sealock et al., 1991). Moreover,
utrophin-specific antibodies react only weakly with the postsynaptic membrane of the
electric organ, whereas antibodies specific for dystrophin produce a more robust signal
(Cartaud et al., 1992; see also Fig. 3.1C). These data suggest that utrophin is expressed at
a much lower level that dystrophin in the electric organ, and that dystrophin substitutes
functionally for utrophin in organizing the postsynaptic membrane in this tissue. The
differential distributions of dystrophin and utrophin in the postsynaptic membrane of
muscle may simply reflect a higher affinity of one or the other for a differentially distributed
component of the DGC. Recently, 82 -syntrophin has been shown to be expressed
exclusively at the NMJ in skeletal muscle (Peters et al., 1994), but it remains unknown
whether its distribution is further restricted to the tops or bottoms of the postjunctional
folds.
We do not know how the loss of dystrophin from skeletal muscle results in
myopathies, but it has been proposed that may affect the stability of the muscle plasma
membrane resulting in damage to the muscle during muscular contraction. Although the
NMJs of DMD patients appear normal with respect to AChR distribution, AChR content,
and the frequency and amplitude of miniature endplate potentials (Sakakibara et al., 1977),
loss dystrophin from the NMJ nevertheless may have consequences which subtly
contribute to muscular dystrophy. Current ideas for therapeutic treatment of patients with
muscular dystrophy include gene replacement therapy (Acsadi et al., 1991; Ragot et al.,
1993), and injections of normal myoblasts into dystrophic muscle to promote formation of
chimeric myotubes containing normal nuclei (Partridge et al., 1989). Since the synaptic
region of a skeletal myofiber is less than 1% of the myofiber volume, and dystrophin may
not diffuse freely in a myofiber, reconstitution of synaptic dystrophin may require that
normal nuclei be situated in the synaptic region. If dystrophin has an important role at the
synapse, successful therapeutic treatment may require a substantial increase in the
efficiency of normal myoblast incorporation into chimeric myotubes.
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Figure 3.1. Antibodies against dystrophin cross-react with the Torpedo
300 kDa subsynaptic protein, which copurifies with AChR-rich membranes.
A) Postsynaptic membranes from Torpedo electric organ were fractionated in an
equilibrium density sucrose gradient and the protein composition was analyzed by SDS-
PAGE. Proteins in AChR-rich (R) and AChR-poor (P) membranes were fractionated by
SDS-PAGE (6% polyacrylamide) and either stained with Coomassie Brilliant Blue or
transferred to nitrocellulose and probed with mAb (602) to the Torpedo 300 kDa protein or
antibodies to murine dystrophin (trpE+60 kDa). Both antibodies react with the 300 kDa
protein (open arrow), which is more abundant in AChR-rich than in AChR-poor
membranes. Labeling of the protein band just beneath the 300 kDa protein with mAbs
against the 300 kDa protein is variable, and is likely due to partial proteolysis of the 300
kDa protein. Antibodies against dystrophin, but not mAbs against the Torpedo 300 kDa
protein, react with several proteins (*) that are enriched in AChR-poor membrane fractions
and are thus not likely to be proteolytic fragments of dystrophin; these proteins are not
labeled with secondary antibody alone, and therefore cross-react with the antibodies against
murine dystrophin. B) Peripheral membrane proteins from AChR-rich were resolved by
two dimensional electrophoresis, transferred to nitrocellulose and probed either with mAb
(602) to the Torpedo 300 kDa protein or with affinity purified antibodies to the carboxy
terminal region of human dystrophin (antibody 11). The different antibodies react with the
same protein, since the 300 kDa protein (arrowhead) as well as the same set of proteolytic
fragments are labeled with both antibodies. The basic (b) and acidic (a) directions are
indicated. C) The innervated surface of the Torpedo electrocyte is labeled with mAbs
against the Torpedo 300 kDa protein and antibodies against dystrophin. Single frozen
sections of Torpedo electric organ were labeled with tetramethylrhodamine-labeled a-
bungarotoxin (BGT) (b, d ,f) and with either mAb 602 (a), antibodies against dystrophin
(c), or mAb against a Torpedo intermediate filament protein (e) (Burden, 1982). The
magnification is 400x.
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Figure 3.2. Both antibodies against murine dystrophin and mAb against
the Torpedo 300 kDa protein label synaptic sites in normal, but not in
dystrophic, mouse muscle.
Frozen sections of normal (a-d) and mdx (e-h) mouse muscle were labeled with
biotinylated mAb 601 (a, e), or anti-dystrophin antibodies (trpE+60) (c, g), followed by
appropriate fluorescein-labeled secondary reagents and TMR-BGT (b, d, f, h). We have
not investigated whether the number or size of endplates is altered in mdx muscle. The bar
is 20 gm.
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Figure 3.3. AChR clusters in primary rat myotubes are labeled with mAb
against the Torpedo 300 kDa protein.
Rat myotubes were labeled with mAb 601 (a, c), followed by fluorescein-labeled goat-anti-
mouse IgG and TMR-BGT (b, d). Antibody labeling is present throughout the myofiber,
but is concentrated at AChR clusters. Within AChR clusters, a similar pattern of labeling is
seen with TMR-BGT and mAb 601. The bar is 10 gm.
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Figure 3.4. The Torpedo 300 kDa protein and murine dystrophin comigrate
in SDS-PAGE.
Proteins from Torpedo electric organ AChR-rich membranes and total protein (-70 mg)
from normal and mdx mouse muscle were fractionated by SDS-PAGE (6%
polyacrylamide), transferred to nitrocellulose and probed with antibodies to murine
dystrophin (trpE+60 kDa; Hoffman et al., 1987). The Torpedo electric organ 300 kDa
protein and murine dystrophin comigrate in SDS-PAGE (arrowhead), since antibodies
against murine dystrophin react with a protein of identical size in Torpedo AChR-rich
membranes (R) and in normal (nor), but not mdx (mdx) mouse muscle. Labeling of
skeletal muscle protein(s) that migrate more slowly than dystrophin is non-specific, since
labeling is detected with secondary antibody alone (control); the anti-dystrophin antibodies,
however, cross-react weakly with myosin (arrow), which is present at similar levels in
normal and mdx muscle.
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Figure 3.5. The Torpedo 300 kDa protein is encoded by a 14 kb mRNA.
The cDNA encoding the Torpedo 300 kDa protein hybridizes to a -14 kb RNA
(arrowhead) in Torpedo electric organ. The positions of RNA size markers are indicated.
The filter was exposed to x-ray film with an intensifying screen for 3 days at -700C.
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Figure 3.6. The domain structure of dystrophin and the domain
organization of the Torpedo 300 kDa protein is identical.
A.) The cartoon illustrates the location of the amino terminal region (shaded box), repeat
units (open boxes), hinge regions (black boxes), cysteine-rich region (hatched box) and
carboxy-terminal domain (cross-hatched box) in dystrophin (Koenig and Kunkel, 1990).
Homologous regions within the Torpedo 300 kDa protein are labeled similarly. Repeat
units 3-17 and the 2 nd hinge region of dystrophin are indicated by the broken line.
Parentheses illustrate the region of the 300 kDa protein that is not encoded by any of our
300 kDa protein cDNAs. The putative 21st and 22nd repeats of the 300 kDa protein
(question marks) have not been sequenced, but are presumably included in the Tordys2
cDNA. The approximate location of the thirteen amino acid alternatively spliced exon
which is absent in the dystrophin b isoform is indicated by the arrow. The three cDNAs
described in this study are shown below the regions of the Torpedo 300 kDa protein they
encode. Tordys1 is the original Torpedo 300 kDa protein cDNA identified as the
dystrophin b isoform. Tordys2 is the cDNA (2.4 kb) that encodes sequence further 5' to
Tordysl. Tordys3 encodes the a isoform of Torpedo dystrophin, as it has the thirteen
amino acids (residues 3410-3422 in human dystrophin) which are characteristic of the
dystrophin a isoform. Light gray shaded regions represent the approximate locations of
sequenced portions of the cDNAs. B) Homology between human dystrophin and the
Torpedo 300 kDa protein is indicated separately for each domain: 18th repeat, amino acids
2209-2318; 19th repeat, amino acids 2319-2423; 3rd hinge, amino acids 2424-2470; 23rd
repeat, amino acids 2803-2931; 24th repeat, 2932-3040; 4th hinge, 3041-3112; cysteine-
rich, 3113-3360 and carboxy-terminal, 3361-3685 (Koenig and Kunkel, 1990; Koenig et
al., 1988).
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Figure 3.7. The amino acid sequences of the Torpedo 300 kDa subsynaptic
protein and human dystrophin are similar.
A) The nucleic acid and amino acid sequence of the protein coding portion of the 4.1 kb
Tordys 1 cDNA are shown. B) The protein coding portion of the Tordys cDNA encoding
the 300 kDa protein (TORDYS) is aligned with the human dystrophin (HUMDYS)
sequence that extends from amino acid 2803 to the carboxy-terminus of the a isoform.
Identical residues in the HUMDYS sequence are indicated with a dash (-) and amino acid
substitutions are shown by the one-letter amino acid notation. A gap in the TORDYS
sequence, which is indicated by asterisks (*), aligns with amino acids 3409-3421 in
HUMDYS, and signifies the b isoform of dystrophin; homology between the human
dystrophin b isoform and the portion of the Torpedo 300 kDa protein encoded by the
Tordys1 cDNA is 84%. The boundaries between specific domains in human dystrophin
are shown below the aligned sequences (R - repeat unit; 4th H - 4th hinge domain; Cys -
cysteine-rich domain; C-term - carboxy-terminal domain).
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AAGTCGTGAGCAGTGAAGCGGCTGCAGATCTCCCTCCAGGACTTCCTGACGTGGATGAATTTGAAGAACGATGAACTAAGGAGGCAAATCCCATTGGTGGTGATCTCCCACAGT 120
S G E Q W K R L Q I S L Q D F L T W M N L K N D E L R R Q M P I G G D A P T V C (40)
CAGCAGAACGATGTTCACCGAATTTTCAAGCGAGAGTAAGGCAAGGAACCAGTGGTATGAGCGCTTGACACAGTGCATTTTTCTTGGCTGATCCACAATCAGACTCCTGAA 240
Q Q N D V H R I F K R E L K A K E P V V M 9 A L D T V H L F L A D P A I R A P E (80)
AGTCTTTTAACTGACCAAGAGAGAAAATACCTGAAGAGAACATCCAAATGTTGCGAAACGCATTGGAAGATCCGAGGAGGTGAAGTGGAATGGGATAAGCTGAGCAATCGCTCT 360
S L L T G P R E K I P E E N I Q N V A K R I R K Y A E E V K V E W D K L S N R S (120)
GTGA CAGAAGCGTATAGATGAGCCTTGAAGAGACTACTGGAA A GA ATGAATTGAACCTCAAATTGAGACAGGCAAGCTATCAAAATACAGCAACCT 480
V D W 0 K R I D E A L K R L L E L Q D S M D E L N L K L R Q A E A I K D T W Q P (160)
GTCGGGGATCTACTAATAGACTCATTGCAGGATCACATTGA AGG TTTT AGAAAGCTCCCATGAAGGAAAATGTGACTCTCGCTCCCAGTTC 600
V G D L L I D S L Q D H I E K V K V F R A E I A P M K E N V T H M N D L A S Q F (200)
ACACCACCTGATATCCAATTATCCCCGTACAATCTAAACCAGTTGGAGGATCTGAACACACGGTGGAAACTCTTGCAGGTGTCTATAGATGAGCTTCTGAAGCAGCTGCATGAGGCTCAT 720
T P P D I Q L S P Y N L N Q L E D L N T R W K L L Q V S I D E L L K Q L H E A H (240)
AGAGATTTTIGGACCAACATCCCAGCACTTCCTATCAACTTCTGTCCAGGGTCC GGA CGAGCAA ATCACCCAACAAGGTCCCTACTACATTAACCACCAAACTCAGACCACCTGC 840
R D F G P T S Q H F L S T S V Q G P W E R A I S P N K V P Y Y I N H Q T Q T T C (280)
TGGGATCACCCCAAGATGACGGAGCTCTATCAGTCACTAGCCGATCTAAATAATGTCAGGTTTTCTGCATATAGAACTGCCATAAACTGCGAAGACTGCAGAAAGCTCTTTGCTTGGAT 960
W D H P K M T E L Y Q S L A D L N N V R F S A Y R T A M K L R R L Q K A L C L D (320)
CTTCTCTCCCTGCCAAGTGCTTGTGAGGCCTTTGATCAGCACAACCTGAAACAGAACGATCAACTGTTGGATATTTTAGAAATAATTAACTGCTGACTTCAATCTAATCGGCGAG 1080
L L s L P S A C E A F D Q H N L K Q N D Q L L D I L E I I N C L T S I Y D R L E (360)
CAGGAACACAGCAACCTTGCAACGTGCTCTTTGTGTGGACATGTTTAAACTGGCCTCAAGTCTATGACATGGTCGAACAGGGAAGATCCGTCCTCCTTTAAAAGTGA 1200
Q E H S N L V N V P L C V D M C L N W L L N V Y D T G R T G K I R V L S F K S G (400)
ATCATGTCTATGTGCAAAGCACACCTGGAGGACAAATACCGTTATCTGTTCAAGCAAGTGCGAGTCCCACTGGATTCTGTGATCAGCGCAGGCTTGGGCTTCTACCATGAGGCGATT 1320
I M S M C K A H L E D K Y R Y L F K Q V A S P T G F C D Q R R L G L L L H E A I (440)
CAGATTCCACGCCAGCTGGGAGAGGTTGCATCCTTTGGAGGCAGCAACATAGAACCCAGTGTTCGCAGCTGCTTCCAGTTTGCCAATAACAAGCCGGAGATCGAGGCAGCTTTGTTCCTG 1440
Q I P R Q L G E V A S F G G S N I E P S V R 8 C F Q F A N N K P E I E A A L F L (480)
GAGGATGAGGCTGGAGCCTCAGTCCTTGGTCTGGATCCAGTCCTCCACAGAGTGCAGCAGCTGAGACAGCCAAACACCAGGCCAAGTGCAATATATGCAAAGAA CATCAT 1560
D W M R L E P Q S L V W M P V L H R V A A A E T A K H Q A K C N I C K E C P I I (520)
GGATTCAGATACCGGAGCTTAAAGCACTTCAATTATGATGTCTGCCAAAGTTGCTTCTTTTCTGGTCGAACACAAAATCATAAAATCATTACCCAATTGGAATATTGTACACCG 1680
G F R Y R S L K H F N Y D V C Q S C F F S G R T A K G H K M H Y P M V E Y C T P (560)
ACCCATCAGGAGAAGATCCGAGA CCAA AAAAACAAGTTCCGAACAAAGAGACTTCAAAACACCCGGATGGATATCTGCCA CAGACAG G A 1800
T T S G E D V R D F A K V L K N K F R T K R Y F A K H P R M G Y L P V Q T V L E (600)
GGGGATAACTTAGAAACACCTGCCTCCTCCCCTCAGTGTCACATGATGATACTCATTCACGAATTGAACATTATCTGAGCAGGCTAGCAGAAATGGAAAACAGAAATGATTTACTTG 1920
G D N L E T P A S S P Q L S H D D T H S R I E H Y L S R L A E M E N R N G S Y L (640)
AATGACAGCATCTCACCCAATGAGAGCATAGATGATGAGCATCTTGATTAGCATTACTGCCAGAGCCTGAACCAGGAGTCGCCACTGAGTCAGCCTCGAAGCCCTGCTCAAATTCC 2040
N D S I S P N E S I D D E H L L I Q H Y C Q S L N Q E S P L S Q P R S P A Q I L (680)
ATCTCC GTGAAGAGAGGGGAGAGGGAAAGAATCCTCGCTGACCTGGAGGATGAAAACAGAAACCTTCAGTCTGAGTATGAGAAGCTAAAGCAGAACATGATCACAAGGGT 2160
I S L E S E E R G E L E R I L A D L E D E N R N L Q S E Y E K L K Q Q H D H K G (720)
CT CTCCTGAGATGATGCCCATTTCACCGCAGAGTCCCAGGGATGCCGAGCTCATCGCTAAGCCAAACTCTCGTCAGCACAAAGGTCGCC AG AGG 2280
L S P L P S P P E M M P I S P Q S P R D A E L I A E A K L L R Q H K G R L E A R (760)
ATGCAGATCCGGAAGATCACAACAAGCAGTTGGAATCGCAGCTCCACAGACTGAGGCAGCTCTGGAGCAGCCACAGCGGAGTCAGAGTCAATGTACTTCGGTTTCCTCACCCTCG 2400
M Q I L E D H N K Q L E S Q L H R L R Q L L E Q P Q A E V R V N G T S V S S P S (800)
ACTTCCTCACAAAGATCAGACAGCAGCCAGCCAGTCCTACTGCATGGAGTTGGCAGTCAAACTTCAGGAATACTGGGTGAGGATGATTTGTTGAGTGCTCCCCAAAGTACCArCAGTAA 2520
T S 9 Q R S D S S Q P V L L H G V G S Q T S G I L G E D D L L 9 A P Q S T S S E (840)
TTGGAAATGTAATGAGCAACTCAGCAGTTCCTTTCCAAGCTCTCAACGGAGGGATACTCCTGGAAAGAAAATGAAAGAGGTACCAATGTAG 2613
L E D V M E Q L S S S F P S S Q R R D T P G K K M K E V P M (870)
B
TORDYS SGEQWKRLQISLQDFLTWMNLKNDELRRQMPIGGAPTVCQQNDVHRIFKRELKAKEPVVMSALDTVHLFLADPAIRAPESLLTGPREKIPEENIQNVARRIRKYAEEVKVEWDKLSNRS 120
HUMDYS -SD ---- --- EL-V-LQ--D---S--A-----F-A-QK------ A ------ T --- I--T-ET--I--TQPLGL-K-QE---LP---RA---TRLL--Q----NT--E--NLH- 2922
TORDYS VDWQKRIDEALKRLLELQDSMDELNLKLR4QAEAIKDTWQ PVGDLLIDSLQDHI•KVFRAE0IAPMKENTHMLASQFTPPDIQLSPYNLNQLEDLNTRWKLVSIDELLKQLHE 240
HUMDYS A-.-RK ------- EAT----------V--G-- ---- ---- AL-G----L----S-V----R-L-TLG--------ST------------- AVEDRVR-- 3042
23R 24R 24R 4 NhH
TORDYS RDFGPTSQHFLSTSVQGPWERAISPNKVPYYINHQTQTTCWDHPKMTELYQSLADLNNVRFSAYRTAMKLRRLQKALCLDLLSLPSACEAFDQHNLKQNDQLLDILE INCLTSIYDRLE 360
HUMDYS ----- A - --------------------------------- SA---- D-L ---------- PM--------T------ 3162
4flH Cys
TORDYS QEHSNLVNVPLCVDMCLNWLLNVYDTGRTGKIRVLSFKSGIMSMCKAHLEDKYRYLFKQVASPTGFCDQRRLGLLLHEAIQIPRQLGEVASFGGSNIEPSVRSCFFANNKPEIEAALFL 480
HUMDYS --- N------------- ----------- R T------------- - 3282
TORDYS DWMRLEPQSLVWMPVLHRVAAAETAKHQAKCNICKECPIIGFRYRSLKHFNYDVCQSCFFSGRTAKGHKMPMVEYCTPTTSGEDVRDFAKVLKNKFRTKRYFAKHPRMGYLPVTLE 600
HUMDYS --------- M--L------------------------------------------------------------- -----------------------------------  3402
Cya C-rnn
TORDYS GDNLET*************PASSPQLSHDDTHSRIEHYLSRLAEMENRNGSYLNDSISPNESIDDEHLLQHYCQSLNQESPLSQPRSPAQILISLESEERGELERILADLEDENRNLQS 707
HUMDYS --- M--PVTLINFWPVDSA ------------------------ - ---- - - - - - - --- E------A 3522
TORDYS EYEKLKQQHDHKGLSPLPSPPE8MPISPQSPRDAELIAEAKLLRQHKGRLEARMQILEDHNKQLESQLHRLRQLLEQPQAEVRVNGTSVSSPSTSSQRSDSSQPVLLHGVGSQTSGILGE 827
HUMDYS -- DR----- E --------------- T-------------------- --------------- --- AK----T-------L--------M--RV------DSM-- 3642
TORDYS DDLLSAPQSTSSELEDVMEQLSSSFPSSQRRDTPGKKMKEVPM 870
HUMDYS E----P--D--TG--E-----NN-----RG-N----P-R-DT- 3685
Figure 3.8. The amino acid sequence of upstream regions of the Torpedo
300 kDa protein also show similarity to dystrophin.
A) The partial nucleotide and amino acid sequence encoded by the 5' end of the Tordys2
cDNA is shown. This cDNA was isolated by rescreening the Torpedo electric organ cDNA
library with a 5' fragment of the Tordys cDNA. The 3' end of the Tordys2 cDNA
corresponds to nucleotide 742 in the Tordysl cDNA (see Fig 3.6), confirming that the
Tordys and Tordys2 cDNAs encode overlapping regions of the same RNA. B) The
amino acid sequence encoded by the Tordys2 cDNA (TORDYS) is aligned with amino
acids 2221-2522 of human dystrophin (HUMDYS). Identical residues in the HUMDYS
sequence are indicated with a dash (-) and amino acid substitutions are shown by the one-
letter amino acid notation. Gaps have been introduced to optimize alignment and are
indicated by asterisks (*). Boundaries between specific domains in the human dystrophin
sequence are indicated beneath the aligned sequences (R - repeat unit; 3rd H - 3rd hinge).
The 7 amino acids in human dystrophin (amino acid 2325-2331) which span the gap
introduced in the 19th repeat of the TORDYS sequence are also absent from the
corresponding region of chick dystrophin. The homology between human dystrophin and
the region of the 300 kDa protein shown is 56%.
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A
GAATTCCCCCATTGGCTAGAAGATGCAGTGAACACTCTGGGATTAGTACCTGACCCTGGAAATGAGCAGCAGCTG 75
E F P H W L E D A V N T L G L V P D P G N E Q Q L (25)
AAAGATTCACTGGAGAGCGTCAAGTTGCGAGTGGAGCAATTACCCACACGGAAAGGGATATTGAAGTGTTTAAAT 150
K D S L E S V K L R V E Q L P T R K G I L K C L N (50)
GATAGAGGAGCATCAGCATTCCAAAGCAAGTCTCTGGTCCCAGAACAACGCTTTAAATTGGAAACACATCTCCTG 225
K R G A S A F Q S K S L V P E Q R F K L E T H L L (75)
CAGGGTAATAATCGCTGGACAAAGGTATCAAAAGATCTGCCTGAGAAACAAAAAGAAATCGAAGAGTCTTTGAAG 300
Q G N N R W T K V S K D L P E K Q K E I E E S L K (100)
GACTTTGCACTATTTCAGCAGCAGCTCAACCTGCTGACTCTCTGGATCTCCACAACAAAGCAGCAGTTGGAATCA 375
D F A L F Q Q Q L N L L T L W I S T T K Q Q L E S (125)
TACACGCAAGCACCATTGCCAGGAATCTTTAATATTCAGGAGACAGAAGAAAGAGTACTAGCCAAACAGCCTGAT 450
Y T Q A P L P G I F N I Q E T E E R V L A K Q P D (150)
GTGGAAGACATATTTTCCAAGGCACAGCATTTCTATCAGGATAAACCGATTTCTCAACCATTAAAGGGAAAAATT 525
V E D I F S K A Q H F Y Q D K P I S Q P L K G K I (175)
GACAACCTGAATTCTGACTGGAAGATAATAAACAAGTTATTGCATGACCTGAAACAAAGTCATCAACCTGGTGTT 600
D N L N S D W K I I N K L L H D L K Q S H Q P G V (200)
GCTTCATCCACACTGCAAACAGTATCCGTGGTGGCACAGATGCCCGTTACCACGGAAACATCCTTCACAAAGTTA 675
A S S T L Q T V S V V A Q M P V T T E T S F T K L (225)
GACATGCCATCCTCTTTGCTCATGGATGTCCCAGCTCTGGCTGACTTCAATAAGGCCTGGGTGGAACTGACAGAC 750
D M P S S L L M D V P A L A D F N K A W V E L T D (250)
TGGCTCTCACTGCTGGATCGTGTGATCAAGTCTCAGCTTGTGACTGTGGGAGACGTTGAAGAAATCAATGACATG 825
W L S L L D R V I K S Q L V T V G D V E E I N D M (275)
ATCATAAAACAGAAGGCCACTCTGCAAGACTTGGATCAAA... 865
I I K Q K A T L Q D L D Q ... (288)
B
TORDYS EFPHWLEDAVNTLGLVPDPGNEQQLKDSLESVKLRVEQLPTRKGILKCLN 50
HUMDYS --VL---E-D-IASIPLE--K-----EK--Q---L--E--L-Q----Q-- 2271
TORDYS DRGASAFQSKSLVPEQRFKLETHLLQGNNRWTKVSKDLPEKQKEIEESLK 100
HUMDYS ET-GPVLV-APIS--EQD---NK-K-T-LQ-I---RA---G-I-AQI- 2321
18R 19R
TORDYS DFA*******LFQQQLNLLTLWISTTKQQLESYTQAPLPGIFNIQETEER 143
HUMDYS -LGQLEKKLEDLEE---H-L--L-PIRN---I-N-PNQE-P-DV----IA 2371
TORDYS VLAKQPDVEDIFSKAQHFYQDKPISQPLKGKIDNLNSDWKIINKLLHDLK 193
HUMDYS -Q-K------- L--GQ-L-KE--AT--V-R-LED-S-E--AV-R--QE-R 2421
TORDYS *******QSHQPGVASSTLQTVSVVAQMPVTTETSFTKLDMPSSLLMDVP 236
HUMDYS AKQPDLAPGLTTIG--P-*---TL-T-PV--K--AIS--E-----MLE-- 2471
19R 3rd H 3rd H
TORDYS ALADFNKAWVELTDWLSLLDRVIKSQLVTVGDVEEINDMIIKQKATLQDLDQ 288
HUMDYS ------ R--T----------Q-----R-M---L-D--E-------- M---E- 2522
20R
Figure 3.9. The dystrophin a isoform is present in Torpedo electric organ.
The region of human dystrophin (amino acids 3400-3432) that includes the thirteen amino
acids which are characteristic of the a isoform (boxed amino acids) is aligned with the
corresponding region of a Torpedo dystrophin cDNA (Tordys3 in Fig. 3.6). Amino acids
residues of human dystrophin that are identical to those in the Torpedo 300 kDa protein are
illustrated by dashes (-), otherwise the one letter amino acid notation is used.
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Torpedo 300 kDa
dystrophin
VLEGDNLETPVTLINFWPVDYEPASSPQLSHDD
---- M------------SA- ------------ 3432
Chapter 4.
Identification and Partial Characterization of INN1, DENI, and
DEN2: Three Novel Genes That are Regulated by Innervation
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SUMMARY
Innervation is an important regulator of neuromuscular development and muscle
physiology. Upon innervation, localized factors released from the nerve terminal
concentrate acetylcholine receptors (AChRs) in the postsynaptic membrane by inducing
both a redistribution of existing AChRs, and by activating AChR gene expression in
nuclei near the synaptic site. Simultaneously, electrical stimulation of the muscle fiber by
the motoneuron inactivates AChR gene expression in all myofiber nuclei, while it
activates expression of acetylcholine esterase (AChE). In addition, nerve-evoked
electrical activity in muscle has been implicated in secondary fiber myogenesis,
motoneuron survival and polyneuronal synapse elimination. To further understand how
innervation affects neuromuscular physiology and gene expression, we used a
subtractive-hybridization and cloning approach to identify three novel genes, INN1,
DEN], and DEN2, whose expression are differentially regulated in innervated and
denervated rat skeletal muscle. In RNA blots, three distinct INN] RNAs are detected in
adult muscle (1.7, 2.3, and 5.2 kb). Expression of the 1.7 kb major INN] transcript is
down-regulated -5-fold following denervation, whereas expression of the 2.3 and 5.2 kb
minor transcripts are up-regulated 2- to 3-fold and -5-fold, respectively. Thus, while the
total level of INN] RNA does not change dramatically following denervation, the levels
of individual INN] transcripts change differentially, and these results suggest that
splicing of INN] transcripts is regulated by innervation. A cDNA corresponding to the
denervation down-regulated 1.7 kb INN1 transcript was isolated, and sequencing showed
that this transcript encodes a 22 kDa protein with 66% identity to a protein encoded by
NSP], a gene which has been cloned from both rat brain and human small cell lung
carcinoma. Tissue distribution studies reveal that INN] is expressed at low levels in
many tissues, but it is expressed at much higher levels in brain, heart and skeletal muscle,
suggesting a role of INN 1 in the response of these tissues to electrical stimulation.
Consistent with this idea, immunolocalization of INN1 in skeletal muscle suggests that
INN 1 is a component of the sarcoplasmic reticulum and may be involved in the
regulation of sarcoplasmic calcium levels in response to electrical stimulation. In
contrast to INN], DEN1 and DEN2 encode single transcripts (-9 and 2 kb, respectively)
which are up-regulated following denervation (>50-fold and 3- to 5-fold, respectively).
Sequencing of a partial DEN] cDNA reveals that DEN1 contains multiple
immunoglobulin C2 and fibronectin type III motifs similar to those found in muscle
structural proteins such as titin, while DEN2 has similarity to the family of small heat
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shock proteins which include aB-crystallin and HSP27. In light of these findings,
potential functions of DEN1 and DEN2 in muscle physiology are discussed.
INTRODUCTION
Denervation of skeletal muscle results in profound atrophy of myofibers correlated
with changes in electrophysiological properties (Thesleff, 1974), sarcomeric morphology
(Engel and Stonnington, 1974), an overall increase in proteolysis (Furano et al., 1990)
and the loss of contractile strength (Finol et al., 1981). Similar effects are observed also
when muscle is rendered electrically inactive by pharmacological blockade of neuronal
stimulation (Drachman and Johnston, 1975; Brown et al., 1982; Spector, 1985a). Direct
electrical stimulation of denervated muscle lessens the effects of denervation on the
properties of the myofiber (see Lomo, 1976), and these results point to the importance of
nerve-evoked electrical activity in the maintenance of skeletal muscle physiology.
Nerve-induced muscle activity has been implicated also in many aspects of
neuromuscular development, including myogenesis, fiber-type differentiation, synapse
formation, motoneuron survival, and poly-neuronal synapse elimination. During skeletal
muscle myogenesis, two populations of myotubes, termed primary and secondary, form
during two distinct waves of proliferation and fusion (Kelley and Zacks, 1969; Ross et
al., 1987a). Primary myotube fusion occurs independent of innervation, since initial
myotube formation proceeds normally in both aneural and electrically inactive muscle
(Harris, 1981; McLennan, 1983; Ross et al., 1987b). In contrast, secondary myotubes fail
to form under these conditions, and these results indicate that formation of secondary
myotubes is dependent upon electrical activity. Since the numbers of mononucleated
cells are also reduced in aneural or partially denervated muscle, the regulation of
secondary myotube formation by electrical activity may be mediated through the
activation of myoblast proliferation (Ross et al., 1987b).
The frequency of the nerve-evoked electrical stimulation also affects the
differentiation of muscle fiber types. Mature muscle fibers can be broadly classified by
their contractile and biochemical properties as either fast of slow. These classifications
also reflect the nature of the motoneurons which innervate them in that fast and slow
muscles are innervated by neurons which provide either high or low frequency
stimulation, respectively. Many years ago, Buller et al. demonstrated that when the nerve
from a slow twitch muscle is redirected to innervate a fast twitch muscle, the myofibers
acquire properties of slow-twitch muscle. Similarly, a slow muscle can be transformed
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into a fast muscle by cross-innervation with a fast-twitch nerve (Buller et al., 1960).
Subsequent studies showed that simply altering the firing patterns of the innervating
motoneurons is sufficient to transform muscle fibers from one type to the other (for
review, see Pette and Vrbovi, 1985). Moreover, in denervated rat soleus (a slow muscle)
which is reinnervated by both the regenerated slow motoneuron and ectopically by a fast-
twitch nerve, fast muscle myosin heavy chain is induced in a localized area around the
ectopic endplate (Salviati et al., 1986). Taken together, these studies convincingly
demonstrate that motoneuron activity influences the expression of muscle fiber type-
specific genes.
During synapse formation, muscle activity has been implicated in maturation of the
postsynaptic membrane. In muscle paralyzed during the period of synapse formation by
treatment with a-bungarotoxin, folding of the post-synaptic membrane is simpler when
compared to untreated controls (Duxson, 1982). In addition, synaptic AChE is greatly
reduced in paralyzed muscle both in vivo and in vitro (Giacobini et al., 1973; Rubin et
al., 1980), but direct electrical stimulation of the paralyzed muscle can counteract this
effect (Rubin et al., 1980). Further, studies using ectopically innervated muscle have
demonstrated that while contact between the muscle and foreign nerve is required to
determine the location of the ectopic synapse, the continued presence of the ectopic nerve
is not required; direct stimulation of the muscle induces AChE expression and folding of
the postjunctional membrane at ectopic synapses even after the degeneration of the
ectopically innervating motor axon (Lomo and Slater, 1980; Brenner et al., 1983). These
results strongly indicate that electrical activity is required for both synapse maturation
and AChE expression in muscle.
In contrast, muscle activity has a repressive effect on AChR expression. In adult
muscle, AChRs are approximately 1000- to 5000-fold more concentrated in the
postsynaptic than in the extrasynaptic membrane (Fertuck and Salpeter, 1976).
Following denervation, however, the expression of extrajunctional AChRs increases
dramatically (Axelsson and Thesleff, 1959; Hartzell and Fambrough, 1972), and this
increase in extrasynaptic AChRs can be reversed by direct stimulation of the muscle
(Lomo and Rosenthal, 1972; Lomo and Westgaard, 1975). Thus, while electrical activity
induces the appearance of AChE, it simultaneously suppresses the expression of
extrasynaptic AChR.
The increase in extrasynaptic AChR expression following denervation results from
synthesis of new receptors and not simply redistribution of junctional AChRs (Brockes
and Hall, 1975; Linden and Fambrough, 1979; Merlie et al., 1984). More recently,
electrical activity has been shown to down-regulate the levels of AChR subunit mRNAs
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in myofiber nuclei in vivo (Goldman, et al., 1988; Merlie and Kornhauser, 1989; Tsay
and Schmidt, 1989; Simon et al., 1992), and in myotubes in culture (Klarsfeld and
Changeux, 1985; Dutton et al., 1993). Thus, inactivation of extrasynaptic AChR
expression in innervated muscle is regulated at the level of transcription. Members of the
MyoD family of transcriptional activators, which are involved in the induction of many
muscle specific genes during myogenesis, are regulated by electrical activity in parallel
with AChR genes (Duclert et al., 1991; Eftimie et al., 1991; Witzemann and Sakmann,
1991; Neville et al., 1992; Weis, 1994). Moreover, recent studies have demonstrated that
an E-box near the transcription start site of the AChR 8 regulatory region is critical for
regulation of the gene by electrical activity (Tang et al., 1994), and similar results have
been reported for the regulation of the AChR a-subunit following denervation (Bessereau
et al., 1994). Since the expression of other muscle genes with E-boxes in their regulatory
regions, such as muscle creatine kinase, is relatively unaffected by denervation (Asher et
al., 1992), E-boxes alone are not sufficient to confer activity-dependent regulation. These
results raise the possiblity that additional transcriptional regulators, in conjuction with E-
box binding proteins, regulate electrical activity-responsive gene expression.
Electrical activity regulates AChR levels post-translationally as well as
transcriptionally. By three weeks following denervation, the half-life of pre-existing
junctional AChRs decreases roughly 4-fold, from -10 days to -3 days (Loring and
Salpeter, 1980; Bevan and Steinbach, 1983; Fumagalli et al., 1990). Since treatment of
innervated muscle with TTX mimics the effect of denervation on AChR stability,
whereas direct stimulation of denervated muscle prevents the change in synaptic AChR
half-life (Fumagalli et al., 1990), junctional AChR stability is regulated by electrical
activity.
The mechanism of activity-dependent AChR stabilization appears to involve
changes in cytosolic calcium and/or cyclic AMP (cAMP). Treatment of chronically
denervated muscle in organ culture with calcium ionophore stabilizes synaptic AChRs,
while blockade of dihydropyridine sensitive Ca2+ channels in electrically stimulated
muscle prevents stabilization of endplate AChRs (Rotzler et al., 1991). Curiously, Ca 2+
influx through the plasma membrane seems to be required for maintenance of junctional
receptor stability since increasing internal calcium levels through release of Ca2+ from the
sarcoplasmic reticulum does not stabilize junctional AChRs in denervated muscle
(Rotzler et al., 1991). Treatment of muscles in organ culture with agents which elevate
cytoplasmic cAMP levels also can reverse the denervation-dependent changes in the half-
life of junctional AChRs (Shyng, et al., 1991); it is not clear, however, whether the cAMP
and Ca 2+ mediated pathways affecting AChR stability share the same mechanism.
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In addition to its effects on muscle development and physiology, muscle activity
also affects the development of motoneurons. Concomitant with synapse formation, a
large fraction of motoneurons degenerate and die. If muscle fiber activity is blocked
either presynapticly or postsynapticly during this period, however, a greater percentage of
motoneurons survive (Pittman and Oppenheim, 1978; 1979; Laing and Prestige, 1978).
On the other hand, electrical stimulation of the muscle increases the number of
motoneurons which die (Oppenheim and Niinez, 1982). These studies argue that muscle
activity has a role in motoneuron survival.
Similar studies have also demonstrated the role of muscle activity in the elimination
of polyneuronal innervation at motor endplates. During the period of synaptogenesis,
myofibers become innervated by multiple motoneurons, usually at a single synaptic site.
Later in development, the number of motoneurons innervating any single myofiber are
culled until each myofiber is innervated by a single motoneuron (Redfern, 1970; Brown
et al., 1976). Studies in both developing rat and chick demonstrated that pharmacological
paralysis of muscle prevents the loss of multiple innervation (Thompson et al., 1979;
Brown et al., 1981; Ding et al., 1983). In contrast, direct electrical stimulation of muscle
enhances the rate of synapse elimination (O'Brien et al., 1978).
Additional studies showed that high frequency stimulation of muscle is more
effective at accelerating synaptic loss than low frequency stimulation (Thompson, 1983).
Moreover, in singly innervated myofibers, local application of a-bungarotoxin to a small
region of the endplate results in the loss of postsynaptic AChRs and the withdrawal of
that portion of the nerve terminal overlying the region of treated endplate (Balice-Gordon
and Lichtman, 1994). These studies suggest that differences in the activity of synaptic
sites determine which synapses are lost during synapse elimination. Efforts to test this
hypothesis directly in developing muscle, however, have led to conflicting results; in one
case the more active input at the endplate was favored, while in another, endplates of the
least active input were preserved (Betz et al., 1990; Callaway et al., 1987). Another
hypothesis proposed to explain synapse elimination is competition between motoneurons
for muscle derived neurotrophic factors. Indeed, recent studies demonstrated that
exogenous application of ciliary neurotrophic factor (CNTF) or basic fibroblast growth
factor (bFGF) near developing neuromuscular synapses extends the period of
polyneuronal innervation in rats (English and Schwartz, 1995). In addition, injections of
insulin-like growth factor IGF1 prevent the normal down-regulation of growth-associated
proteins in motoneurons which normally occurs during the period of synapse elimination
in adult rats (Caroni and Becker, 1992); whether these molecules play any role in
endogenous synapse elimination, however, remains unknown.
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Nerve terminal sprouting is another phenomenon associated with muscle
denervation which is affected by muscle activity. Both presynaptic and postsynaptic
blockade of electrical activity induces neurite sprouting from motoneuron terminals
(Duchen and Strich, 1968; Brown and Ironton, 1977; Holland and Brown, 1980), and,
again, such sprouting can be blocked by direct stimulation of the denervated muscle
(Brown et al., 1980). Since extracts of denervated muscle have an enhanced neurite-
promoting activity in vitro compared with extracts of innervated muscle (Henderson et
al., 1983), it is believed that denervated muscle releases one or more diffusable factors
which stimulate nerve terminal sprouting. Electrical activity presumably inhibits
synthesis of these factors, or, as with AChRs, restricts their expression to the motor
endplate region of the innervated muscle fiber. Indeed, studies in partially denervated
muscle have suggested that release of sprouting factors may be coupled to AChR
insertion into the sarcolemma, since sprouting from terminals adjacent to extrasynaptic
regions of the denervated muscle fibers is delayed with respect to sprouting from
terminals closer to the denervated endplate (Pockett and Slack, 1982).
Nerve terminal sprouting and synapse elimination may be closely linked
mechanisticly. CNTF, bFGF, and IGFs, in addition to affecting synapse elimination, all
promote neurite outgrowth in vitro and in vivo (Gurney et al., 1992; Caroni and Grandes,
1990). Consistent with a role for IGFs in the regulation of neurite sprouting, increases in
the levels of IGF1 mRNA and protein in skeletal muscle are detectable within 12 hours
following denervation or paralysis, and remain at elevated levels for many days thereafter
(Caroni and Schneider, 1994). Similarly, IGF2 mRNA levels are up-regulated in
denervated muscle, but with a much slower time course, reaching a maximum (-4-fold
increase) at 10 days following denervation (Ishii, 1989; Glazner and Ishii, 1995).
Moreover, adult rat motoneurons express IGF1 receptors (Caroni and Becker, 1992), and
IGF binding proteins delivered to paralyzed muscle effectively prevent nerve sprouting in
vivo (Caroni et al., 1994). These studies all suggest a role for IGFs in the regulation of
motoneuron physiology by muscle.
In an effort to further understand the affects of innervation and electrical activity on
muscle physiology and gene expression, Xuejun Zhu, a graduate student in the lab,
developed a PCR-based subtractive-hybridization and cloning technique to identify
mRNAs that are differentially-expressed in innervated and denervated rat skeletal muscle.
This chapter describes the partial characterization of three novel genes in skeletal muscle,
INN], DEN], and DEN2, that Xuejun and I identified using this technique. Our results
show that the expression of both DEN] and DEN2 are up-regulated following
denervation. In contrast, the regulation of INN] expression response to denervation is
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more complex; whereas the expression of one transcript decreases, the expression of two
other transcript increases following denervation. In addition, our subtractive-
hybridization screen identified several known genes whose expression in muscle was not
previously known to be regulated by innervation. One of these, the acute myeloid
leukemia gene AML1, encodes a DNA binding protein with homology to the protein
encoded by the Drosophila pair-ruled gene runt, and disruptions or translocations of the
AML1 gene can result in a form of acute myeloid leukemia. A paper describing the
expression of AMLI in innervated, denervated and developing rat muscle has been
published (Zhu et al., 1994) and is included in the following chapter.
MATERIALS AND METHODS
Denervation of rats and preparation of RNA
Adult Sprague-Dawley rats were anesthetized by interperitoneal injection (20
mg/ml ketamine (KetaSet), 1 mg/ml xylazine (Xylaject) in 0.9% NaC1), and the lower leg
was denervated by removing -2 mm of sciatic nerve. RNA from the denervated (4 - 5
days) and the contralateral innervated lower leg muscle was isolated as described
(Chomczynski and Sacchi, 1987), and stored at -80°C. Poly (A)+ RNA was purified with
oligo(dT) cellulose (Aviv and Leder, 1972).
Preparation of subtraction libraries
Oligo(dT) 12-18 (Pharmacia) was used to prime the first strand cDNA synthesis from
2 gg of poly (A)+ RNA. The second strand was synthesized as described (Gubler and
Hoffman, 1983). The average size of the cDNA was about 2 kilobases. Innervated and
denervated muscle cDNAs were digested with AluI and RsaI separately and pooled to
produce short fragments appropriate for PCR amplification. Linkers bearing EcoRI sites
were added to the blunt-ended cDNAs, and cDNAs in the range of 150 bp to 1 kb were
gel-purified and pooled. PCR amplification, photo-biotinylation of driver DNA,
hybridization and removal of biotinylated driver DNA were done as described (Wang and
Brown, 1992), except that only 2 gg of target DNA and 40 jgg of driver DNA were
included in the hybridization reactions. Four rounds each of long and short
hybridizations were carried-out and the subtraction efficiency was evaluated by probing
subtracted innervated and denervated cDNA with denervated cDNA probe. Denervated
subtracted cDNA hybridized 40x stronger than the innervated cDNA, indicating that there
is minimal shared sequences between the two subtracted libraries. The subtracted DNAs
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were digested with EcoRI and cloned into the EcoR1 site of pBluescript II SK+
(Stratagene) to generate the subtracted libraries. The libraries were screened with
random-primed 32 P-labeled subtracted probe, and positive colonies were then subjected to
further analysis. DNA was sequenced with Sequenase, according to the manufacturer's
(USB) instructions.
Initially, 20 colonies from the denervated-minus-innervated subtracted library were
screened; 13 colonies contained cDNA encoding aB-crystallin, and 7 colonies contained
cDNA encoding either MAPla, filamin, or AML1. A second denervated subtracted
library was prepared by subtracting aB-crystallin sequences from the original library.
Eighteen colonies from this library contained cDNAs encoding mRNAs that are
expressed at higher levels in denervated than in innervated skeletal muscle; these
included cDNAs encoding AChR subunits, N-CAM, filamin, DEN1 and DEN2. At
present, only 2 colonies from the innervated-minus-denervated subtracted library have
been screened.
Muscle cDNA library construction
Innervated and denervated muscle cDNA libraries were constructed for the isolation
of full-length sequences using the isolated cDNA fragments from the subtracted libraries
as probes. Muscle mRNA was isolated as described above. First strand of cDNA was
primed with an oligo(dT) primer containing a SalI site at the 5' end. The second strand
was synthesized as described (Gubler and Hoffman, 1983). The cDNAs were blunt-
ended with T4 polymerase and EcoR1 adapters were ligated to the ends. The cDNAs
were size selected, digested with SalI, and cloned between the SalI and EcoRI sites of
pBluescript II SK+. The average size of the cloned inserts was approximately 1.5 kb.
RNase protection assay
RNase protection assays were performed as described (Simon et al., 1992). Briefly,
antisense RNA probes were radiolabelled during transcription in vitro from linearized
plasmids containing short cDNA inserts, and were hybridized to total RNA in
hybridization buffer overnight at 42TC. The reactions were treated with RNases A and T1
to remove unhybridized RNA, digested with proteinase K, and extracted using
phenol/chloroform. Protected RNA was precipitated with ethanol, and fractionated in 5%
denaturing polyacrylamide gels. Protected RNAs were quantitated by Phosphoimager
(Bio-Rad).
Northern blots
132
Total RNA was fractionated by electrophoresis in 1.1% agarose/formaldehyde gels
and transferred to Nytran membrane (Schleicher and Schuell) by downward alkaline
capillary transfer (Chomczynski, P., 1992). DNA probes were labeled by random-
oligonucleotide priming (High Prime Labeling Kit - Boehringer-Mannheim), and
hybridized to membranes overnight in 6X SSPE, 5X Denhardt's solution, 0.5% SDS, and
100 gg/ml herring sperm DNA at 68°C. Membrane were washed in 0.1% SDS, 0. 1X
SSPE for 1-2 hours at 68°C and exposed with an intensifying screen for up to 8 days. In
some experiments, radiolabelled probe was removed prior to rehybridization with a
second probe by boiling the membrane in 0.1X SSPE, 0.5% SDS for 10 min.
Immunohistochemistry
Frozen sections (-10 jim) from unfixed rat soleus muscle were stained with a rabbit
polyclonal antiserum raised against the N-terminal INN peptide
(MDGQKKHWKDKVVD) coupled to a MAP-carrier (Research Genetics, Huntsville,
AL). Sections were stained overnight at 4°C, followed by incubation with fluorescein-
conjugated goat-anti-rabbit IgG (Cappel) (1:200). Sections were mounted in 100 jlg/ml
paraphenylenediamine, 90% glycerol, 100 mM Tris, pH 9.5, and visualized using optics
selective for fluorescein. Images were captured and digitized using a CCD camera
(Princeton Instruments), and image processing software software (Metamorph; Universal
Imaging Corp.)
Preparation of protein extracts and fractionation.
Muscle from 5-day denervated and contralateral innervated rat lower leg muscle
was harvested and quickly frozen in liquid nitrogen. The muscle was pulverized using
mortar and pestle under liquid nitrogen and homogenized using a Polytron homogenizer
(Brinkman Scientific) in RIPA buffer (20 mM HEPES, pH 7.4, 150 mM NaC1, 0.1%
SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 1mM EDTA, plus protease
inhibitors: 2 gig/ml aprotinin, 2jig/ml leupeptin, 1 glg/ml pepstatin, 1 mM pefabloc
(Boehringer-Mannheim Pharmaceuticals)). The lysates were cleared by centrifugation,
aliquoted, and stored at -800C.
For fractionation, pulverized tissue was homogenized in 20mM Tris maleate pH 7,
0.3 M sucrose, 0.5 mM EDTA, 0.1 mM DTT, 1 mM iodoacetamide, 1 mM benzamidine,
2 jig/ml aprotinin, 2gg/ml leupeptin, 1 jgg/ml pepstatin, 1 mM pefabloc using a
glass/Teflon homogenizer on ice. The homogenate was centrifuged at 15,000xg for 15
min. at 4°C to remove unbroken cells, nuclei, and connective tissue. KCl to 0.6M was
added to the supernatant and the mixture was incubate 1 hr. at 4°C on a rocker platform.
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The KCl treated lysate was centrifuged at 100,000xg to pellet membranes. The
supernatant containing soluble proteins was saved, and the pellet resuspended in Tris
maleate/0. 1% Triton X-100 buffer. Aliquots of both soluble and membrane protein
fractions were flash frozen in liquid nitrogen, and stored at -800C.
Protein concentrations were estimated using the DC Protein Assay (Bio-Rad).
Western blots
SDS sample buffer was added to whole muscle or fractionated muscle lysates to 1X
(62.5 mM Tris pH 6.8, 10% glycerol, 0.1 M DTT, 1% SDS, 2.5 gg/ml bromophenol
blue), the samples heated for 5 min. at 65°C, and the proteins fractionated by SDS-PAGE
on 12% gels. Following electrophoresis, proteins were transferred to nitrocellulose
filters, and stored at 4°C. Protein blots were probed with either the anti-INN1 polyclonal
antiserum (1:2000) or monoclonal antibody IXE112 (1:500) against the rabbit TS28
transverse-tubule antigen (Jorgensen et al., 1990). Horseradish peroxidase (HRP)
coupled antibodies were used to detect bound primary antibody, and were visualized by
enhanced chemilluminescence (ECL, DuPont).
RESULTS
Identification of mRNAs that are regulated by innervation
We used a PCR-based subtractive-hybridization and cloning method (Wang and
Brown, 1991) to identify genes which are regulated by innervation in rat skeletal muscle.
Approximately twenty or so genes are known to be regulated by electrical activity and/or
innervation (see Table 4.1 legend). cDNAs encoding transcripts from four of these genes
(AChR a and 8 subunits, N-CAM, and aB-crystallin), whose expression increases
following denervation, were detected in a denervated-minus-innervated library screened
with a subtracted probe. cDNAs encoding three characterized proteins (MAPla, filamin,
AML1) whose expression was not known to be regulated by electrical activity were also
identified in this screen. In addition, we identified cDNAs encoding two novel proteins
(DEN], DEN2) whose expression increases following denervation and a novel protein
(INN]) whose expression decreases following denervation. The results of the subtractive-
hibridization and cloning screen are summarized in Table 4.1. I selected three of these
genes, INN], DEN] and DEN2 for further study.
INN] mRNA exoression is down-regulated following denervation.
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To confirm that INN1 expression in rat muscle is down-regulated following
denervation, the levels of INN] RNA in both innervated and 5 day denervated rat skeletal
muscle were quantified by RNase protection. Figure 4.1 shows that INN] mRNA levels
decrease approximately 5- to 7-fold following denervation.
Since the expression of several genes are restricted to subsets of muscle fibers (i.e.
fast and slow fibers) (see Gunning and Hardeman, 1991), I also examined the expression
of INN] mRNA in muscles comprised primarily of either fast (extensor digitorum longus,
EDL) or slow (soleus) fibers. Figure 4.1 shows that INN] mRNA is expressed in both
fast (EDL) and slow (soleus) muscle fibers. The level of INN] mRNA in innervated fast
muscle was slightly higher (approximately 30%) than in innervated slow muscle. INN]
mRNA, however, is down-regulated similarly (5- to 7- fold) in both fast and slow
muscles.
RNase protection assays were also used in a time course experiment to study the
rate at which INN] mRNA levels fall following denervation. This study reveals that
INN] mRNA levels decrease gradually following denervation (Fig. 4.2).
In innervated skeletal muscle, mRNAs from several genes are concentrated at
synaptic sites owing to selective expression of these genes in subsynaptic nuclei (Merlie
and Sanes, 1985; Goldman and Staple, 1989; Brenner et al., 1990). Several non-muscle
cell types, including Schwann cells and fibroblast-like cells (Conner and McMahan,
1987; Gatchalian et al., 1989; Weis et al., 1991), are also found near synaptic sites and
respond to denervation. Thus, these perisynaptic cells could be the source of INN]
expression in muscle. Since synaptic sites are usually confined to a restricted area of
mammalian muscles, the synapse-enriched and synapse-poor regions of the rat soleus
muscle were dissected, and the level of INN] mRNA in each fraction was measure by an
RNase protection assay. These experiments show that equal amounts of INN] RNA are
expressed in both synapse-enriched and synapse-poor regions (Fig. 4.3). Thus, INN]
expression is not restricted to synaptic sites, but is expressed throughout the muscle,
presumeably in myofibers. These studies, however, do not exclude the possibility that
INN] mRNA is expressed in Schwann cells and synaptic fibroblasts in addition to
skeletal muscle.
In order to determine whether INN] is expressed in tissues other than skeletal
muscle, RNase protection assays were performed using RNA isolated from a variety of
rat tissues. These studies demonstrate that low levels of INN] mRNA can be detected in
almost all rat tissues assayed. Significantly higher levels of INN] RNA (-10- to 75-fold),
however, are expressed in brain, cerebellum, heart, and innervated skeletal muscle (Fig.
4.4). Since brain, heart and skeletal muscle are all electrically active tissues, the
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increased expression of INN] in these tissues suggests that INN] protein may have a
function related to responsiveness of these tissues to electrical stimulation (see
Discussion).
Cloning of a full-length cDNA encoding INN]
The INN] cDNA isolated from the library enriched for sequences that are up-
regulated in innervated muscle encodes only 217 nucleotides. In order to obtain a full-
length INN] cDNA, the 217 bp fragment was used to screen an innervated rat muscle
cDNA library. A 1650 bp cDNA was isolated from this screen, and sequencing revealed
an open reading frame encoding a 199 amino acid protein with a predicted molecular
weight of approximately 22 kDa (Fig. 4.5). An ATG start codon at nucleotide (nt) 129
from the 5' end of the insert, is preceded by an in frame stop codon at nt 87 and is flanked
by nucleotides with similarity to the consensus sequence for vertebrate translation
initiation (Cavener and Ray, 1991). A polyadenylation addition site at nt 1633 is
followed by a 20 nucleotide poly A sequence at the 3' end of the 1650 bp cDNA insert.
These results suggest that the 1650 bp cDNA represents a full-length INN] transcript.
A hydropathy analysis of the INN1 primary sequence reveals two large hydrophobic
regions within the INN1 protein (amino acid 24 - 59, and 126 - 151) (Kyte and Doolittle,
1982) (Fig. 4.6A), and this suggests that INN] may encode a transmembrane protein; the
INN1 protein, however, lacks an amino terminal signal peptide. The INN1 protein
contains two N-glycosylation consensus sequences (i.e. Asn-X-Ser/Thr) at residues 106-
108 and 177-179, as well as sites for potential phosphorylation by protein kinase C (PKC)
(Ser60, Ser125, and Ser179), and tyrosine kinase (Tyr 12), but whether such modifications of
the INN protein occur remains unknown.
INN1 is related to NSPl.
A search of protein databases reveals a striking similarity between INN 1 and
proteins encoded by the neuroendocrine specific protein gene (NSP]) from human small
cell lung carcinoma cell lines (Roebroek et al., 1993) The human NSP1 gene encodes
three alternatively spliced mRNAs, (-3.4 kb, 2.1-2.3 kb and 1.8 kb), encoding NSP1A,
lB and 1C proteins respectively, and cDNAs encoding each of these transcripts have
been isolated (Roebroek et al., 1993). In addition, a rat homologue of NSP1, which is
identical to human NSP1C at all but two amino acids (98% identity) has been identified
from a rat brain library (Wieczorek and Hughes, 1991). The primary sequences of INN 1
and NSP1C, are 66% identical (Fig. 4.6B), thus, the INN] cDNA does not encode rat
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NSPl. Rather, INN] is related to NSP1 and may be a new member of a larger gene
family.
Alternative splicing of INN] is regulated by innervation.
To confirm that the 1650 bp INN1 cDNA encodes the full-length INN1 transcript,
this fragment was used to probe blots of total RNA isolated from innervated and 5-day
denervated rat muscle. Figure 4.7 shows that this probe hybridizes to a major transcript
of approximately 1.7 kb whose expression is down-regulated in denervated muscle in
accordance with the 5- to 7-fold decrease in INN] RNA levels measured by an RNase
protection assay. Two minor transcripts of -2.4 kb and -5.2 kb were also detected in
these experiments, and this result suggests INN] encodes multiple transcripts derived by
alternative splicing. Further, whereas expression of the 1.7 kb transcript is down-
regulated following denervation, expression of the 2.4 and 5.2 kb transcripts is up-
regulated, and these results suggest that these splicing events are regulated by
innervation.
Since the denervation-induced decrease in 1.7 kb INN] transcript levels parallels the
decrease in INN] RNA measured by RNase protection assays, it seems likely that the
probe used in the RNase protection assays described above only recognizes the 1.7 kb
INN] transcript. If so, then the change in the overall level of INN] RNA following
denervation may be less significant than those measured by RNase protection, since the
2.4 kb and 5.2 kb INN] transcripts are up-regulated following denervation. The sequence
of the 217 bp INN] cDNA fragment isolated from the innervated-minus-denervated
subtractive library is identical to the 5' end of the 1.65 kb INN] cDNA (nt 1 - 217). In
order to investigate the possibility that this probe only recognizes the 1.7 kb INN]
transcript, the RNase protection assay was repeated using a probe from an overlapping
region of the 1.65 kb INN] cDNA (nt 169 - 410). In contrast to the previous results, no
difference in the levels of INN] RNA in innervated and denervated muscle was detected
(Fig. 4.8A). These results suggest that while alternative splicing of INN] transcripts
responds to denervation, the total amount of INN] mRNA remains unchanged.
Moreover, these results suggest that at least one additional INN] transcript shares the
same 3' sequence with the 1.7 kb INN] transcript.
Since I have not isolated cDNAs encoding the 2.4 and 5.2 kb INN] mRNAs, the
sequences of the proteins encoded by these transcripts remains unknown. Comparison
with the human NSP1 gene, however, may provide some insight into the proteins that are
likely to be encoded by the alternatively spliced INN] mRNAs. NSP1 encodes at least
three proteins which are produced by alternative splicing of the NSP1 transcript such that
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the three proteins share the same 188 carboxy terminal amino acids. If splice sites are
conserved between INN] and NSPJ, the different INN] transcripts should share the same
3' sequences and should have unique 5' ends. This idea is consistent with the results from
the RNase protection assays described above. Moreover, when the sequences of INN]
and NSPI C are aligned, the position of the NSPI C splice site aligns with the INN]
sequence just upstream of the region shared by the two INN] RNase protection assay
probes (Fig. 4.8B). These results are consistent with the idea that INN] is alternatively
spliced and that the location of the splice sites in INN] and NSP1 are conserved such that
at least two of the three INN] transcripts share the same 3' sequences. Further, since the
location of this splice site (nt 162) is between Lysll and Vall2 in the INN1 sequence, it is
possible that the INN1 proteins contain unique amino termini.
A 22 kDa protein encoded by INN] is expressed in skeletal muscle.
In order to determine the subcellular distribution of INN 1 protein in skeletal
muscle, I produced a polyclonal antiserum against a peptide encoding the amino-terminal
14 amino acids of INN 1. Immunoblotting of extracts from lower leg muscle showed that
the INN1 antiserum recognizes a 22 kDa protein (Fig. 4.9), which is consistent with the
size of the INN1 protein predicted from the 1.65 kb cDNA sequence. Binding of
antibodies to the 22 kDa protein is specific since it can be blocked by preincubation of
the antiserum with the appropriate peptide (Fig. 4.9), and the protein is not recognized by
pre-immune serum (see Fig. 4.13). The antiserum also recognizes a second protein at 42
kDa, and binding to this protein is also specific since it is not observed with pre-immune
serum and is competed with peptide. The 42 kDa protein may represent the protein
product of one of the larger INN1 transcripts. Indeed, if INN] transcripts are alternatively
spliced and if the splice sites in INN] and NSP1 are conserved as described above, the
last three amino acids in the 14 amino acid immunizing peptide should be shared by all
INN1 proteins. Thus, binding of the INN1 antiserum to multiple proteins is not entirely
unexpected. Alternatively, the 42 kDa protein could be a protein unrelated to INN1
which nevertheless cross-reacts with the INN1 antiserum. Figure 4.9 also shows that
roughly equivalent levels of both the 22 kDa and 42 kDa proteins are expressed in
innervated and 5-day denervated muscle. Thus, the differential regulation of INN]
transcripts in innervated and denervated muscle is not reflected in a similar regulation of
the level of the INN1 protein at 5 days after denervation. Perhaps longer denervations
will be required to detect changes in the level of INN1 protein.
Since the protein encoded by the 1.65 kb INN] cDNA contains hydrophobic regions
characteristic of membrane proteins, crude membrane fractions from innervated rat
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muscle were prepared, and the abundance of INN1 protein was assayed by
immunoblotting. Figure 4.10 demonstrates that the 22 kDa INN 1 protein is enriched in
membrane fractions of rat muscle extracts, and this result is consistent with the idea that
INN1 is a membrane protein, tightly associated with membranes, or sequestered within a
membrane-bound organelle. Surprisingly, the 42 kDa protein appears to be enriched in
the supernatant fraction from these preparations, suggesting that it is a soluble protein. If
the splicing of INN] and NSP1 transcripts is conserved, the carboxy-termini of all INN1
proteins should contain two large hydrophobic regions which have been proposed as
transmembrane domains (see above). Thus, if the 42 kDa protein is a protein encoded by
INN], these hydrophobic regions may not be transmembrane domains. Further, these
results would suggest that differences in the amino-terminal portions of the 22 kDa and
42 kDa INN] proteins would be responsible for their differential fractionation.
I stained frozen sections of skeletal muscle with the INN1 antiserum to determine
the distribution of INN1 protein within skeletal myofibers. In cross-sections of skeletal
muscle, anti-INN 1 staining reveals a honeycomb-like, reticulated pattern within each
myofiber (Fig. 4.11). This staining is specific since it is not observed with pre-immune
serum and is competed with preincubation of the antiserum with the peptide. In
longitudinal sections of muscle, stripes of a-INN1 staining are observed in register with
the sarcomeric I bands (Fig. 4.12). Similar immunostaining patterns have been reported
for proteins found in the sarcoplasmic reticulum and in transverse tubules (Jorgensen et
al., 1979; Jorgensen et al., 1990). These results suggest that INN1 proteins may be
localized to the SR and/or transverse tubules as well. In order to determine whether
INN1 is localized to transverse tubules, preparations of KCl-washed microsomal
membranes and purified transverse tubule membranes from skeletal muscle were
obtained, and the presence of INN was determined by immunoblotting. These
experiments show that INN1 protein is present in the microsomal membrane
preparations, but not in purified transverse tubules which are enriched for the transverse
tubule protein TS28 (Fig. 4.13). Thus, INN1 is membrane associated, but is not localized
to the transverse tubule membranes of skeletal muscle.
DEN 1 and DEN2 are up-regulated following denervation.
Two novel genes, DEN] and DEN2, which are up-regulated in denervated muscle,
were identified by subtractive-hybridization and cloning. RNase protection assays show
that DEN] and DEN2 are up-regulated 50- to 100-fold and 3- to 5-fold, respectively, after
5-days of denervation (Fig. 4.14). To determine how rapidly DEN] and DEN2 RNA
levels increase following denervation I measured their expression levels by an RNase
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protection assay and found that increases in DEN] and DEN2 RNA levels are first seen
two days following denervation (Fig. 4.15). Between 2 and 5 days following
denervation, DEN2 RNA levels increase only slightly, whereas DEN] RNA levels
increase substantially (25- to 50-fold) (Fig. 4.15). The time course of the increase in
DEN] RNA levels in response to denervation is similar to that observed for AChR
subunit RNAs (Fig. 4.15).
Northern blots of total RNA from innervated and 5-day denervated rat skeletal
muscle show that DEN1 and DEN2 encode single transcripts of approximately 9 kb and 2
kb, respectively (Fig. 4.16). These RNA blots confirm the results from RNase protection
assays that the levels of DEN1 and DEN2 RNA increase approximately 50- and 5-fold,
respectively, by 5-days following denervation.
DEN] encodes a protein with fibronectin type III and immunoglobulin-like repeats.
The 198 bp DEN] cDNA isolated by subtraction hybridization cloning was used to
probe a cDNA library made from 5-day denervated rat skeletal muscle RNA, and several
overlapping cDNAs were isolated. The longest of these, a 3318 bp cDNA, contains a
large open reading frame encoding 929 amino acids (Fig. 4.17). The open reading frame
begins at the 5' end of the 3.3 kb cDNA and extends to a stop codon at nt 2790. This stop
codon was followed by 529 bp of additional DNA, including a polyadenylation addition
site (ATTAAA) at nt 3293 and 25 bp of poly A sequence. Since the open reading frame
begins at the very 5' end of the 3.3 kb DEN] cDNA, and since RNA blots reveal that the
full-length DEN] cDNA is approximately 9 kb, this 3.3 kb cDNA encodes only the C-
terminal region of the DEN] protein.
Database searches revealed that DEN1 contains domains which are similar to
fibronectin type III motifs (FnIII, F) and immunoglobulin C2 domains (Ig, I). Both FnIII
and Ig domains are common to a variety of thick filament-associated structural proteins
found in vertebrate and invertebrate muscle, including titin (Labeit et al., 1990; Labeit
and Kolmerer, 1995), C-protein (Einheber and Fischman, 1990), M-protein (Noguchi et
al., 1992), twitchin (Benian et al., 1989), and smooth muscle myosin light chain kinase
(Olson et al., 1990). Beginning with Met 141 in the DEN1 sequence, each motif is
repeated four times within the C-terminal region of DEN 1. The arrangement of the FnIII
and Ig repeats with respect to one another is illustrated in Figure 4.18.
For the most part, the --100 amino acid FnIII and Ig repeats in the DEN1 C-terminal
region follow one right after the other, with no intervening sequence between domains.
However, FnIII domain Fd and Ig domain Id are separated by a 12 amino acid stretch
containing a KSP motif. Multiple KSP motifs are tandemly arrayed in the interdomain
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insertion sequence between Ig domains 5 and 6 in the C-terminus of human cardiac titin
(Gautel et al., 1993), and studies have demonstrated that these KSP motifs in titin can be
phosphorylated in myoblast-derived cell extracts by cdc2 kinase (Gautel et al., 1993). It
is possible that DEN1 may be phosphorylated in a similar manner. Since
phosphorylation of KSP motifs in neurofilaments inhibits the ability of neurofilaments to
association with microtubules (Hisanaga et al., 1991), KSP motifs may similarly regulate
the ability of titin and/or DEN1 to interact with other muscle structural proteins.
Database searches showed that the 5' most 140 amino acids preceding the first
DEN1 FnIII domain bear little similarity with any known proteins. However, this region
is enriched in charged amino acids (45 of 140, 32%), suggesting that this region of the
protein may interact with other hydrophilic moieties. Alternatively, this region of the
DEN] protein may be an interdomain insertion sequence separating the first FnIII motif
(Ia) of the C-terminal region with other, as yet unsequenced, upstream FnIII and Ig
motifs. Since the largest interdomain insertion sequence in the C-terminal region of titin
is 490 bp (Gautel et al., 1993), finding additional FnIII and Ig domains further 5' would
not be unexpected. Isolation of cDNAs encoding more 5' DEN] sequence should resolve
this issue, and may provide greater insight into DEN1 function.
DEN2 encodes a heat shock-related protein.
The DEN2 cDNA fragment isolated from the subtractive-hybridization screen was
used likewise to screen a 5-day denervated rat muscle cDNA library, and a 1.7 kb cDNA
was isolated. Since RNA blots demonstrate that DEN2 encodes a single transcript
approximately 2 kb in length, it is likely that the 1.7 kb cDNA encodes the full-length
DEN2 protein. Using convenient restriction sites to create several deletion constructs,
greater than 90% of this 1.7 kb cDNA has been sequenced (Fig. 4.19A). Searches of
nucleotide databases reveal a region of the DEN2 cDNA that is identical to an expressed
sequence tag (EST) (EST111753) isolated from an NGF-treated rat PC-12 cell library.
Regions of the DEN2 cDNA also share considerable homology (71% to 90%) to EST
sequences isolated from diverse species and tissues, including mouse liver/spleen, and
human placenta and eye, and the high degree of similarity between these sequences and
the DEN2 sequence suggests that these ESTs may be derived from homologs of DEN2.
Searches of protein databases using ORFs from the sequenced portions of the 1.7 kb
cDNA reveal an ORF with similarity to a family of small, 20 - 28 kDa heat shock
proteins, one of which, HSP27, has been cloned from rat (Uoshima et al., 1993). aB-
crystallin, whose expression also increases in skeletal muscle following denervation (see
Table 4.1, but see Inaguma et al., 1993), is also related to these small heat shock proteins,
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and recent studies have shown that both aB-crystallin and HSP27 proteins can serve as
molecular chaperones to prevent aggregation of unfolded proteins during heat shock
(Jakob et al., 1993). Sequence comparison shows that DEN2 is 41% (80/196 a.a.) similar
to rat HSP27 and 31% similar (60/196 a.a.) to rat aB-crystallin (Fig 19B). (HSP27 and
aB-crystallin are 36% (74/205 a.a.) identical.) Taking conserved amino acid substitutions
into consideration, similarities between DEN2/HSP27 and DEN2/aB-crystallin rise to
approximately 62% and 57%, respectively. Thus, DEN2 appears to encode another
member of the family of small heat shock proteins with slightly greater similarity to
HSP27 than to aB-crystallin.
DISCUSSION
We have used subtractive-hybridization cloning to identify three novel genes -
INN], DEN] and DEN2 - whose expression is differentially regulated in innervated and
denervated rat skeletal muscle. RNase protection assays and RNA blots confirmed that
INN] is down-regulated, while DEN] and DEN2 are up-regulated following denervation.
Using the original isolates as probes, cDNAs encoding full-length INN] and DEN2
transcripts and a partial DEN] transcript were isolated, and sequencing of these showed
that all three genes encode proteins which bear significant similarity to different, known
proteins.
INN] is a novel gene which is related to NSPl. Sequence analysis showed that the
1.65 kb INN] cDNA encodes a 22 kDa protein which is 66% identical to NSP1C.
Further, both genes encode multiple transcripts, and RNase protection assays using
probes from two adjacent regions of the INN] sequence suggest that INN] transcripts,
like NSP1 transcripts, share the same 3' sequences, and that the location of at least one
splice site may be conserved between NSP1 and INN]. NSP1 has been cloned from both
human small cell lung carcinoma cells (Roebroek et al., 1993) and rat brain (Wieczorek
and Hughes, 1991), and its expression is limited to tissues of neuroendocrine origin. In
rat, tissue distribution studies showed that NSP] is expressed only in brain. Since NSP1
expression was detected in cultured neurons, but not in cultured glia, the NSP1 expression
detected in brain is probably neurally derived (Wieczorek and Hughes, 1991). Results
reported here show that INN], unlike NSP], is expressed at low levels in nearly all
tissues, however, expression is substantially higher in brain, heart and skeletal muscle.
Thus, although INN] and NSP1 are expressed in different subsets of rat tissues, both are
expressed to the greatest extent in electrically excitable tissues.
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The functions of the INN]- and NSPl-encoded proteins remain unknown, but, the
fact that both genes are expressed preferentially in electrically stimulated tissues, suggests
that they may play rolls in the responsiveness of these tissues to electrical stimulation.
Primary sequence analysis did not reveal any functional domains which might provide
clues as to the roles INN1 and NSP1 play in electrically excitable cells, but both proteins
contain two large hydrophobic regions which suggests that they are transmembrane
proteins. Indeed, immunoblotting experiments using an antiserum raised against the
amino terminal peptide of INN 1 showed that INN1 is enriched in the high-speed pellet of
fractionated skeletal muscle, and this is consistent with the idea that INN 1 is associated
with membranes. Immunofluorescence studies using the INN1 antiserum revealed a
polygonal staining pattern within each individual myofiber in cross-sections of skeletal
muscle, while staining of longitudinal sections revealed INN1 immunoreactivity
associated with the Iband region of the sarcomere Similar polygonal patterns and I-band
associated immunofluorescence have also been observed in muscle sections stained with
antibodies directed against proteins of the sarcoplasmic reticulum (SR) and transverse
tubules (Jorgensen et al., 1979; Jorgensen et al., 1990), and these results suggest that
INN 1 may be associated with one of these intracellular membrane compartments.
Systematic immunoblotting studies to determine the subcellular distribution of INN1
have yet to be performed, however, I found that INN1 immunoreactivity is not enriched
in immunoblots of muscle membrane fractions enriched in transverse tubular proteins.
Therefore, INN1 may be associated with SR rather than transverse tubules.
Despite the absence of INN 1 in preparations enriched in transverse tubules, a role
for INN1 in excitation/contraction coupling, remains intriguing. One of the functions of
the SR is to regulate intracellular Ca2+ concentration during excitation-contraction
coupling (for review see Rtiegg, 1988). Electrical stimulation of muscle induces Ca2+ion
release from the SR, resulting in an increase in intracellular Ca2+ concentrations and the
initiation of contraction. Ca2 1 is then rapidly resequestered into the SR, causing the
contractile apparatus to return to the resting state.. Local changes in Ca2+ concentrations
have also been observed in dendritic spines of hippocampal neurons following
stimulation (Guthrie et al., 1991; Miiller and Connor, 1991; Yuste and Denk, 1995), and
precise regulation of intracellular Ca2+ concentrations within dendritic spines is thought to
be important in neuronal input integration and synaptic plasticity. During long-term
potentiation (LTP), the most commonly studied model for synaptic plasticity, most of the
stimulus-induced rise in internal Ca2 within post-synaptic dendrites has been attributed to
Ca 2 flux through NMDA receptors (for review, see Malenka, 1992), but recent studies
have suggested that Ca 2÷-induced Ca 2+release from internal Ca2+ stores can occur
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following repeated presynaptic stimulation (Alford et al., 1993; Llano et al., 1994). In
addition, thapsigargin, an inhibitor of Ca2+ release for internal stores, interferes with the
induction of LTP (Harvey and Collingridge, 1992). Thus, regulation of Ca2+ release from
intracellular compartments may also play a role in synaptic modulation in the CNS. The
apparent enrichment of INN1 immunoreactivity in muscle membrane fractions, its
intracellular distribution in stained muscle sections, and the preferential expression of
INN1 in muscle and neural tissues, are all consistent with the a role for INN1 (and by
analogy, NSP1) in the release and/or uptake of intracellular Ca2'ions. Localization of
INN 1 in both heart and brain and more precise immuno-ultrastructural localization in
muscle should provide further insight in the role of INN1 in electrically excitable cells.
My analysis of INN] transcripts in muscle shows that INN1 encodes three
transcripts, and that these transcripts are differentially regulated by innervation. Further,
comparison with NSP1 suggests that the multiple INN] transcripts are generated by
alternative splicing, and this implies that alternative splicing of INN] is regulated by
innervation. Although cDNAs encoding the two larger INN] transcripts have not been
cloned, my data shows that two probes derived from adjacent regions of the INN1 cDNA
yield divergent results in RNase protection assays of innervated and denervated muscle,
and these results are consistent with the idea that splicing of INN1 is regulated by
innervation. Studies have shown that NCAM transcripts are differentially regulated in
innervated and denervated muscle (Covault et al., 1986), and that expression of fast
muscle troponin T isoforms is altered following denervation of adult muscle (Matsuda et
al., 1984; Shimuza and Shimada, 1985). Since the different isoforms of both N-CAM
and troponin T are encoded by a single gene (Wilkinson et al., 1984; Breitbart et al.,
1985), these studies demonstrate that alternative splicing can be a target for neural
regulation in muscle. The biochemistry of alternative splicing mechanisms has been
studied extensively in the rat troponin T and a-tropomyosin genes (for reviews, see
Nadal-Ginard, 1990 and Nadal-Ginard et al., 1991), and these studies suggest that both
cis- and tissue-specific trans-acting factors are important for splicing decisions. Although
splicing factors may be activated in response to denervation by post-translational
mechanisms, trans-acting splicing factors may be a targets for differential transcriptional
regulation by innervation. Subtraction-hybridization strategies similar to the one reported
in this study may prove useful in the isolation and characterization of such splicing
factors.
We isolated a partial cDNA encoding the C-terminus of the putative DEN1 protein,
and sequencing analysis showed that the C-terminal end of DEN 1 is composed of four
copies of each of FnIII and Ig motifs. Although identified originally in the sequences of
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extracellular proteins, both FnIII and Ig motifs are commonly found in a variety of
filamentous, thick filament-associated, sarcomeric proteins in both vertebrate and
invertebrate muscle. These include: titin (Labeit et al., 1990; Labeit and Kolmerer,
1995), skelemin (Price and Gomer, 1993), C-protein (Einheber and Fischman, 1990), H-
protein (Vaughn et al., 1993 ) M-protein (Noguchi et al., 1992), twitchin (Benian et al.,
1989) and projectin (Ayme-Southgate et al., 1991). FnIII and Ig motifs are found also in
smooth muscle myosin light chain kinase (Olson et al., 1990). In extracellular proteins,
FnlI and Ig motifs are thought to mediate cell-cell and cell-substrate interactions through
both homophilic interactions between like domains and heterophilic interactions with
cell-surface receptors (Cunningham et al., 1987 ; Williams and Barclay, 1989).
Similarly, in sarcomeric proteins, these domains are thought to mediate interactions
among thick filament-associated proteins, and between these proteins and myosin. For
example, titin is capable of binding both myosin and C-protein (Soteriou et al., 1993;
Labeit et al., 1992), and can cause synthetic myosin filaments to aggregate in vitro
(Maruyama et al., 1988). Further, the myosin binding domain of C-protein has been
localized to its C-terminal Ig motif (Okagaki et al., 1993). When compared with those of
other proteins, the FnIII and Ig repeats in DEN1 most resemble those in titin, but their
arrangement in the C-terminus of DEN1 (I-I-F-F-F-I-F-I), clearly distinguishes DEN]
from any previously cloned muscle structural gene. Thus, DEN] encodes a novel protein
with structural similarity to thick-filament-associated proteins in muscle sarcomeres. At
present, antibodies against DEN1 protein are not available, and the distribution of DEN1
in denervated and/or innervated muscle remains unknown, yet the similarity between
DEN1 protein and these sarcomeric proteins suggests that DEN1 can interact with
components of the thick filament assembly.
The C-terminal region of DEN1 also contains a KSP sequence within the short 12
amino acid sequence separating the last FnIII and Ig repeats. Large, tandem arrays of
KSP motifs have been characterized in the multi-phosphorylation repeat in the C-terminal
tail domain of neurofilament-H and -M subunits (Myers et al., 1987; Lees et al., 1988),
and studies have shown that phosphorylation of this KSP containing domain by cdc2
kinase abolishes interactions between neurofilaments and microtubules (Hisanaga et al.,
1991). Thus, the regulation neurofilament interactions with other proteins is mediated by
phosphorylation of these KSP sequences. Four such KSP motifs are present also in an
interdomain insertion sequence in the C-terminus of cardiac titin, and studies have shown
that the Ser residues on all four KSPs motifs are phosphorylated in vitro by neonatal
muscle extracts (Gautel et al., 1993). Further, these authors found that KSP
phosphorylation is two orders of magnitude lower in extracts prepared from adult muscle,
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and that KSP kinase activity falls dramatically following differentiation of myotubes in
culture. These data suggest that titin phosphorylation is under developmental control,
and that regulation of titin phosphorylation is important in maturation of the sarcomere.
The presence of a KSP motif in the C-terminus of DEN 1 raises the possibility that
phosphorylation of DEN1 is regulated in a similar fashion; however, I have not
investigated whether DEN 1, like titin, is developmentally regulated, nor whether
phosphorylation of the KSP motif in DEN1 occurs. Studies directed at addressing these
issues, in conjunction with the preparation of antibodies to determine the distribution of
DEN1 protein in muscle, will certainly aid in understanding DEN1 function.
DEN2, the third novel cDNA isolated from our subtracted muscle libraries, encodes
a member of the family of small heat shock proteins which include HSP27 and aB-
crystallin. Both HSP27 and aB-crystallin have been cloned from rat (Uoshima et al.,
1993; Atomi et al., 1991), and studies have shown that significant levels of HSP27 and
aB-crystallin protein are expressed in rat skeletal muscle (Kato et al., 1991; Inaguma et
al., 1993) Curiously, the levels of both proteins are considerably higher in slow-twitch,
than in fast-twitch muscle (Kato et al., 1991; Inaguma et al., 1993), and, at least in the
case of aB-crystallin, the higher level of protein in soleus is reflected in significantly
higher levels of RNA (Atomi et al., 1991). Moreover, studies in denervated muscle have
demonstrated that the levels of aB-crystallin RNA and protein increase dramatically in
fast-twitch muscle by 3 days following denervation, but decrease in slow-twitch muscle
(Atomi et al, 1991; Inaguma et al., 1993). Changes in the level of HSP27 protein in fast
and slow muscle in response to denervation parallel those seen for aB-crystallin protein,
but the decrease in HSP27 protein in denervated slow muscle is less dramatic than that
observed for aB-crystallin (Inaguma et al., 1993). Thus, expression of both aB-crystallin
and HSP27 and their response to denervation are regulated by fiber type. Our studies
show that DEN2 expression increases 3- to 5-fold by 5 days following denervation;
however, we have not studied the fiber type specificity of DEN2 expression, nor whether
the increased expression of DEN2 in response to denervation is restricted to either fast or
slow muscle. It may be that denervation-induced changes in DEN2 gene expression in
certain fiber-types may be masked by minimal, or even inverse changes in other fiber
types. Thus, as was done for INN1, it will be necessary to study both the fiber-type
specificity, and whether changes in expression following denervation are restricted to
certain fiber types for all of the cDNAs isolated from our subtraction hybridization
libraries.
HSP27 and aB-crystallin are expressed in a variety of rat tissues in addition to
skeletal muscle (Kato et al., 1991; Inaguma et al., 1993). Although we have not studied
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the distribution of DEN2 in different rat tissues, ESTs encoding what appear to be DEN2
homologues have been isolated from cDNA libraries derived from several different
tissues from various species, including liver/spleen (mouse), placenta (human), and eye
(human). Thus, it seems likely that DEN2 is expressed in other tissues in addition to
skeletal muscle, and this suggests a more ubiquitous role for DEN2 in cellular
physiology.
Biological functions for the small heat shock proteins remain unclear. Studies have
shown that both aB-crystallin and HSP27 proteins are induced by heat shock (Klemenz et
al., 1991), and that both proteins can act as molecular chaperones preventing aggregation
of unfolding proteins during heat shock (Jakob et al., 1993). HSP27 mRNA and protein
levels are also induced in estrogen stimulated cells (Adams et al., 1983; Fuqua et al.,
1989), and a recent study has implicated HSP27 in the increase of endothelial cell growth
rates in response to estrogen (Piotrowicz et al., 1995). Other studies have implicated
HSP27 in the regulation of microfilament dynamics. In mouse fibroblasts, HSP27 is
localized in lamellapodia, and overexpression of HSP27 in these cells increases both the
concentration of cortical F-actin and the rate of pinocytotic activity, and prevents actin
stress-fiber depolymerization induced by heat shock or cytochalasin D treatment (Lavoie
et al., 1993a; 1993b). Moreover, the HSP27-mediated affects on actin filament dynamics
appear to be dependent on phosphorylation of HSP27 (Lavoie et al., 1993b; 1995), and
this result suggests that HSP27 may have a role in signal transduction between mitogens
and actin filaments. Interestingly, an avian homologue of HSP27 blocks actin
polymerization in vitro (Miron et al., 1988; 1991), and the inhibitory affect of this protein
on actin polymerization is reduced also by phosphorylation (Benndorf et al., 1994).
Denervation of skeletal muscle is characterized by atrophy of the myofibrillary
apparatus featuring an early accelerated loss of myosin thick filaments relative to actin
thin filaments (Jakubiec-Puka et al., 1981), and changes in the dimensions of
mitochondria and the SR/transverse-tubule membrane systems (Engel and Stonnington,
1974). Denervated muscle also manifests increased endocytotic activity, particularly at
the motor endplate (Libelius and Tagerud, 1984), which appears to be coupled to an
increased rate of exocytotic activity (Vult von Steyern et al., 1993). Thus, it is tempting
to speculate that DEN2 and perhaps other members of the small HSPs play a role in
modulating the muscle cytoskeleton, including stabilizing actin filaments in the
sarcomere. Our finding that RNAs for the cytoskeletal proteins filamin and MAPla are
also enriched in denervated muscle may be indicative also of the degree of cytoskeletal
remodeling occurring in denervated muscle. Again, immunohistochemical studies on the
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localization of DEN2 and the other small HSPs in may shed some light on their role in
skeletal muscle physiology.
The mechanisms regulating the innervation-dependent changes in muscle gene
expression are unknown, but at least two pathways are indicated: first, expression might
be regulated by myotrophic factors released from the nerve terminal, and second,
expression is influenced by nerve-induced electrical stimulation.
Evidence for the first comes from studies demonstrating that functional and
morphological changes in immobilized or paralyzed muscle are less severe than in
denervated muscle (Spector, 1985b). Further, the administration of extracts from
peripheral nerve can partially ameliorate denervation-induced atrophy of skeletal muscle
(Davis and Kiernan, 1981; Heck and Davis, 1988). In this model, denervation and
subsequent degeneration of the nerve results in the removal of such factors from the
muscle milieu. The proposed myotrophic factor could have either positive or negative
effects on muscle gene expression in innervated muscle; for example, either maintaining
the expression the 1.7 kb INN] transcript or repressing transcription of genes such as
DEN1 whose expression is very low in innervated muscle.
No specific myotrophic factors have been identified, however, a molecule from
peripheral nerve extracts with myotrophic activity in denervated muscle has been
partially purified (Davis et al., 1985), and more recently, ciliary neurotrophic factor
(CNTF) has been shown to have a similar trophic effect on denervated muscle (Helgren et
al., 1994). Since CNTF is expressed abundantly in myelin-related Schwann cells in
sciatic nerve (Rende et al., 1992; Friedman et al., 1992), and expression of receptors for
CNTF are rapidly up-regulated following denervation of muscle (Davis et al., 1993),
CNTF seems a likely myotrophic factor in vivo. On the other hand, mice which lack a
functional CNTF gene are viable, and only exhibit signs of muscle weakness many
months after birth at a time when motoneurons in these mice have begun to degenerate
(Masu et al., 1993). In any case, such myotrophic signals are clearly different from the
molecule which has been implicated in gene activation in synaptic nuclei, since this
signal persists in the synaptic basal lamina following nerve lesion and degeneration (Jo
and Burden, 1992).
The ability of electrical activity to regulate muscle genes expression is well
established; studies have shown that exogenous stimulation of denervated muscle via
implanted electrodes prevents the expression of extrasynaptic AChRs which normally
occurs following denervation, whereas extrasynaptic AChR expression is enhanced in
muscle which has been rendered electrically inactive either by pharmacological paralysis
or blockade of synaptic transmission (Lomo and Rosenthal, 1972; L0mo and Westergard,
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1975). Interestingly, the mechanisms linking electrical stimulation to gene transcription
appear to differ among species. In rat myotubes in culture, suppression of AChR
expression by electrical activity can be reversed by increasing intracellular cAMP levels,
which suggests that muscle activity and AChR expression are coupled via a cAMP-
dependent pathway (Chahine et al., 1993). Consistent with this notion, both denervation
and TTX paralysis of muscle increase cAMP and protein kinase A activity in muscle
(Chahine et al., 1993). In contrast, the down-regulation of AChR expression by muscle
activity in chick appears to involve a PKC-dependent pathway, since inhibitors of PKC or
depletion of PKC activity by prolonged exposure to phorbol esters increases expression
of AChR a subunit in myotube cultures (Klarsfeld et al., 1989) and prolongs AChR
subunit gene expression in electrically stimulated, denervated muscle in vivo (Huang et
al., 1992). Moreover, PKC activity is rapidly increased in electrically stimulated,
denervated chick muscle, and this is consistent with PKC's role in negative regulation of
muscle gene expression in response to electrical stimulation. (Huang et al., 1992). In
both organisms, however, calcium appears to play a central role, since treatment of both
chick and rat myotubes in culture with calcium ionophore blocks TTX-induced increases
in AChR mRNA (Klarsfeld et al., 1993; Walke et al., 1994), and in chick, treatment of
myotube cultures with the calcium channel blocker verapamil increases the levels of
AChR a subunit RNA and protein (Klarsfeld et al., 1989).
One of the targets for stimulation-evoked kinase activity may be one of the
myogenic factors. Studies in transgenic mice have demonstrated that mutation of an E-
box near the transcriptional start site in a gene fusion between the mouse AChR 8 subunit
promoter and human growth hormone (hGH) reduces the amount of hGH expressed in
denervated muscle compared to a gene fusion with the wild-type AChR 8 promoter (Tang
et al., 1994). In addition, mRNAs for several myogenic factors increase following
denervation (Duclert et al., 1991; Eftimie et al., 1991; Witzemann and Sakmann, 1991;
Weis, 1994), and this is consistent with a possible role for these myogenic factors in
electrical activity-dependent regulation. Since phosphorylation of myogenin by PKC can
abolish its DNA-binding activity (Li et al., 1992; Mendelzon et al., 1994), it has been
proposed that stimulation-dependent activation of PKC results in phosphorylation of
myogenin, and abolishes myogenin's ability to activate target genes (Mendelzon et al.,
1994).
While myogenic factors may be important for regulating transcription of muscle
genes in response to electrical activity, not all genes containing E-boxes in their
regulatory regions are affected by stimulation. E-box containing genes which do not
respond to electrical activity may be regulated by factors indifferent to electrical activity.
149
These factors may dominate the affect of bHLH proteins on the expression of these genes
in adult muscle, rendering them insensitive to electrical activity-induced changes in
bHLH protein activity. Alternatively, additional trans-acting factors, acting via as yet
uncharacterized electrically responsive cis-elements, may exist which are required, in
conjunction with E-boxes, to regulate electrical activity-dependent gene expression. If
additional factors are induced in denervated muscle, we may be able to identify them
using the same subtractivehybridization libraries we used to isolate cDNAs for DEN] and
DEN2. Since the denervation-induced increase in the expression of these factors may
precede that of their target genes, as has been observed for myogenin, subtraction-
hybridization libraries using RNA prepared from 1-2 day denervated muscle may be more
useful in identifying additional denervation-responsive factors.
Interestingly, one of the cDNAs isolated from our subtractive-hybridization libraries
encoded rat AML1, and RNase protection assays revealed that AML1 transcripts increase
S-100-fold following denervation. Since AML1 encodes a DNA binding protein with
similarity to the protein encoded by the Drosophila pair-ruled gene runt, our results
suggest that AML1 is a potential mediator of denervation-dependent gene expression.
We went on to characterize the expression of AML1 more thoroughly in rat muscle, and
these results are reported in the following chapter.
Our screens of the innervated- and denervated-subtractive libraries were not
exhaustive (see Materials and Methods), since we isolated only four of the twenty genes
known to be induced by denervation. These libraries have also proven useful in
identifying genes (e.g. INN]) in which splicing, rather than gene expression, changes in
response to denervation. Additional rounds of subtraction to remove sequences identified
from previous screens may facilitate identification of additional cDNAs which may be
represented in lower abundance in these libraries.
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Table 4.1. mRNAs identified by subtractive-hybridization cloning
cDNA RNA level (Den/Inn) Abundance (%) in
innervated muscle
AChR a subunit 15 0.001
AChR 8 subunit 15 0.001
N-CAM 40 0.001
crystallin (aB) 6 0.02
MAPla 12 0.001
filamin 5 0.04
AML1 100 0.0001
DEN1. Novel. Contains Ig
and Fn III repeats
characteristic of muscle 50-100 0.001
structural proteins
DEN2. Novel. Similarity to
aoB crystallin and small heat 3-5 0.05
shock proteins.
INN 1. Novel. Similarity to 0.2 0.05
NSP1C.
The following mRNAs are known to be up-regulated (>3-fold) following denervation of skeletal
muscle: aB crystallin (Atomi et al., 1991), AChR subunits (Evans et al., 1987), muscle specific kinase
(Valenzuela et al., 1995), N-CAM (Covault et al., 1986), sodium channels (SkM2 subtype) (Yang et al.,
1991), myogenin and MyoD (Duclert et al., 1991; Eftimie et al., 1991; Witzemann and Sakmann, 1991),
jun proto-oncogenes (Bessereau et al., 1990), muscle LIM protein (Arber et al., 1994), glucose transporter
(GLUT-1) (Block et al., 1991), N-cadherin (Hahn and Covault, 1992), CNTF receptor subunits (Helgren et
al., 1994), carbonic anhydrase III (Milot et al., 1991), and decorin (Brandan et al., 1992).
In contrast, the following RNAs are down-regulated (>3-fold) following denervation: AChE
(Michel et al., 1994), glucose transporter (GLUT-4).(Block et al., 1991), and sarcoplasmic reticulum Ca2 +
pump (Schulte et al., 1994).
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Figure 4.1. INN1 is down-regulated following denervation.
Levels of INN1 RNA decrease -5-fold by 5 days following denervation in both fast and
slow muscle. Total RNA was prepared from innervated (I) and 5-day denervated (D) rat
EDL and soleus (Sol) muscles, and levels of INN1 and GAPDH RNA were measured by
an RNase protection assay. -10 gg or -5 gg of total RNA were used for the INN1 and
GAPDH assays, respectively. In most experiments, we observed a decrease (<50%) in
GAPDH RNA:total RNA ratio following denervation. Quantitation by Phosphoimager
showed that approximately equal ratios of INN1 RNA relative to GAPDH are present in
EDL and soleus.
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Figure 4.2. INNI RNA decreases gradually following denervation.
Total RNA was prepared from innervated (Inn) rat lower leg muscle and muscle
denervated for 1, 2 and 5 days, and the levels of INN1, AChR 8-subunit and GAPDH
RNA were measured by an RNase protection assay. The GAPDH control suggests that
the amount of RNA used in the 1-day denervated muscle lanes is -50% lower than that
used in 2-day denervated muscle lane.
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Figure 4.3. INN1 RNA is not enriched at the motor endplate.
Rat soleus muscle was dissected into synapse-enriched (ep+) and synapse-free (ep-)
regions, total RNA was prepared, and the level of INN1 RNA was measured by an RNase
protection assay. 10 glg and 1 pgg of total RNA were used in the INN1 and GAPDH
assays, respectively. The levels of both INN1 and GAPDH RNA are similar in both the
synapse-enriched and synapse-free fractions. In contrast, the level of AChR E-subunit
RNA is approximately 12-fold higher in the synapse-enriched fraction than in the
synapse-poor fraction, demonstrating that the dissection enriches for synaptic nuclei.
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Figure 4.4. Tissue distribution of INN1 RNA.
Total RNA was prepared from the indicated rat tissues, and the levels of INN1 RNA were
measured by an RNase protection assay (20 gLg RNA/assay). Low levels of INN1 RNA
were detected in kidney, lung, stomach and testes. Significantly higher levels of INN1
RNA were detected in brain, cerebellum, heart, and skeletal muscle. Little, if any, INN]
RNA was detected in liver, but GAPDH RNA levels were also substantially lower,
suggesting that the concentration of liver RNA used in the assays was much lower than
expected. INN1 RNA levels are -~ 10-fold higher in cerebellum and -30-fold higher in
brain than in stomach and kidney (normalized to GAPDH). GAPDH is reported to be
expressed at higher levels in skeletal and heart muscle than in non-muscle rat tissues (2 -
5-fold) (Stauffer et al., 1993). Therefore, the levels of INN] RNA in heart and innervated
skeletal muscle are on the order of 20- to 75-fold higher relative to that found in kidney.
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Figure 4.5. Complete nucleotide sequence of the INNI cDNA.
The complete nucleotide and encoded amino acid sequence of the 1.65 kb INN1 cDNA is
shown. A TGA stop codon is indicated by an asterisk. Sites for potential N-linked
glycosylation are boxed, and a site for polyadenylation addition is underlined.
Nucleotide and amino acid positions (parentheses) are given at right.
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5' GAATTCGGACTGCAGGCTTAGTCTGGGGAAGCGGGTGTTTCATGTCTCAGGGAGAATTTT
GCAGTTTACAGCGTTTCTGTTGGTATGCATAATTTGTAATTGCTGCTGGAGGGCAGATCG
TGGCAAGAA ATG GAC GGA CAG
M D G Q
GAC CTC CTC
D L L
AAG AAA CAT TGG AAG GAC AAG GTT GTT
K K H W K D K V V
TAC TGG AGA GAC ATT AAG AAG ACT GGA GTG GTG TTT GGT
Y W R D I K K T G V V F G
GCC AGC TTA TTC CTG CTG CTG TCT CTG
A S L F L L L S L
GTA ACG GCC TAC ATT
V N A Y I
GCC TTG GCC CTG CTC
A L A L L
ACA GTG TTC AGC ATT GTC AGT
T V F S I V S
TCG GTG ACT ATC AGC TTT
S V T I S F
AGG ATA TAT AAG GGC GTG ATC CAG GCT ATC CAG AAA TCA GAT GAA GGC
R I Y K G V I Q A I Q K S D E G
CAC CCA TTC AGG GCA TAT TTA GAA TCT GAA GTT GCT ATA TCA GAG GAA
H P F R A Y L E S E V A I S E E
60
120
168
(13)
216
(29)
264
(45)
312
(61)
360
(77)
408
(93)
TTG GTT CAG AAA TAC AGT AAT TCT
L V Q K Y S N S
GCT CTT GGT
A L G
ATA AAA GAA CTG AGG CGG CTT TTC TTA GTT GAT
I K E L R R L F L V D
CAT GTG AAC AGC ACA 456
H V N S T (109)
GAT TTA GTT GAT TCC 504
D L V D S (125)
CTG AAG TTT GCA GTG TTG ATG TGG GTG TTT ACT TAT GTT GGT GCC TTG 552
L K F A V L M W V F T Y V G A L (141)
TTC AAT GGT CTG ACA
F N G L T
CTA CTG ATT TTA GCT CTG
L L I L A L
ATC TCA CTC TTC AGT 600
I S L F S (157)
ATT CCT GTT ATT TAT GAA CGG CAT CAG GTG CAG ATA GAT CAT TAT CTA 648
I P V I Y E R H Q V Q I D H Y L (173)
GGA CTT GCA
G L A
AAC AAG AGT GTT AAG GAT GCC ATG GCC AAA ATC CAA GCA 796
IN K Sý V K D A M A K I Q A (189)
AAA ATC CCT GGA TTG AAG CGC AAA GCA GAT TGA
K I P G L K R K A D *
AAAAGCCCCAAACAGA
AGTTCATCTTTAAAGGGGACACTCACTTGATTACGGGGGTGGGAGGGTCAGGGGTGAGCC
CTTGGTGGCCGTGCGGTTTCAGCTCTTTATTTTTAGCAGTGCACTGTTTGAGGAAAAATT
ACCTGTCTTGACTTCCTGTGTTTATCATCTTAAGTATTGTAAGCTGCTGTGTATGGATCT
CATTGTAGTCACACTTGTCTTCCCCAATGAGGCGCCTGGTGAATAAAGGACTCGGGGAAA
GCTGTGCATTGTATCTGCTGCAGGGTAGTCTAGCTGTATGCAGAGAGTTGTAAAGAAGGC
AAATCTGGGGGCAGGGAAAACCCTTTTCACAGTGTATGTGTTTGGTAGTGTACTGT
ATGCAGATTTTTCTGAAATGAAATGTTTAGATGAGAGCATACTACTAAAGCAGAGTGGAA
AACTCTGTCTTTATGGTGTGTTCTAGGTGTATTGTGAATTTACTGTTATATTGCCAATAT
AAGTAAATATAGACCTAATCTATATATAGTGTTTCACAAAGCTTAGATCTTTAACCTTGC
AGCTGCCCCACAGTGCTTGACCTCTGAGTCATTGGTTATGCAGTGTAGTCCCAAGCACAT
AAACTAGGAAGAGAAATGTATTTGTAGGAGTGCTACCTACCACCTGTTTTCAAGAAAATA
TAGAACTCCAACAAAAATATAGAATGTCATTTCAAAGACTTACTGTATGTATAGTTAATT
TTGTCACAGACTCTGAAATTCTATGGACTGAATTTCATGCTTCCAAATGTTTGCAGTTAT
CAAACATTGTTATGCAAGAAATCATAAAATGAAGACTTATACCATTGTGGTTTAAGCCGT
ACTGAATTATCTGTGGAATGCATTGTGAACTGTAAAAGCAAAGTATCAATAAAGCTTATA
GACTT(A)20 3'
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Figure 4.6. Hydrophobicity plot of INN1 protein and comparison of INN1 and
NSP1C.
A. A Kyte-Doolittle hydrophobicity plot of INN1 shows that the protein contains two
regions of hydrophobicity. The sites for potential N-linked glycosylation relative to these
hydrophobic regions are indicated (*). B. Comparison of INN1 and NSPIC protein.
Conserved amino acids between the two proteins are indicated by dashes in the NSP1C
sequence. Overall, the INN1 and NSP1C are 66% identical, however, many of the amino
acid substitutions are conserved with respect to charge, resulting in an overall similarity
of 82% between the two proteins. Sites for potential N-linked glycosylation in INN1 are
indicated (*).
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Figure 4.7. INNI encodes multiple transcripts.
15 gg of total RNA from innervated (I) and 5-day denervated (D) rat lower leg muscle
was fractionated by formaldehyde/agarose gel electrophoresis, and transferred to Nytran
membrane. The blot was hybridized with radiolabeled 1.65 kb INN1 cDNA and exposed
for 5 days with an intensifying screen. Consistent with RNase protection data, a major
transcript at -1.7 kb is -5-fold more abundant in innervated muscle than in 5-day
denervated muscle. Additional transcripts were detected at 2.3 and 5.2 kb. In contrast to
the 1.7 kb transcript which is more abundant in innervated muscle, the 5.2 kb transcript is
-5-fold more abundant in denervated muscle. The 2.3 kb transcript appears -2-fold
enriched in denervated muscle as well. The blot was stripped and rehybridized with a
GAPDH cDNA probe (below).
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Figure 4.8. Different levels of INNI RNA in denervated muscle are detected by
probes from adjacent regions of the INNI cDNA.
A. The levels of INN1 RNA in innervated (I) and 5-day denervated (D) muscle were
measured by RNase protection using two probes from overlapping regions of the INN1
cDNA. Probe 1 is the original INN1 cDNA isolated by subtractive-hybridization, and
encodes the 5' 217 bp of the 1.65 kb cDNA. Probe 2 encodes nucleotides 169-410 of the
1.65 kb INN1 cDNA (see part B; also Fig. 4.6). Using probe 1, approximately 5-fold less
INN1 RNA is detected in denervated muscle than innervated muscle. In contrast, no
difference in the level of INN1 RNA was seen using probe 2. These data suggest that the
multiple INN1 transcripts are derived from alternative splicing, and that transcripts
containing only the 5' sequence of the 1.65 kb INN1 cDNA are down-regulated following
denervation. The assays were done at the same time, using the same RNA preparations
(10 jig/assay), and are reproducible. A GAPDH probe indicates approximately equivalent
levels of RNA were used in each assay (5 jig RNAlassay). B. The cartoon shows the
positions of the probe 1 and 2 sequences relative to one another in the INN1 1.65 cDNA
and relative to the alternatively spliced domain in NSPIC (open box). This splice site
aligns with nucleotide 162 in the INN1 sequence.
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Figure 4.9. INN1 protein is expressed in both innervated and denervated muscle.
Crude lysates from innervated and 5-day denervated muscle were prepared, and proteins
were separated by SDS-PAGE (12% gel, 50 gg protein/lane). Proteins were transferred
to nitrocellulose and blotted with an INN1 antiserum (1:2000) (see Materials and
Methods), followed by a horseradish peroxidase conjugated secondary antibody. The
INN1 antiserum binds to a major protein at -22 kDa, consistent with the size of the INN1
protein predicted from the cDNA sequence. The antiserum also reacts with a second
antigen at -42 kDa which may be the product of one of the larger alternatively spliced
INN1 transcripts or an unrelated, cross-reacting protein. Both antigens react with the
INN1 antiserum specifically since they can be competed with peptide and are not seen in
blots stained with preimmune serum (not shown, but see Fig. 4.13). The levels of the two
proteins appear to be equivalent in both innervated and denervated muscle, suggesting
that although the level of 1.7 kb INN1 transcript decreases 5- to 7-fold the level of protein
is unaffected 5 days following denervation. Two lanes from the same gel and stained with
Coomassie stain (Coo), are shown to compare the levels of protein loaded for each
extract; the position of size markers is indicated.
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Figure 4.10. INN1 is enriched in membrane fractions of rat skeletal muscle.
Lysates of innervated rat skeletal muscle were fractionated by centrifugation as described
in Materials and Methods. Equivalent volumes of high-speed supernatant (S) and pellet
(P) fractions (30 glg and 4 gLg, respectively) were loaded onto each lane, and the proteins
separated by SDS-PAGE in a 12% gel. Nitrocellulose blots of the separated proteins
were incubated with INN1 antiserum (1:2000), followed by a horseradish peroxidase
conjugated secondary antibody. The 22 kDa INN1 protein is enriched in the membrane-
containing pellet fraction compared to the soluble protein-containing supernatant fraction.
Low levels of the 42 kDa protein (see Fig. 4.9 and Fig. 4.13) are detected in the
supernatant fraction, suggesting that this protein is cytosolic. Preincubation of the
antiserum with the immunizing peptide blocks antibody staining of both the 22 kDa and
42 kDa antigens. Two lanes from the same gel and stained with Coomassie stain (Coo)
are shown to compare the levels of protein loaded for each fraction; the position of size
markers is indicated.
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Figure 4.11. Localization of INN1 in cross-sections of skeletal muscle.
Frozen transverse sections of innervated rat soleus muscle were stained with INN1
antiserum (1:500) (a-INN1), INN1 antiserum preincubated with peptide (+ pep), or pre-
immune serum (1:500) (pre) followed by a fluorescein-conjugated secondary antibody as
described in Materials and Methods. A reticulated pattern can be seen in cross-sections of
muscle fibers stained with the INN1 antiserum. This staining pattern is eliminated by
preincubation of the INN1 antiserum with peptide (+pep), and is absent in sections
stained with preimmune serum (pre).
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Figure 4.12. Localization of INN1 in longitudinal sections of skeletal muscle.
A. A longitudinal frozen section of innervated rat soleus muscle was stained with INN1
antiserum (1:500) followed by a fluorescein-conjugated secondary antibody (1:200). B.
A phase-contrast image of the the same field in panel A only inverted with respect to
vertical to permit alignment of anti-INN1 staining with sarcomeres. Stripes of INN1
staining (arrowheads) align with the I band regions of each sarcomere. The A and I
bands of three sarcomeres are indicated. The length of each sarcomere (distance between
the midlines of consecutive I bands) is approximately 2.2 gim.
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Figure 4.13. INN1 is not enriched in transverse tubules.
Rat skeletal muscle total extract (Rt. ext. - 50 gg), rabbit microsomes (gs - 75 gg), and
rabbit T-system (TT - 20 gg) preparations were separated by SDS-PAGE (12% gel) and
transferred to nitrocellulose. Blots from the same gel were then stained with INN1
antiserum (1:2000), pre-immune serum (pre), or IXE112 (1:500) monoclonal antibody
against TS28, a protein enriched in transverse tubule preparations (Jorgensen et al., 1990)
(a-TS28 ), followed by appropriate HRP-conjugated secondary antibodies. The INN1
antiserum recognizes 22 and 42 kDa proteins in both rat muscle extracts and rabbit
microsomes, but neither protein is enriched in rabbit T-system preparations. Molecular
weight size markers are indicated.
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Figure 4.14. DENI and DEN2 are up-regulated in denervated muscle.
Total RNA was prepared from innervated (I) and 5-day denervated (D) rat lower leg
muscle, and the levels of DENI, DEN2, and GAPDH RNA were measured by an RNase
protection assay. Approximately 10 pgg (DEN1 and DEN2 lanes) or 1 gg (GAPDH lanes)
of total RNA were used in each lane. Quantitation of these results showed that DEN1 is
- 100-fold and DEN2 is -4-fold more abundant in denervated muscle than in innervated
muscle.
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Figure 4.15. Expression of DENI and DEN2 increases with a slow time course
following denervation.
Total RNA was prepared from innervated rat lower leg muscle (Inn) or lower leg muscle
denervated for 1, 2, or 5 days, and the levels of DEN1, DEN2, AChR 8, and skeletal actin
were measured by an RNase protection assay. 10 jig (DEN1, DEN2, AChR 8 lanes) or 1
gg (actin lanes) of total RNA were in each assay.
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Figure 4.16. Both DEN1 and DEN2 encode single transcripts.
Total RNA from innervated (I) and 5-day denervated (D) rat lower leg muscle were
separated in 1.1% formaldehyde/agarose gels, and transferred to nitrocellulose
membranes (15 gg/lane (DEN1 lanes ); 20 gg/lane (DEN2 lanes)). The RNA blots were
hybridized with either DEN1 or DEN2 probes, washed and exposed to film with an
intensifying screen. Both probes detect single transcripts (arrows) which are up-regulated
following denervation. The blots were then stripped and re-hybridized with a GAPDH
probe (shown below each blot). The migration of 28S and 18S ribosomal RNA in each
gel is shown.
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Figure 4.17. Sequence of a partial cDNA encoding DEN1.
The complete nucleotide and encoded amino acid sequence of the 3.3 kb DEN1 cDNA is
shown. Each fibronectin type III repeat (F) and immunoglobulin C2 motif (I) is
underlined and labeled. The KSP sequence between motif Fd and Id is indicated (A). The
TAG stop codon is indicated by an asterisk (*), and a polyadenylation addition site in the
3' untranslated sequence is boxed.
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...GAATTCGGAAGGCCGAGACTGACAAGGTCCAAGGATCCAGGACCTCAATG 50
I R K A E T K D V Q G S R T S M (16)
AAGTCTGAAAGTCAGGAAGGGAAAGACTCTGGCTGGTCAGGCAGGAAGCCTGGCCTCTGTGGAAGTGGGCATCAG 125
K S E S Q E G K D S G W S G R K P G L C G S G H Q (41)
GTGCAGGCTGGGACTGAAGTTGGATCAGCAAAGAGAGGGAGCACAGAGGAGGCCGGAGGTCTGGGGACTTGGACT 200
V Q A G T E V G S A K R G S T E E A G G L G T W T (66)
GGCAATGAGGAGAGAGGGTCTCTGAGAGAACCTTGGAGTGAAGACAGGAGGCGAGGCCCCCACAGGCATCTTGGC 275
G N E E R G S L R E P W S E D R R R G P H R H L G (91)
AGCAGGAGAGATACCCAAGAGGGCAGGTCAGATGTCTATGGCCAGGCACAAGATGCTACCCAGAGCCCCAGATCC 350
S R R D T Q E G R S D V Y G Q A Q D A T Q S P R S (116)
AGATACAAGCCTGGCCCTGGCTGCTCTTCTTCGGAGGCCCGAGGCTCCATGGACCACTTCTCTCAGGGTCTGACT 425
R Y K P G P G C S S S E A R G S M D H F S Q G L T (141)
la
GATACAGAGGTACAACTGGGGGAAGCTGCCATACTCTCCTGTACCCTTTCCAGTGACCTGGGACCTGGCACCTGG 500
D T E V Q L G E A A I L S C T L S S D L G P G T W (166)
TTCAAGGATGGCGTCAAGCTCACTGCCCAAGATGGGGTCATCTTTGAGCAAGATGGGCTCACACACAGACTGATC 575
F K D G V K L T A Q D G V I F E Q D G L T H R L I (191)
CTCACCCACGTGGAGGGGACCCAAGCTGGGAGATACACTTTTGTAGCCGGCCGCCAGCACAGTGAGGCCAGTCTG 650
L T H V E G T Q A G R Y T F V A G R Q H S E A S L (216)
ACCGTTCAGGATCCCCCCACCATTGCTCCAGATGTGACCGAGAAACTGAGAGAGCCACTGGTGTTCAAGGCTGGG 725
T V Q D P P T I A P D V T E K L R E P L V F K A G (241)
lb
AAGCCGGTCACTGTGAAAATACCTTTCCAGAGCCGCCTCCCTGTCCAGGCTGCCTGGAGGAAAGATGGGAAGGAA 800
K P V T V K I P F Q S R L P V Q A A W R K D G K E (266)
GTGGCGGGCAGCAACCACAAGGGCATCCAACTTGCTCTGGGAGATGGCTACACCCGGCTGTGCCTCCCCAGTGTG 875
V A G S N H K G I Q L A L G D G Y T R L C L P S V (291)
TGCAGGAAGGACAGTGGCCGGTACAGCGTGAGGCTGAAGAGTGAGGGAGGCTGTGTGGAGGCTGAGTTCACCCTG 950
C R K D S G R Y S V R L K S E G G C V E A E F T L (316)
CAAGTTATAGATAAGCCTCGGCCCCCACAAGGACCCCTGGAGGTTCAGGCTTGCCACAGAGCAGGTGTCTGCCTC 1025
Q V I D K P R P P Q G P L E V Q A C H R A G V C L (341)
Fa
CGCTGGTTACCCCCGAGGGACGATGGGGGACAGGTCATACAACACTATGTGGTGGAGAGGCGACAGGCTGGAAGG 1100
R W L P P R D D G G Q V I Q H Y V V E R R Q A G R (366)
AGCACTTGGCTGAAGGTGGGAGAGCCCCCACCAGACAGTACCAGCTTCACGGATGTCATCGTGGAGCAGGGCAGG 1175
S T W L K V G E P P P D S T S F T D V I V E Q G R (391)
AAGTATGCCTTCCGTGTTCGGGCCGTGACCTCAGAGGGAGCCGGGGATGCCCTGGAGTCTGAGGAGGTGCTGATA 1250
K Y A F R V R A V T S E G A G D A L E S E E V L I (416)
GCTCCTGAGGCTCTCCCGGGGCCCCCTTCTGCTCCCTCCTTCCCTCCAGCCAGAGCATCACTCTCACG 1325
A P E A L P G P P S A P A I L S A S S Q S I T L T (441)
Fb
TGGGGAGCACCACAGGGCCCTGGCAGTACCCACATCTTGGGCTACCTGGTTGAGAAGCGCAAGAAGGGGAGCAGC 1400
W G A P Q G P G S T H I L G Y L V E K R K K G S S (466)
ACCTGGATGGCTGTGAATGAGCAGCCCGTGTCTGAAAGGAGGTACACTGTGGTGGATCTGCGACAGGGTTGCCAG 1475
T W M A V N E Q P V S E R R Y T V V D L R Q G C Q (491)
TATGAGTTCAGGGTCATGGCTGTGACTCTGTCGGGCCCTGGAGAGCCTGGGCCTCCATCCGATGCTGTCTTTGCC 1550
Y E F R V M A V T L S G P G E P G P P S D A V F A (516)
AGAGATCCCATGAGACCTCCAGGGCCTGTGCGGGATCTCCAGGTTACAGACACATCAGACACTAGCATCACCGTG 1625
R D P M R P P G P V R D L Q V T D T S D T S I T V (541)
Fc
AGCTGGATGGTGCCAGATGCCCAGGATGCTGATGAAGCTCAGGGATACATTGTCGAGCTGTGTGGTTCAGACAGC 1700
S W M V P D A Q D A D E A Q G Y I V E L C G S D S (566)
CATCAGTGGAGCCCATGCCACATGGGCACTGTGCCAGGCACCATCTTCACAGCCAAGGGGCTTCGGCCACAAGAA 1775
H Q W S P C H M G T V P G T I F T A K G L R P Q E (591)
GGCTACTTTGTACGAGTGACAGCGGTGAATGATGGGGGCCGGAGTCCGGCCATGTCCCTGGACACATTGGTTCAT 1850
G Y F V R V T A V N D G G R S P A M S L D T L V H (616)
GCCATGCCTGCCACTGTCTGTCCCAGGTTCCTCATGGATTCCAGCACAAAGGATACACTGATGGTCAGGGTTGGG 1925
A M P A T V C P R F L M D S S T K D T L M V R V G (641)
Ic
GACAGCATTCGAGTTCCTGTCCCGTTCGAAGCTGCCCCCATGCCTGAGGTGACCTGGTTGAAGGACGGTTTGCCT 2000
D S I R V P V P F E A A P M P E V T W L K D G L P (666)
TTGCCCAAAAGAAGTGTGACCACTGTGAAGGATGGCCTCACCCAGCTTCTGATTCCTGTAGCTAGCCTCTCAGAC 2075
L P K R S V T T V K D G L T Q L L I P V A S L S D (691)
TGTGGCCGATACACGGTGAGGCTGAGGAACCTACAGGGAAAGGAAGCCACCTACAGCTTCTTCATCAGTGTGGCA 2150
C G R Y T V R L R N L Q G K E A T Y S F F I S V A (716)
GCATGCCCACAGGCACCGGGTTCCATCTATCTTCAGGAGAATGTGCCTGGGACAGTGACGGTCCAATGGGAACCC 2225
A C P Q A P G S I Y L Q E N V P G T V T V Q W E P (741)
Fd
TCTCCGGATGAGGCTCAGGGCACCCCCTTGCATTATACAGTGTTGATGCGGTCCTCATCTCACGGATCCTGGCAT 2300
S P D E A Q G T P L H Y T V L M R S S S H G S W H (766)
GAGGTGGCCGACTATGTCCGCACCAACCGCTTTACCCTCCTAGGGGTCCTCCCTGGCCATGAGTATCACTTCCGG 2375
E V A D Y V R T N R F T L L G V L P G H E Y H F R (791)
GTGCTGGCCAAGAATGAGCTGGGGCCAGCAAACCTTCAGACACCAGCCAACCCTGGTGTATCCCCAGGCAGAGA 2450
V L A K N E L G A S K P S D T S Q P W C I P R Q R (816)
GACAGGTTCTCAGTGAAGTCTCCAACCTACCGGGAACCTGACCTGAGCCAGAAACCCCGCTTCCTGGTGGGTCTG 2525
D R F S V K S P T Y R E P D L S Q K P R F L V G L (841)
AAA Id
CGGGCTCACCTTCTGCCCCAGGGCTGCGAGTGCCGCATGACCTGCGCGGTGCAGGGCTCACCCCAGCCCCAAGTC 2600
R A H L L P Q G C E C R M T C A V Q G S P Q P Q V (866)
ACCTGGTTCAAGAACGACCAAAGCTTGGACAGCAACCCTGCGATGTACAGCACCGACTTGCTGGGTGTGTGCTCC 2675
T W F K N D Q S L D S N P A M Y S T D L L G V C S (891)
CTCATCATCCCCAGCGTGTCCCCTAAGGACAGTGGCGAATACAAGGCCGTGGCCAAAAACCCACTCGGACAAGCC 2750
L I I P S V S P K D S G E Y K A V A K N P L G Q A (916)
ATCAGCACAGACACCCTCATCGTCACAGAATACAACTCCTAGTCCACTGGATCTGCAATGCTAGCCTTGCCCCAC 2825
I S T D T L I V T E Y N S * (929)
CCTTCAGCTATGAGATGGATTGCAGACCTCTGAAGCTTTGCTCCTGATACCCACACTGACCTGGGGAGCAGTCCA 2900
GCATGACAGGAAATGTTCCAGGGTGAGACAGGAACAAGGGGGCTTCTGGTGAGAGTGACCAGAAGGGCTGAAGTC 2975
CTTGGAGAAGAAATAGAAGAAGAGTGGAGGATGTAGCCTGGAGCTGAATGAAGGCTTGGAGTGACCCTGTTCCTG 3150
TTCTTTGTTCTGCACCTCTGGAGGAGCTCCAGAGAGAGTGGTCCACAGGGTGGAAACTGAGCCCACAGTGACCCC 3225
AGGAATGGAAAGTCATAGAGCAGAGGGCCTGGGTGAGGGCACCAAGGGGAGGCACTGTCTGTACTTC T 3300
GACAAGCAACTGAAGGTG(A)N 3318
Figure 4.18. Organization and alignment of DEN1 repeats.
A. The arrangement of fibronectin type Ill (open boxes) and immunoglobulin C2 (shaded
boxes) motifs in the carboxy terminus of DEN1 is illustrated. B. The alignment of DEN1
FnlI and Ig repeats with respect to each other and the FnIl and Ig consensus sequences
from titin and twitchin are shown. Amino acids which are shared in three of the four
DEN1 repeats, or amino acids which are shared with the repeat consensus sequences in
titin and twitchin, are shaded. Gaps have been introduced to optimize alignments, and
dashes in the titin and twitchin consensus sequences represent non-conserved amino
acids.
Among the DEN1 FnIII and Ig repeats, amino acid identities range from 32% ( Fa
versus Fb) to 21% (Fa versus Fc and Fc versus Fd) among the FnIl motifs and from 27%
(Ib versus Ic) to 16% (Ia versus Ic) among the Ig motifs. Within each class of DEN1
domain, several amino acids are conserved in all four copes of the motifs, and often these
same amino acids are conserved also within the FnIII and Ig consensus sequences of
other muscle structural proteins. The FnlI and Ig repeats in the DEN1 C-terminus are
more similar to FnIII and Ig repeats of other thick filament associated muscle proteins,
most notably titin, than with non-muscle proteins containing similar motifs (e.g.
immunoglobins, N-CAM), and the degree of amino acid identity between the DEN1
repeats and individual FnILI and Ig repeats in titin ranged from 22% (Ib) to 38% (Fb).
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Figure 4.19. Restriction map of DEN2 cDNA, and comparison of DEN2, HSP27
and aB-crystallin proteins.
A. Restriction map of the DEN2 1.7 kb cDNA. The length of sequences determined from
internal deletions and subcloning of DEN2 fragments are represented by arrows. The
position of the DEN2 ORF is shaded, and the position of the 217 bp DEN2 cDNA
isolated from the subtractive-hybridization library is shown below the map (thin open
box). Restriction sites: Accl (A); BamH1 (B); EcoR1 (E); Kpnl (K); Ncol (Nc); Ndel
(Nd); Pstl (P); Sall (S); Xbal (X). B. Comparison of DEN2 amino acid sequence with
HSP27 (top) and aB-crystallin (CRY - bottom). Amino acids shared between DEN2 and
HSP27 or DEN2 and aB-crystallin are shaded. Gaps were introduced to optimize the
alignment, and are indicated with dashes.
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Chapter 5.
AML1 Is Expressed in Skeletal Muscle and
Is Regulated by Innervation
The work described in this chapter has been published in:
Zhu, X., Yeadon, J. E., and Burden, S. J. (1994) AML1 is expressed in skeletal muscle
and is regulated by innervation. Mol. Cell. Biol. 14, 8051-8057.
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SUMMARY
Although most skeletal muscle genes are expressed at similar levels in
electrically active, innervated muscle and in electrically inactive, denervated muscle, a
small number of genes, including those encoding the acetylcholine receptor, N-CAM
and myogenin, are expressed at significantly higher levels in denervated than in
innervated muscle. The mechanisms that mediate electrical activity-dependent gene
regulation are not understood, but these mechanisms are likely to be responsible, at least
in part, for the changes in muscle structure and function that accompany a decrease in
myofiber electrical activity. To understand how muscle activity regulates muscle
structure and function, I used a subtractive-hybridization and cloning strategy to identify
and isolate genes that are expressed preferentially in innervated or denervated muscle.
One of the genes which we found to be regulated by electrical activity is the recently
discovered acute myeloid leukemia 1 (AML1) gene. Disruption and translocation of the
human AML1 gene is responsible for a form of acute myeloid leukemia. AML1 is a
DNA binding protein, but its normal function is not known and its expression and
regulation in skeletal muscle was not previously appreciated. Because of its potential
role as a transcriptional mediator of electrical activity, we characterized expression of
the AML1 gene in innervated, denervated and developing skeletal muscle. We show that
AML1 is expressed at low levels in innervated skeletal muscle and at 50 to 100-fold
greater levels in denervated muscle. Four AML1 transcripts are expressed in denervated
muscle, and the abundance of each transcript increases after denervation. We
transfected C2 muscle cells with an expression vector encoding AML1, tagged with an
epitope from hemagglutinin, and we show that AML1 is a nuclear protein in muscle.
AMLi dimerizes with core binding factor p (CBF p), and we show that CBF P is
expressed at high levels both in innervated and denervated skeletal muscle. PEBP2a,
which is structurally related to AML1 and which also dimerizes with CBF P, is
expressed at low levels in skeletal muscle and is up-regulated only weakly by
denervation. These results are consistent with the idea that AML1 may have a role in
regulating gene expression in skeletal muscle.
INTRODUCTION
Vertebrate neuromuscular synapses arise as a result of complex interactions
between motor neurons and developing skeletal muscle cells (Hall and Sanes, 1993).
One of the more striking specializations of the neuromuscular synapse is the remarkable
concentration of acetylcholine receptors (AChRs) in the postsynaptic muscle membrane
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(Hall and Sanes, 1993; Jennings and Burden, 1993). Experiments designed to determine
how AChR expression is regulated have revealed that a combination of three separate
mechanisms mediate the clustering of AChRs at synaptic sites. First, motor neurons
synthesize and deposit agrin in the synaptic basal lamina, where it induces a
redistribution of non-synaptic AChRs to the newly formed synapse (Anderson and
Cohen, 1977; McMahan, 1990; Nastuk and Fallon, 1993). Second, an unknown factor,
which like agrin is deposited into the synaptic basal lamina and which is presumably
synthesized by motor neurons, activates a signaling pathway leading to transcription of
AChR genes selectively in nuclei near the synaptic site (Burden, 1993). Finally, nerve-
induced muscle electrical activity represses AChR transcription throughout the muscle
fiber, decreasing the number of AChRs expressed in the non-synaptic region (Hall and
Sanes, 1993; Jennings and Burden, 1993).
The molecular mechanisms that mediate electrical activity-dependent regulation
of AChR genes are unknown, but a clearer view of the electrical activity-dependent
signaling pathway is beginning to emerge (Huang et. al, 1992; Laufer and Changeux,
1989; Tang et al., 1994). Recent studies demonstrate that a binding site (E-box) for
myogenic basic helix-loop-helix (bHLH) proteins in the AChR 8 subunit gene is critical
for activity-dependent gene regulation, and these results suggest that an E-box binding
protein(s) is directly involved in electrical activity-dependent regulation of the 8 subunit
gene (Tang et al., 1994). Because the level of mRNAs encoding myogenic bHLH
proteins rises substantially following denervation (Duclert et al., 1991; Eftimie, et al.,
1991; Neville et al., 1992; Voytik et al., 1993; Witzemann and Sakmann, 1991), these
proteins may directly mediate the increase in AChR expression in denervated muscle by
binding to the AChR regulatory region (Jennings and Burden, 1993). Nevertheless,
electrical activity-dependent regulation of the AChR subunit genes may be controlled by
transcription factors in addition to E-box binding proteins, and expression of other genes
that are regulated by electrical activity may be controlled by other pathways and
transcription factors. Thus, it remains unclear whether E-box binding proteins are the
only transcriptional mediators of electrical activity-dependent regulation.
In addition to its role in repressing AChR gene expression, nerve-induced muscle
activity has been implicated as a regulator of other steps in the formation and maturation
of synapses. For example, motor neuron survival, motor neuron growth and editing of
initial synaptic connections are affected by nerve-induced muscle activity (Hall and
Sanes, 1993). To understand how muscle activity regulates muscle structure and
function, we used a subtractive-hybridization and cloning strategy to identify and isolate
genes that are expressed preferentially in innervated or denervated muscle. We
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identified several genes that are expressed preferentially in denervated muscle and one
gene that is expressed preferentially in innervated muscle. One of the genes that we
found to be regulated by electrical activity is the recently discovered acute myeloid
leukemia 1 (AML1) gene (Miyoshi et al., 1993).
Disruption and translocation of the human AMLI gene is responsible for a form
of acute myeloid leukemia (Erickson et al., 1992; Miyoshi et al., 1993). AML1 is a
DNA-binding protein, containing a DNA-binding region homologous to the Drosophila
runt protein (Bae et al., 1994; Daga et al., 1992; Erickson et al, 1992; Kania et al., 1990).
The normal function of AML1, however, is not known and its expression and regulation
in skeletal muscle was not previously appreciated. AML1 is thought to dimerize with
core binding factor 3 (CBF P) (Ogawa et al., 1993a; Ogawa et al, 1993b; Wang et al.,
1993), and translocations in the P subunit gene likewise cause acute myeloid leukemia
(Liu et al., 1993). The AML1/CBF P heterodimer was purified independently on the
basis of its ability to bind core sequences (Speck and Baltimore, 1987; Wang and Speck,
1992), which are important for viral pathogenesis, in murine leukemia virus enhancers
(Hallberg et al, 1991; Speck et al., 1990). Because of its potential role as a
transcriptional mediator of electrical activity, we characterized expression of the AML1
gene in innervated, denervated and developing skeletal muscle.
MATERIALS AND METHODS
RNA analysis
RNase protection assays were performed as described previously (Wang et al.,
1993). Briefly, antisense RNA was hybridized with total RNA (Chomczynski and
Sacchi, 1987) in hybridization buffer overnight at 420C. Non-hybridized RNA was
digested with RNase (A and Tl) for 1 hour at 300C. Following proteinase K digestion
and phenol extraction, the protected RNA was precipitated by ethanol and fractionated
in 5% denaturing polyacrylamide gels.
mRNA was purified by oligo-dT cellulose chromatography (Aviv and Leder,
1972), electrophoresed in a 1% formaldehyde agarose gel and transferred to a
GeneScreen (Du Pont) membrane. DNA probes were labelled by random-hexamer-
priming. The membranes were hybridized overnight in 5XSSPE, 5X Denhardt's
solution, 0.1% SDS, and 100 gLg/ml salmon sperm DNA at 680C. The filter was washed
in 0.1% SDS, 0.1XSSPE for 1 hour at 68 0C and exposed for 2 days with an intensifying
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screen. Northern blots and RNase protection assays were quantitated with a
PhosphorImager.
Epitope-tagging ofAML1
The hemagglutinin (HA) epitope-tag was added to the carboxyl terminus of
AML1 by PCR. The HA-tagged AML1 cDNA was inserted into a myosin light chain
vector (MDAF, kindly provided by Dr. J. P. Merlie). Mouse C2 cells were grown and
transfected as described previously (Simon and Burden, 1993). Pooled stably
transfected cells were stained with a monoclonal antibody (9E10) against the HA
epitope; the 9E10 hybridoma cell line was obtained from ATCC.
Site-directed mutagenesis
The AChR 8 subunit 5' regulatory sequence, -840/+25, was mutagenized by site-
directed mutagenesis (Simon and Burden, 1993). The mutations were confirmed by
sequencing, and the mutated regulatory sequence was subcloned into pOhGH (Selden et
al., 1986). AChR 8-hGH and pSV2-CAT plasmids were co-transfected into C2
myoblasts, the amount of hGH secreted from myotubes was determined by a
radioimmunoassay 4 or 5 days after transfection and the amount of secreted hGH was
normalized to the level of CAT activity (Simon and Burden, 1993). Duplicate dishes
were included in each experiment; expression from duplicate dishes varied by less than
20%.
Electrophoretic mobility-shift assay
AML1-binding to wild-type and mutated sequences was assayed by an
electrophoretic mobility-shift assay (Wang et al., 1993). Oligonucleotides were end-
labelled and purified with a Biospin-3 column (Biorad), and AML1/CBF P proteins were
translated in reticulocyte lysates (Promega).
The GenBank/EMBL accession number for the rat AML1 sequence is L35271.
RESULTS
AML1 expression increases following denervation.
We isolated several cDNA fragments encoding the rat homologue of human
AMLi from our denervated minus innervated muscle library, and we used the cDNA
fragment to isolate a cDNA encoding full-length AML1 protein from a rat skeletal
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muscle library. The 1.98 kb cDNA contains an ORF of 1.35 kb that encodes a 48.5 kDa
protein (Fig. 5.1) which is highly homologous to human (99%) and mouse (99%) AML1
(Bae et al., 1993) and less homologous (82%) to the related mouse protein, PEBP2a
(Ogawa et al., 1993b). The rat cDNA encodes an AML1 protein that is identical in
length to the mouse AML1 protein but longer than the human AML1 protein.
To confirm that AML1 expression is regulated by innervation, we measured the
level of AML1 mRNA in innervated and denervated muscle by an RNase protection
assay. Figure 5.2 shows that AML1 is expressed in rat skeletal muscle and that AML1
expression increases substantially (50- to 100-fold) following denervation.
Because Schwann cells and other perisynaptic cells respond to denervation
(Brocks, 1984; Gatchalian, et al., 1989; Reynolds and Woolf, 1992), we considered the
possibility that perisynaptic cells, rather than muscle cells, accounted for the increased
AML1 expression in denervated muscle. Muscle can be conveniently dissected into a
synaptic region, containing perisynaptic cells, and a non-synaptic region, lacking
perisynaptic cells (Merlie and Sanes, 1985). We dissected the synaptic and non-synaptic
regions of innervated and denervated skeletal muscle and measured the level of AML1
expression in each region. Figure 5.3 shows that AML1 expression in the non-synaptic
region increases 50 to 100-fold following denervation. Because non-synaptic regions of
muscle lack Schwann cells and other perisynaptic cells, this result indicates that muscle
fibers are the predominant source of AML1 RNA in denervated muscle.
Although AML1 is expressed at similar levels in synaptic and non-synaptic
regions of innervated muscle, AML is expressed preferentially in the synaptic region of
denervated muscle (Fig. 5.3). We do not know the cellular source of the preferential
AML1 expression in the synaptic region of denervated muscle; AML1 expression may be
greater in the synaptic than the non-synaptic region of denervated muscle fibers and/or
AML1 expression may also increase in Schwann cells or other perisynaptic cells
following denervation.
The distribution of AML1 expression in different tissues has received little
attention. Both B-cell lines and T-cell lines express multiple AML1 transcripts (2.1, 4.3,
5.4, 8.2 kb), although the rank order of their abundance differs among different cell lines
(Bae et al., 1993; Miyoshi et al., 1991). Although little is known about the different
transcripts, there is evidence that the different transcripts encode different proteins (Bae
et al., 1994). Four AML1 transcripts, which are similar in size to those in B-cell lines
and T-cell lines, are expressed in denervated skeletal muscle, and the abundance of each
transcript increases following denervation (Fig. 5.4). The predominant AML1 transcripts
in denervated skeletal muscle are -7.0 and 6.3 kb long.
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We measured the time course of AML1 expression following denervation using
an RNase protection assay. A two-fold increase in AML1 expression is detectable by 1
day after denervation, and a 50- to 100-fold increase is detectable by 5 days after
denervation (Fig. 5.4). The increases in AChR and N-CAM expression following
denervation follow a similar time course (Covault et al., 1987; Merlie et al., 1984),
whereas the increase in myogenin expression precedes that of the other genes (Duclert et
al., 1991; Eftimie et al., 1991; Neville et al., 1992; Voytik et al., 1993; Wilson et al.,
1984).
Although most skeletal muscle genes are expressed at similar levels in fast and
slow muscle fibers, a subset of muscle genes are expressed preferentially in certain fiber
types (Atomi et al., 1991; Donoghue et al., 1991; Hughes et al., 1993; Pette and Staron,
1990; Schiaffino et al., 1989; Voytik, et al., 1993). To determine whether AML1 is
expressed preferentially in fast or slow myofibers, we measured the abundance of AML1
RNA in innervated and denervated rat soleus (slow) and extensor digitorum longus
(EDL) (fast) muscles. Figure 5.6 shows that AML1 is expressed at similar levels in rat
soleus and EDL muscles and that denervation causes a 50- to 100-fold increase in AML1
expression in both slow and fast muscles. Thus, the regulation of AML expression is
similar in slow and fast muscles.
Many genes that are expressed in skeletal muscle are expressed at low levels in
myoblasts and at significantly higher levels following myoblast fusion and muscle
differentiation. To determine whether AML1 is induced during muscle differentiation,
we measured AML1 expression in C2 myoblasts and myotubes. Figure 5.7 shows that
expression of AML1 is not up-regulated during muscle differentiation. Indeed, the level
of AML1 expression is similar in myoblasts, embryonic myotubes and denervated adult
muscle (Fig. 5.7).
CBF 0 and PEBP2a mRNAs are expressed in skeletal muscle.
AML1 is thought to complex with a second protein, termed CBF P, and the
heterodimer, CBF, has a higher affinity for an AML1 binding site (see below) than
AML1 alone (Ogawa et al., 1993a; Ogawa et al., 1993b; Wang et al., 1993). Therefore,
we determined whether CBF P is expressed in skeletal muscle. Figure 5.8 shows that
CBF P RNA is expressed in skeletal muscle (Wang et al., 1993). CBF P is more
abundant than AML1 in innervated muscle, but CBF P expression increases little
following denervation. As a consequence, CBF p and AML1 are expressed at similar
levels in denervated muscle.
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PEBP2a is structurally related to AML1 and contains a runt homology region
(Ogawa et al., 1993b), but its expression is thought to be restricted to T cells, where it
can function as a transcriptional activator (Ogawa et al., 1993b). To determine whether
PEBP2a is expressed in skeletal muscle, we measured the level of PEBP2a RNA in
innervated and denervated muscle. Figure 5.8 shows that PEBP2a is expressed at low
levels in innervated skeletal muscle and at -4-fold greater levels following denervation.
CBF was purified from thymus nuclear extracts on the basis of its ability to bind
core sites in viral enhancers (Kamachi et al., 1990; Wang and Speck, 1993). To
determine whether AML1 is a nuclear protein in skeletal muscle, we transfected an
expression vector encoding AML1, tagged with an epitope from HA, into C2 muscle
cells and located the epitope-tagged protein by immunofluorescence. Figure 5.9 shows
that AML1 expression is restricted to the nuclei of myoblasts and myotubes. Thus,
AML1 is a nuclear protein in muscle.
The cis-acting region of the AChR 8 subunit gene that confers regulation by electrical
activity lacks a functional binding site for AML1/CBF D.
A consensus binding site for CBF has been determined by site-selection assays
(Melnikova et al., 1993). The regulatory region of the AChR 8 subunit gene, which
confers innervation-dependent regulation (Tang et al., 1994), lacks this consensus
sequence but contains a sequence which deviates from the consensus sequence by a
single nucleotide.
We used recombinant AML1/CBF f, synthesized in vitro, to determine whether
this variant sequence binds AML1. Figure 5.10 shows that AML1 and AML1/CBF P
bind the variant sequence in the 8 subunit regulatory region but with a 30-fold lower
affinity than the consensus CBF target sequence.
To determine whether the weak AML1-binding sequence is required for 8
subunit gene expression, the AML1-binding site (AACCACC) in the AChR 8-subunit
regulatory region (positions -31 to -25) was mutagenized to generate either a
nonfunctional (AACGTCC) or a consensus (AACCACA) binding sequence for AML1
(Melnikova et al, 1993). Gene fusions between hGH and wild-type or mutated AChR 5-
subunit sequences (nucleotides -840 to +25) were transfected into C2 myoblasts, and
hGH expression was measured as described in Materials and Methods. We found that a
mutation which prevents AML1/CBF p binding has little or no effect on 8-subunit
expression in cultured myotubes. Moreover, mutation of the weak AML1-binding
sequence to a consensus AML1-binding sequence has little or no effect on 8 subunit
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expression. These results indicate that the weak AML1-binding sequence is not a target
for AML1-mediated transcriptional activation in myotubes grown in cell culture.
DISCUSSION
We show that AML1 is expressed in skeletal muscle and is regulated by electrical
activity. Although previous studies had shown that AML1 is expressed in 3T3 cells, B-
cell lines and T-cell lines, expression of AML1 in other cell types and tissues had not
been examined. Our results demonstrate that AML1 expression is not restricted to the
hematopoetic lineage; rather, AML1 is expressed in skeletal muscle where it is regulated
by physiological signals.
Alternative splicing of AML1 RNA results in four transcripts of different sizes.
We found that the level of all four AML1 transcripts increases in response to
denervation. Although little is known about the different transcripts, the different
transcripts encode different proteins which may have different functions (Bae et al.,
1994; Bae et al., 1993; Meyers et al., 1993; Miyoshi et al., 1991). Indeed, others have
speculated that certain isoforms of AML1 may bind DNA and activate transcription
whereas other isoforms may bind DNA but repress gene expression (Meyers et al.,
1993).
Since translocations involving either AML1 or the CBF P subunit gene lead to
leukemia, one might predict that AML1 might participate in regulation of cell growth or
differentiation. Our data, however, does not support the idea that AML1 regulates
proliferation during muscle differentiation, since AML1 is expressed at similar levels in
both proliferating myoblasts and in differentiated myotubes grown in cell culture. Our
studies, however, do not address the possibility that AML1 might be regulated post-
transcriptionally during muscle differentiation or that AML1 might regulate muscle
growth later in development.
It is not clear how the t(8;21) DNA rearrangement, which results in a fusion
between the AML1 and ETO genes, causes leukemia. Since AML1 can bind to target
sequences in the T-cell receptor P enhancer and activate transcription (Bae et al., 1994),
it is possible that the gene fusion disrupts the normal transcriptional activity of AML1
and that the function of wild-type AML1 is inhibited by the mutant AML1 protein in a
dominant negative manner (Bae et al., 1994; Miyoshi et al., 1993). Alternatively, the
gene fusion could result in a novel transcriptional activity, which in turn leads to
aberrant gene expression and cell proliferation.
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Some of the muscle genes whose expression is repressed by electrical activity,
such as AChR subunit genes and N-CAM, are also locally expressed or concentrated in
the synaptic region. At present, we do not know the distribution of AML1 protein or
mRNA within the muscle fibers. Our experiment to examine the localization of AML1
mRNA by measuring its abundance in dissected synapse-rich and synapse-free muscle
fractions does not provide evidence for the enrichment of AML1 mRNA in the synaptic
region. However, our dissection was relatively crude, the synaptic-rich region we
obtained still contains a vast number of non-synaptic nuclei; therefore, even a very low
level of AML1 expression in the non-synaptic region would mask the mRNA
concentration gradient. A more careful study with in situ hybridization will be
necessary to determine the distribution of AML1 mRNA in muscle.
Muscle genes that are regulated by electrical activity, including those that
regulate muscle atrophy, motor neuron survival, motor neuron growth and editing of
initial synaptic connections are potential targets for AML1. Our data, however,
demonstrate that the AChR 8 subunit gene is not directly regulated by AML1 in
developing muscle, and these results suggest that AML1 does not directly regulate
expression of the AChR 8 subunit gene in response to changes in muscle fiber electrical
activity. If AML1 has a role in electrical activity-dependent regulation of the AChR 8
subunit gene, then AML1 is likely to act indirectly. The target genes for AML1 and the
consequences of increased AML1 expression in muscle may be best examined by
increasing AML1 expression in innervated muscle or decreasing AML1 expression in
denervated muscle.
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Figure 5.1. The complete nucleotide sequence of the rat AMLI cDNA.
The complete nucleotide and encoded amino acid sequence of the 1.98 kb AML1 cDNA
is shown. A TGA stop codon at nt 1726 is indicated by an asterisk. Amino acids are
represented by their single letter abbreviations below the codons encoding them. A
polyadenylation addition site at position 1837 in the 3' untranslated sequence is boxed.
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5' GAATTCTCCAAATCTAGTTTGTTTT 25
TTTTTCTGGTCATTTTTTTTAATTCTGCGCATAAATATTTTAGGACGCATACGGGAATTTTGCCTCCGGGACCGT 100
TTGTAATAGCCAAAGACTGAACTCCAAACTCTGAAAGCGAGGCTCCTTGGGGCATTTGACTTTGAATTCTGGGTT 175
GCCCACTTTTCAATGCACTAAGCGGCCAGTTGCTAACCCTGCCTGGGTGTAAGGCCGATCCGCGTAACTAGATCT 250
CAGTCCTGCTACCCCCACAACCCTCCGGTAGTAATAAAGGCTCCTGAACTTGTATGTTGGTCTCCCGGGAGCAGC 325
TTGCAGAAGATCCGAGTCCCTGTCGCCGTCTAGTAGGAGCTGTTTTCAGGGTCCTTACTCAATCGGCTTGTTGTG 400
ATGCGTATCCCCGTAGATGCCAGCACGAGCCGCCGCTTCACGCCGCCTTCCACTGCGCTGAGCCCCGGCAAGATG 475
M R I P V D A S T S R R F T P P S T A L S P G K M (25)
AGCGAGGCGCTGCCGCTGGGCGCCCCGGATGGCGGCGCCGCAGC 550
S E A L P L G A P D G G A A L A S K L R S G D R S (50)
ATGGTGGAGGTACTAGCTGACCACCCCGGCGAGCTAGTCCGCACCGACAGCCCCAACTTCCTCTGCTCCGTGCTG 625
M V E V L A D H P G E L V R T D S P N F L C S V L (75)
CCCACTCACTGGCGCTGCAACAAGACCCTGCCCATCGCTTTCAAGGTGGTAGCGCTGGGCGACGTTCCGGATGGC 700
P T H W R C N K T L P I A F K V V A L G D V P D G (100)
ACTCTGGTCACCGTCATGGCGGGCAATGACGAAAACTACTCGGCGGAGCTGAGAAACGCCACCGCGGCCATGAAG 775
T L V T V M A G N D E N Y S A E L R N A T A A M K (125)
AACCAAGTGGCGAGATTCAACGACCTCAGGTTTGTCGGTCGGAGCGGCAGAGGCAAGAGCTTCACTCTGACCATC 850
N Q V A R F N D L R F V G R S G R G K S F T L T I (150)
ACCGTCTTTACAAACCCCCCACAAGTTGCCACCTACCATAGAGCCATCAAAATCCACAGTGGACGGCCCGAGAA 925
T V F T N P P Q V A T Y H R A I K I T V D G P R E (175)
CCCCGAAGACATCGGCAGAAACTAGATGATCAGACCAAGCCCGGGAGTTTGTCCTTTTCCGAGCGGCTCAGTGAA 1000
P R R H R Q K L D D Q T K P G S L S F S E R L S E (200)
CTGGAGCAGCTGCGGCGCACGGCCATGAGGGTCAGCCCGCATCACCCAGCCCCCACGCCCAACCCC TCC 1075
L E Q L R R T A M R V S P H H P A P T P N P R A S (225)
TTGAACCACTCCACTGCCTTTAACCCTCAGCCTCAAAGTCAGATGCAGGATGCCAGGCAGATCCAGCCGTCCCCA 1150
L N H S T A F N P Q P Q S Q M Q D A R Q I Q P S P (250)
CCGTGGTCCTATGACCAGTCTTACCAGTACCTGGGGTCCATCACCTCTTCTGTGCACCCGGCGACA TTTCT 1225
P W S Y D Q S Y Q Y L G S I T S S V H P A T P I S (275)
CCCGGCCGAGCCAGTGGCATGACCAGCCTCTCAGCGGAACTTTCCAGTCGACTCTCAACAGCCCCGGACCTGACA 1300
P G R A S G M T S L S A E L S S R L S T A P D L T (300)
GCCTTCGGCGACCCGCGCCAGTTCCCCACGCTGCCGTCCATCTCCGCCCGCCGCATGCACTACCCAGGCGCCTTC 1375
A F G D P R Q F P T L P S I S D P R M H Y P G A F (325)
ACCTACTCGCCTCCTGTCACATCGGGCATCGGCATTGGCATGTCAGCCATGAGCCTCGCCCCGCTACCACACC 1425
T Y S P P V T S G I G I G M S A M S S T S R Y H T (350)
TACCTGCCGCCGCCCTACCCAGGCTCCTCOCAGGCGCAGGCCGGGCCCTTCCAGACCGGCTCGCCCTCCTACCAC 1500
Y L P P P Y P G S S Q A Q A G P F Q T G S P S Y H (375)
CTGTACTACGGCACCTCGGCAGGCTCCTACCAATTCTCCATGGTGGGCGGCGAGCGATCACCCCCGCGCATCCTG 1575
L Y Y G T S A G S Y Q F S M V G G E R S P P R I L (400)
CCGCCCTGCACCAACGCGTCCACCGGAGCCGCGCTGCTCAACCCCAGCCTCCCCAGCCAGAGCGACGTGGTGGAA 1650
P P C T N A S T G A A L L N P S L P S Q S D V V E (425)
ACCGAGGGCAGCCATAGCAACTCGCCCACCAACATGCCACCCGCGCGCCTGGAGGAGGCTGTCTGGCGGCCCTAC 1725
T E G S H S N S P T N M P P A R L E E A V W R P Y (450)
TGAGCGCCTTCGGGGGACTGAGCCCGCCGTCCATGCACAGACCCCGCCAGGAGAGCCCTTGGAGGCCAACAGGAG 1800
GGA A ATGCTTCTGATTTAGTAATGCTGTC GAAAGATTTTATACCCTTGACTTCACTTTTTA 1875
ACCACGTTGTTTATTCCAAAGAGTGTGGAATGTTTTCGGTTCCGGGTGGGGAAGACGCAGCCCATCCTGTTTGGC 1950
ATCTATTTCTTTTCCGCACCTTATTGATTGC (A) 10 3' 1981
Figure 5.2. AML1 expression increases 50 to 100-fold following denervation.
RNA was extracted from 5-day denervated (Den) or contralateral innervated (Inn) rat
lower leg muscle, and the levels of AML1 and actin mRNAs were measured by RNase
protection. The level of AML1 mRNA increases approximately 50- to 100-fold after
denervation. Actin mRNA level remains unchanged.
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Figure 5.3. AML1 expression increases in non-synaptic regions of rat soleus muscle
following denervation.
Innervated (Inn) and 5-day denervated (Den) soleus muscle were dissected into synaptic
(ep+) and non-synaptic (ep-) regions, and the levels of AML1 and actin mRNAs in each
region were measured by RNase protection. AML1, normalized to actin, is expressed at
similar levels in synaptic and non-synaptic regions of innervated muscle; the synaptic
region contains 10-fold more AChR e subunit mRNA than the non-synaptic region.
AML1 is expressed at 5-fold higher levels in the synaptic than non-synaptic region of
denervated muscle.
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Figure 5.4. The level of four AML1 transcripts increases following denervation.
Innervated and denervated rat muscle mRNA (3 Gg) were fractionated by gel
electrophoresis and transferred to a GeneScreen membrane. The filter was hybridized
with a full-length AML1 cDNA probe and exposed for 2 days with an intensifying screen.
Four transcripts (arrowheads), 7.0, 6.3, 3.9 and 3.4 kb in size, are detected in denervated
muscle but not innervated muscle. The level of actin mRNA in innervated and
denervated muscle was similar.
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Figure 5.5. Expression of AMLI and AChR genes increase with a similar time course
after denervation.
Rat lower leg muscles were denervated for 1, 2 or 5 days, and the levels of AML1, AChR
8 subunit, myogenin and actin mRNAs were measured by RNase protection. AML1
expression increases approximately 2-fold one day after denervation, and increases 50- to
100-fold by 5 days after denervation. AChR 8 subunit expression increases in parallel
following denervation. Myogenin expression, in contrast, reaches its highest level after 2
days and therefore, precedes that of AML1 and the AChR 8 subunit gene.
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Figure 5.6. AMLI expression increases in both slow (soleus) and fast (EDL) muscle
after denervation.
The level of AML1 and actin mRNA in innervated and denervated soleus and EDL
muscles were quantitated by RNase protection. The level of AML1 expression is
comparable in denervated slow (soleus) and fast (EDL) muscles.
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Figure 5.7. AML1 is expressed at similar levels in cultured myoblasts and myotubes.
Total RNA was extracted from cultured C2 myoblasts (MB) and myotubes (MT), and the
level of AML1 and actin mRNAs was quantitated by RNase protection. The level of
AML1 mRNA is comparable in C2 myoblast and myotubes.
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Figure 5.8. CBF P and PEBP2a are expressed in skeletal muscle.
CBF P expression increases -2-fold and PEBP2a expression increases -4-fold following
denervation. Total RNA was extracted from innervated and denervated (4-day) mouse
lower leg muscle, and the level of CBF P and PEBP2a mRNAs were measured by RNase
protection.
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Figure 5.9. AML1 is a nuclear protein in muscle.
HA-tagged AML1 and pSV2 neo plasmid DNAs were co-transfected into C2 myoblasts,
and stably transfected cells were selected with G418 (750 gg/ml). Resistant cells were
pooled, induced to differentiate into myotubes and stained with a monoclonal antibody
(9E 10) against the HA epitope (a). Nontransfected C2 myotubes are not stained by the
monoclonal antibody 12CA5 (b).
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Figure 5.10. AML1/CBF p binds weakly to a sequence in the AChR 8 subunit
regulatory region.
AML1/CBF 3 proteins were translated in vitro and incubated with a consensus binding
sequence for AML1 (AACCACA) or with a similar sequence (AACCACC) present in the
AChR 8 subunit regulatory region (-31/-25). 100-fold excess of unlabelled
oligonucleotides were used in competition experiments. The consensus sequence has a
30-fold higher affinity for AML1/CBF P than the -31/-25 sequence in the AChR 8 subunit
regulatory region.
i; ilcdrp.
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